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Abstract 
Glucocorticoids are used therapeutically for their anti-inflammatory and 
immunosuppressive actions. One of the ways they produce their potent effects is via 
regulation of the anti-inflammatory protein Annexin I (ANX-AI; 37 kDa protein). 
Whereas there is sufficient information on the pharmacological properties of ANX-Al 
and its bioactive peptides, as they have been studied in several models of experimental 
inflammation, much less is known about the functions of the endogenous protein. In 
this thesis I have had access to the recently generated ANX-Al knockout (ANX-AI'4-) 
mice with the scope of elucidating the role of the endogenous mediator on the process 
of leukocyte (mainly neutrophil) recruitment. 
Two main models were used to assess leukocyte recruitment: a) a flow cytometry 
protocol was implemented to quantify the extent and the nature of the cellular influx 
into the inflamed peritoneal cavity and b) intravital microscopy of the inflamed 
cremaster muscle was used to identify which step of leukocyte recruitment was 
potentially altered. 
Overall, ANX-A14- mice were found to have a heightened sensitivity to inflammation. 
In the peritonitis model, ANX-AI4- mice displayed a higher degree of neutrophil 
recruitment into the peritoneal cavity, however this occurred in a stimulus specific 
manner. The functional role of the protein in this model was confirmed by using 
transgenic mice that over-express ANX-Al. These mice were shown to have the 
opposite response to the ANX-A14- mice, since they had a reduced influx of neutrophils 
into the peritoneal cavity in response to zymosan. Intravital microscopy studies 
i 
pinpointed the emigration phase of leukocyte recruitment to be significantly altered in 
ANX-AI-1- mice, and this defect was seen with application of different inflammatory 
agents. 
In conclusion, this thesis has demonstrated, for the first time, that there are altered 
leukocyte-endothelium interactions in ANX-Al-- mice, and these results indicate a 
pivotal role for endogenous ANX-Al in the process of neutrophil recruitment that is 
fundamental to the host inflammatory response. 
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Introducti*on 
1. Introduction 
1.1. Inflanunation 
The environment we live in contains a wide range of agents that can cause injury and 
infection to the cells of our body. A variety of microbes including viruses, bacteria, 
fungi, protozoa and parasites as well as physical agents such as bums, radiation, trauma 
or chemicals can cause injury to cells. Our immune system is a defence mechanism 
that has developed to protect us from these pathogens and injuries. The inflammatory 
process is a series of reactions that bring the cells and molecules of the immune system 
from throughout the body to the site of infection or damage. Inflammation appears as 
four cardinal signs; Rubor et tumor cum calore et dolor: redness and swelling with heat 
and pain. Cornelius Celsus first described these in the first century A. D. Later, a fifth 
cardinal sign, functio laesa or loss of function was added by Galen (129-200 AD). 
The inflammatory response begins with the detection of tissue injury or a potential 
cause of injury (e. g. a microbe). Local tissues and cells release chemical signals 
(inflammatory mediators) that bring about a rapid adaptation of the microvasculature. 
Signals can be generated in interstitial fluid from the complement system (C3a and 
C-5a) or from pre-formed stores in tissue cells (histamine from mast cells or 
neuropeptides from nerve cells) or they can be synthesised de novo by cells in response 
to the stimulus e. g. prostaglandins, leukotrienes, platelet activating factor and 
cytokines. Redness and swelling are the first of the cardinal signs that are manifested 
during inflammation due to vasodilation of blood vessels resulting in an increased 
blood supply to the affected area. The major function of vasodilation is to increase the 
2 
downstream supply of leukocytes and plasma protein. The next stage is an increase in 
vascular permeability. This occurs because of the contraction of endothelial cells, 
interruption of the inter-cellular junctions as well as direct and indirect injury to 
endothelium caused by adherent leukocytes. This allows plasma protein and leukocytes 
(white blood cells, WBQ to leave the vessels and enter the surrounding tissues. The 
extravasated fluid overloads the lymphatic clearance system and this is seen as swelling 
(oedema), another of the cardinal signs. There are numerous reasons for this movement 
of fluids and cells into the tissue; the fluid can play a role in diluting toxic factors 
produced at the site of damage and it allows access for important serum proteins 
including components of the complement system and antibodies which promote 
antimicrobial activity. The changes also allow for the next stage of the inflammatory 
process, the migration of leukocytes to the site of inflammation. The accumulation of 
leukocytes in inflamed tissue occurs within the microvasculature and is mainly limited 
to post-capillary venules (Muller, 2003). 
Inflammation can be divided into either acute or chronic. Acute inflammation is 
usually rapid in onset, of short duration and the main cell type involved is the 
neutrophil (polymorphonuclear cell, PMN). It can be characterised by the exudation of 
fluid and plasma proteins which act to eliminate the inflammatory stimulus. This is 
then followed by recovery including tissue regeneration and repair. In some cases 
acute inflammation is not resolved and this leads to chronic inflammation. Sometimes, 
due to the nature of the irritant the inflammation can be chronic from the onset. 
Chronic inflammation lasts longer and the main cells involved are lymphocytes and 
macrophages. In contrast to acute inflammation the inflammation and repair occur 
together and this is often seen as proliferation of blood vessels and fibrosis. 
3 
1.1.1. Inflanunatory CeR Recruitment 
The classical three-step paradigm (Springer, 1994) of inflammatory cell recruitment are 
the steps of cell rolling, adhesion and en-ýigration. Once the cells have traversed the 
endothelium they must penetrate the basement membrane and finally migrate through 
the sub-endothelial matrix and the interstitial space towards the site of inflammation. 
Complex interactions between the circulating blood cells and the endotheliurn are 
critical in this process and mediate each of the different stages of the recruitment 
process. Cell adhesion molecules (CAM's) expressed on both circulating cells and 
endothelium are involved in this process and include the selectins, integrins and 
members of the immunoglobulin superfamily, all of which will be explained in detail in 
the following sections. Figure 1.1. is a simple summary showing the events that occur 
during leukocyte recruitment which will also be described in detail in the following 
sections. 
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Figure I. I. LeukocYte Recruitment. An inflammatory stimulus causes cells to roll, 
become activated, adhere and emigrate out of post-capillary venules where they can 
migrate towards the source of inflammation. 
Margination 
The increase in permeability of blood vessels leads to slowing of the circulation. As 
fluid moves out of the blood vessel to the extravascular space it leaves the blood in the 
vessel more concentrated and so it moves more slowly. This is described as stasis. The 
haemodynamic forces occurring when leukocytes exit small capillaries leading into 
larger post-capillary venules causes leukocytes to move to a position closer to the 
endothelial surface. This process is known as margination. This is recognised to be due 
to the interaction of leukocytes with the erythrocytes (red blood cells, RBQ travelling 
in a central column in normal blood flow (Nobis et al., 1985; Schmid-Schonbein et al., 
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Blood vessel lumen 
1980). So, the erythrocytes push the leukocytes to the outside favouring interaction 
with the vessel wall. 
Tetheting and Rolling 
If the right cellular conditions exist, leukocyte margination will lead to the initial 
contacts between these cells and the activated endothelium. These interactions 'tether' 
the leukocyte to the endothelium. These interactions are due to an expression of a 
family of CAM's known as the selectins. 
Selecting are a family of three related lectin-like carbohydrate-binding molecules that 
are known to mediate leukocyte tethering and rolling on endothelium. A selectin 
molecule consists of an NH2-terminal sugar-binding domain, an epidermal growth 
factor like region, a variable number of consensus repeats, a membrane spanning region 
and a short cytoplasmic tail. L-selectin is expressed by leukocytes, E-selectin is 
expressed by endothelial cells and P-selectin is expressed by endothelial cells and 
platelets (Rosen, 1993). 
Selectin mediated cell capture initiates the interaction between leukocytes and 
endothelium and leads to rolling (Ley & Tedder, 199.5). P-selectin is located in the 
membrane of Weibel-Palade bodies found in endothelial cells, and also in platelet a- 
granule membranes. On activation with pro-inflammatory mediators such as histamine, 
these organelles are rapidly translocated so they fuse with the plasma membrane and P- 
selectin is displayed on the surface of the cell (Geng et al., 1990). For example, early 
leukocyte rolling (0-60 min) in the cremaster is dependent on P-selectin. This has been 
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demonstrated using antibodies that block P-selectin (Nolte et al., 1994) and P-selectin 
knockout mice (Ley et al., 1995). Histamine release from mast cells is responsible for 
the 'baseline rolling' that is seen during intravital microscopy experiments. Surgery 
induces trauma that causes degranulation of mast cells and this leads to expression of P- 
selectin by the endothelium. Consequently, treatment with a mast cell stabilizer 
markedly reduces trauma-induced cell rolling (Kubes & Kanwar, 1994). Besides 
histamine, P-selectin expression on endothelium can be activated by a number of other 
mediators such as thrombin (Sugama et al., 1992) and oxygen radicals (Patel et al., 
1991). As well as rapid translocation of P-selectin to the cell surface from intracellular 
stores expression of this CAM can also be transcriptionally up-regulated by cytokines 
such as TNF-a (Weller et al., 1992) such that a more sustained P-selectin expression 
occurs. Once P-selectin has been displayed on the endotbelial cell surface, it is 
internalised to storage granules where it can be reused (Hattori et al., 1989; 
Subramaniam et al., 1993). 
E-selectin is also important in the leukocyte-rolling phenomenon. This has been 
established by the use of E-selectin blocking antibodies which could prevent interleukin 
IP (IL- I P) -induced rolling after 4 hr in rabbit mesenteric venules (Olofsson et al., 
1994). E-selectin is found on activated endothelial cells, mainly of the post-capillary 
venules. Whereas P-selectin is preformed and translocated to the cell surface on 
activation, E-selectin requires de novo synthesis of mRNA and protein and this can be 
induced by cytokines and other stimuli. IL-lp and tumour necrosis factor ct (TNF-(X) 
are capable of mediating this stimulation such that E-selectin is expressed 4-6 hr after 
treatment (Bevilacqua et al., 1987). E-selectin is eventually internalised and 
transported to lysosomes for degradation (Subramaniarn et al., 1993). 
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L-selectin is constitutively expressed by most leukocytes and also participates in the 
adhesion of leukocytes to vascular endothelium as shown by the use of L-selectin 
blocking antibodies (Ley et al., 1991; von Andrian et al., 1991). Through the use of L- 
selectin knockout mice it has been shown that L-selectin rolling is mainly important at 
the later time-points (60-120 min) of surgery-induced rolling in the cremaster muscle 
where it acts in concert with P-selectin to produce rolling (Ley et al., 1995). L-selectin 
rolling is important in cytokine (TNF-a) induced rolling, a condition in which P- 
selectin has been shown to have no role (Ley et al., 1995). Once cells are activated L- 
selectin can be shed from the cell surface, for example, after activation with 
chemokines (Kishimoto et al., 1989). A metalloproteinase (L-selectin sheddase) is 
responsible for this shedding although the actual molecule involved has not yet been 
identified (Preece et al., 1996). The sheddase cleaves L-selectin at a membrane- 
proximal site releasing a large soluble extracellular fragment and also a small 
transmembrane peptide fragment (Kahn et al., 1994). 
The ligands for selectins are composed of a carrier molecule (glycoprotein or 
glycolipid) modified by specific glycosylation enzymes with certain oligosaccharides. 
It is the oligosaccharides that are the ligands for the selectins. All three selectins bind 
to the tetrasaccharide sialyl Lewis x (sLe), its isomer sialyl Lewis a (sLe) and other 
related oligosaccharides when assembled and presented on carrier molecules (McEver 
& Cummings, 1997; Vestweber & Blanks, 1999). An important molecule which 
presents selectin ligands is P-selectin glycoprotein ligand I (PSGL-1) (Moore et al., 
1992). PSGL, 1 is found on both leukocytes (Moore el al., 1995) and platelets (Frenette 
et al., 2000). PSGL-1 has been shown to mediate rolling in vivo (Norman et al., 1995) 
as the use of blocking monoclonal antibody (mAb) against PSGL-1 can significantly 
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reduce the rolling of human neutrophils in the rat mesentery. PSGL-1 is also a ligand 
for E-selectin and L-selectin (Asa et al., 1995; Spertini et al., 1996). E-selectin ligand 
1 is a another major ligand for E selectin that has been found on mouse myeloid cells 
and mediates the binding of these cells to E-selectin (Steegmaier et al., 1995). 
The bonds formed between selectins and their ligands are not of sufficient strength to 
support firm adhesion of leukocytes. This is due to the both to the nature of the bonds 
and the force of the blood flow acting on them (Granger & Kubes, 1994). As a result, 
the bonds are continuously broken and reformed leading to rolling of leukocytes along 
the endothelium. Once a leukocyte begins rolling it is able to sample the local 
environment and, if the appropriate signals (i. e. chemokines, CAM expression) are 
present, then the cell may roll more slowly and eventually firmly adhere. If the local 
environment does not exhibit the appropriate signals, rolling cells can detach and return 
to the main blood flow (Lim et al., 1998; Mancuso et al., 1995; Umeno et al., 1990) 
Activation 
During the rolling phenomenon leukocytes are brought into close contact with the 
endothelium. As the rolling leukocytes are in closer contact with the endothelium. they 
can 'sample' the molecules displayed to them. Activated endothelial cells at the site of 
an inflammatory insult can produce chemoattractants which are either secreted into the 
blood vessel or held on the endothelial surface in the blood vessel lumen. If suitable 
chemoattractants are displayed then this can lead to activation of the leukocyte. 
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Leukoeyfe chemoattroctant :A chemoattractant is any chemical that attracts cells to 
move towards it. It will usually be a soluble molecule that can diffuse from its source 
where its concentration will be at its highest. A cell can then follow the gradient from 
lowest concentration to highest, to seek out the source of the chemoattractant. For 
directional migration to occur, cells must be able to sense the concentration difference, 
often as little as 1%, between the leading and trailing edge of the cell. A variety of 
chemoattractants exist and some of these will be described in more detail in the 
following section 
Platelet-activating factor (PAF) is a lipid mediator generated by stimulated cells (e. g. 
neutrophils, monocytes and endothelial cells) by the enzyme phospholipase A. (PLA. ), 
PL-A. mobilizes phospholipids in cell membranes and converts them to arachidonic acid 
and a PAF precursor, lyso-PAF. The latter is then acetylated to PAF by acetyl- 
transferases (Rang et al., 2003). PAF can be produced by endothelial cells in response 
to agonists such as thrombin (Zimmerman et al., 1990) and IL- 1P (Nourshargh et al., 
1995) and then retained on the cell surface where it can induce responses in target cells 
by binding to specific receptors (Hwang, 1988). It has been shown to be a 
chemoattractant for neutrophils, monocytes and eosinophils. 
Leukotriene B4 (LTB4) is an arachidonic acid metabolite formed by the lipoxygenase 
pathway during activation of a variety of cells at the site of inflammation (including 
mast cells, basophils and macrophages) and is a chernotactic agent for neutrophils, 
monocytes, eosinophils and lymphocytes. 
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C5a originates during complement activation at the site of inflammation. Proteolysis of 
the C5 complement protein gives rise to a small peptide fragment, C5a, which is 
chernotactic for neutrophils, monocytes and macrophages and can cause basophils and 
mast cells to degranulate. 
Formyl-Met-Leu-Phe (fMLP) is an N terminal formylated peptide that originates from 
prokaryotes. Prokaryotes (e. g. bacteria) initiate all protein translation with this 
formylated methionine and so this is considered to be a signal of bacterial presence. 
fMLP is a potent chemoattractant for neutrophils, monocytes and eosinophils (Marasco 
et aL, 1984) due to binding to its receptor. 
Chemokines are a group of at least 40 chernotactic cytokines. They are small, 
homologous, 8 to 10 kDa polypeptides that have specificity for leukocyte subsets. 
Chemokines are arranged into four families with a- (CXC) and P- (CC) chemokines 
being the largest families and the basis of division being the relative position of the 
cysteine residues. Both a and A chemokines have 4 cysteine residues in their amino 
acid sequence. In a-chemokines the first two cysteine residues are separated by 
another amino acid (cysteine-X amino acid-cysteine). In P-chemokines the first two 
cysteine residues are adjacent. The a chemokines tend to act on neutrophils whereas 
the P chemokines tend to act on monocytes and other WBC (Adams & Lloyd, 1997; 
Luster, 1998). Chemokines can be released at inflammatory sites along with pro- 
inflammatory cytokines. They can be held in a gradient, most concentrated at the 
source by binding in the tissue to matrix heparan sulphate proteoglycans. Pro- 
inflammatory cytokines, such as ILA and TNF, as well as lipopolysaccharide (LPS) 
and viral infection stimulate the release of chemokines by the endothelial cells into the 
blood vessel lumen adjacent to the inflammatory site (Baggiolini et al., 1994). 
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Chemoattractants such as chemokines induce cell activation and migration by binding 
to specific G-protein coupled cell-surface receptors on target cells (Premack & Schall, 
1996). The binding of chemoattractant receptors can trigger the leukocyte to begin a 
signalling cascade to activate integrins on the leukocyte. This signalling is via the 
cytoplasmic tail of the integrin and so is known as 'inside out' signalling. This is 
thought to provide the signals that convert non-functional integrin molecules into 
functional, binding molecules switching the selectin-mediated rolling to the stronger 
adhesion mediated by integrins (Luster, 1998). The increased avidity of the cell 
integrins will in turn increase binding (Johnston & Butcher, 2002). 
The specificity of chemoattractants is regulated by the cellular distribution of their 
receptors on leukocytes. The receptors for certain chemoattractants, for example, 
fMLP and PAF receptors are found on both neutrophils and monocytes. However, the 
chemokine receptors, CXC chemokine receptors (CXCR1-CXCR4) and CC chemokine 
receptors (CCRI-CCR8) are differentially distributed. For example, CXCRI is found 
predominantly on neutrophils whereas CCR2 is not found on neutrophils but mainly on 
monocytes and basophils (Luster, 1998). Therefore, the cell type specifically recruited 
depends on the chemokines displayed by endothelial cells and the corresponding 
receptors being expressed on the circulating cells. 
Firm adhesion 
Ixukocyte rolling frequently leads to the arrest of cells as they become firmly attached 
to the endothelium. This high-affinity event is also known as firm adhesion or 
adherence. A variety of chemoattractants can cause the induction of adhesion in post- 
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capillary venules (Panes et al., 1999). Many agents and conditions that can cause firm 
adherence can also cause rolling of leukocytes. This has lead to the view that cell 
rolling is a prerequisite for firm adherence. 
Integrins are heterodimeric, transmembrane glycoproteins. Each integrin is made up of 
a non-covalently linked (x and P subunit. To date, 18 ct and 8P subunits have been 
identified in man (van der Flier & Sonnenberg, 2001). These can link in different 
combinations and are grouped according to the P subunit. The a subunit contains an 
extracellular region folded into four divalent-cation-binding domains, a transmembrane 
region and a cytoplasmic tail. The P subunit has an extracellular region containing 
cysteine-rich domains, a transmembrane region and a cytoplasmic tail. The subunits are 
synthesized as precursors and glycosylated cotranslationallY with N-linked, high- 
mannose carbohydrate groups. After the a and P subunits have associated they are 
transported to the cell surface or to intracellular secretory vesicles. 
TheP2-integrins (CDll/CD18) are primarily involved in the process of leukocyte firm 
adhesion to post-capillary endothelium. The family consists of one of four ct subunits 
(CD11a, CD11b, CD11c or CD11d) associated with a common P subunit (CD18). 
CD 11 a/CD 18 (aLP2. leukocyte function associated antigen-1, LFA-1) is expressed on 
virtually all immune cells, whereas CDIlbICD180'MP29Mac-1) is expressed mainly 
on monocytes, macrophages and granulocytes. Intracellular storage pools of CD 1 lb 
and CD11c are found in neutrophils and monocytes however CD11a is not stored 
intracellulary (Arnaout, 1990). Studies using CD18-specific antibodies (which will 
block both CDlla/CD18 and CDllb/CD18) have shown that the P2 integrins are 
involved in the recruitment of leukocytes, at the adhesion stage, as use of these 
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antibodies reduces the number of adherent leukocytes in post-capillary venules induced 
by PAF (Argenbright et al., 199 1; Kubes et al., 1990; Zimmerman et al., 1994). CD 18 
mutant mice (>80% reduction in CD18 expression on granulocytes) show an impaired 
inflammatory response with a decreased number of neutrophils emigrating into the 
thioglycollate inflamed peritoneal cavity (Wilson et al., 1993). 
As described above, stimulation of chemoattractant receptors on the rolling leukocytes 
leads to non-functional P2-integrins becoming fully active binding molecules as well as 
increasing surface expression of integrins by mobilizing preformed stores (Arnaout, 
1990). These integrins are now able to bind to their ligands, members of the 
endothelial immunoglobulin (Ig) superfamily, on the endothelium. 
Immunoglobulin superfamily members as integrin ligands: Intercellular adhesion 
molecule 1 (ICAM-1) has been implicated as a ligand for both CD11a (Marlin & 
Springer, 1987) and CD11b (although the a subunits bind to different domains) 
(Diamond et al., 1991). ICAM-1 has five extracellular Ig-like domains. CDI la has a 
binding site in the N112-terminal of the first domain whereas CD11b binding is 
localized to the third Ig-like domain. ICAM-1 is expressed on both leukocytes and 
endothelial cells. It is found constitutively on the surface of endothelial cells in a 
functionally active form but can also be up-regulated by exposure of the endothelium to 
various cytokines or endotoxin (Dustin et A, 1986). ICAM-2 has two extracellular Ig- 
like domains. The domains are similar to the first domain of ICAM-1 which can 
therefore bind CD11a, but not CD11b. ICAM-2 is also constitutively expressed on 
endothelial cells however it is not up-regulated by cytokines (Staunton et al., 1989). 
De novo protein synthesis is required for cytokine-induced ICAM-1 up-regulation so 
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the adhesive potential of endotheliurn increases over a period of hours. Monocytes, 
eosinophils and lymphocytes express a4P,, and can also bind to vascular cell adhesion 
molecule-1 (VCAM-1) (Elices et al., 1990). VCAM-1 has low basal expression on 
endothelial cells and could also be up-regulated by inflammatory cytokines (Osborn el 
al., 1989). 
In addition to being involved in firm adhesion, integrins have also been shown to play a 
part in leukocyte rolling in certain conditions. For instance, use of knockout mice has 
demonstrated that CDlla/CD18 can sustain cell rolling in mesenteric vessels after 
application of an inflammatory stimulus. These knockout mice show an increased 
rolling velocity and in turn a decreased cell adhesion and emigration in response to 
thioglycollate. The same study showed that ct4p, (very late antigen-4, VLA-4) can take 
over the role played byP2integrins in sustaining cell rolling (Henderson et aL, 2001). 
Emigrationl transmigratioid leukocyte extravasationl diapedesis 
After a leukocyte has been stationary for a period of time it may leave the post- 
capillary venule. The cell extends pseudopodia between apposing endothelial cells and 
pulls itself through to the basement membrane which it must also cross in order to 
migrate through the adjacent interstitial tissues. This is a complex event that depends 
on many cellular processes including adhesion molecule expression and activation, 
cytoskeletal reorganisation, and alterations in membrane fluidity. It is thought that a 
favourable chemoattractant gradient must exist across the vessel wall for adherent 
leukocytes to emigrate. 
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Different molecules are also important in leukocyte transmigration. Platelet endothelial 
cell adhesion molecule (PECAM-1, CD3 1) and CD99 are required for transmigration. 
PECAM-1 is a member of the endothelial Ig-superfamily and consists of six 
extracellular Ig-like domains. It is widely distributed and found on endothelial cells, 
leukocytes and platelets. It is constitutively expressed on endothelial cells and is found 
evenly along the cell borders where it is constitutively recycled (from specific vesicles) 
(Mamdouh et al., 2003). CD99 is a molecule expressed on the surface of most 
leukocytes and is found concentrated at the borders of cultured endothelial cells 
(Schenkel et al., 2002). Both PECAM-1 and CD99 are capable of homophilic 
interactions, i. e. leukocyte PECAM-1 binds to endothelial PECAM-1. The same 
applies to CD99. The use of both neutralizing antibodies (Bogen et aL, 1994; Muller et 
al., 1993; Vaporciyan et al., 1993) and knockout mice (Dangerfield et al., 2002; 
Thompson et al., 2001) has demonstrated the role of PECAM-1 in cell transmigration. 
However, neither of these strategies could totally abolish cell migration in these 
models. Similarly, blockade of CD99 on either monocytes or endothelial cell cultures 
also significantly reduced transmigration without completely abolishing it. However, 
blockade of both CD99 and PECAM-1 has been shown to completely abolish 
transmigration (Schenkel et aL, 2002). In vitro experiments, using human monocytes 
and human umbilical vein endothelial cells (HUVEC) have shown that PECAM-1 
recycling is targeted to surround emigrating cells (Mamdouh et al., 200.3). This may be 
to provide extra endothelial PECAM-1 for interaction with leukocyte PECAM-1. 
Whether or not this occurs with the neutrophil is as yet unknown. Junctional adhesion 
molecule I (JAM-1) is another member of the endothelial Ig superfamily of proteins 
found at the junctions of endothelial cells. It has been shown, using in vitro studies, to 
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contribute to the transmigration of neutrophils and monocytes via interactions with 
CD II a/CD 18 (Ostermann et al., 2002). 
After cells have crossed the endothelium, they must pass through the basement 
membrane and the extracellular matrix of the interstitial tissues to the source of the 
inflammation (e. g. to the bacteria or infected/dead cells). Leukocytes must interact 
with proteins of the extracellular matrix such as collagen, laminin and fibronectin as 
well as the tissue cells via high affinity interactions with 0, -integrins (Hemler, 1990). 
P, -integrins (or very late antigens, VLA's) are only found at very low levels on blood 
neutrophils and are rapidly up regulated after emigration of the cell from the 
vasculature. They are involved in cell movement along the chernotactic gradient in the 
extravascular tissue (Weff et al., 1998). 
Figure 1.2. is a summary showing the events that occur in leukocyte recruitment. 
Figure 13 is a summary of the adhesion molecules involved in the complex process of 
cell recruitment. 
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Figure 1.2. Summary of Leukocyte Recruitment. When an inflammatory stimulus or 
infection occurs, resident tissue cells and tissue leukocytes at the site secret chemokines 
and pro-inflammatory cytokines. The cytokines IL-I/TNF increase expression of 
selectins and ICAM-1 on the surface of endothelial cells. Circulating leukocytes begin 
to roll due to the interaction of oligosaccharides on their surface with the newly 
expressed selectins. Chernokines are released by the interaction of lL-1/TNF with 
receptors on endothelial cells. Chemokines are 'displayed' on the surface of the 
endothelium. by cell surface heparan sulphate proteoglycans. Rolling cells can now 
sample' the chemokines via receptors on their surface. This leads to the up regulation 
of integrins on the rolling cell and the cell becomes activated. The activated cell can 
become firmly adherent by binding of leukocyte integrins to endothelial cell surface 
ICAM- I molecules. Changes occur within the leukocyte allowing it to migrate into the 
surrounding tissue. Chemokine gradients build up in the tissue by the binding of 
chemokines to matrix heparan sulphate proteoglycans and these gradients lead recruited 
cells to the site of the inflammatory stimulus where they can go about removing it. 
Within the tissue recruited cells can also contribute to cell recruitment by the further 
release of chemokines making the gradient even stronger. Adapted from Luster, 1998. 
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Diagram adapted from Ulbrich et al., 2003. 
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1.2. Annexin I 
1.2.1. The Annexin Family 
Annexins are a large family of calcium (Ce) and phospholipid binding proteins. They 
are named from the Greek word 'annex' meaning to bring/hold together. The principal 
characteristic of annexins is the calcium-dependent binding to negatively charged 
phospholipids (Raynal & Pollard, 1994). Thirteen mammalian annexins have been 
discovered so far and many more annexins have also been identified in other organisms 
such as sponges, drosophila and even plants (Smith & Moss, 1994). 
Each annexin has 2 principal domains 
0 The smaller, unique NH. -terminal 'head' domain 
* The larger, conserved COOH-terminal protein core 
The conserved C-terminal region is termed the annexin core and consists of 4 (or 8 in 
annexin VI) repeating units, the "annexin repeat", each comprising of about 70 amino 
acids residues. Each of the repeats corresponds to a domain found in the three- 
dimensional structure of the molecule. The homologous repeats/domains consist of 5 
a-helices connected by short loops. There is a strong homology between each of the 
four repeats found in an individual annexin (25-35%) and also between corresponding 
repeats of the different annexins (40-60%). The helices form a slightly curved disc 
shape with concave and convex sides (see figure 1.4. ). The convex side contains the 
Ca"' binding sites. Specific Ci' binding sites have been identified between the first 
and second a-helices and between the fourth and fifth helices. The concave side points 
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away from the membrane and so appears to be accessible for interactions with the N- 
terminal domain and/or cytoplasmic binding partners (Nevid & Horseman, 1996). 
The N-terminal domain is less homologous than the conserved C-terminal region. The 
N-terminal region varies in sequence and length (from 11 to more than 100 residues). 
Each annexin has a unique N-terminal domain and it is thought that each one of these 
alternative forms determines the specificity of biological action for each annexin. The 
N-terminal contains binding sites for S 100 proteins (as in the case of ANX-A 1, ANX- 
A2 and ANX-A 11) and phosphorylation sites for serine/threonine and tyrosine-specific 
kinases (for example in ANX-AI) (Rosengarth et al., 2001). Crystal structure analysis 
of ANX-A5 indicates that the N-terminal region is located on the concave side of the 
core domain (Huber et al., 1992). 
1.2.2. Annexin 1: Structure and Distribution 
Annexin 1 (ANX-A I), also known as lipocortin-1, is a 37kDa member of the annexin 
family. The N-terminal domain of ANX-Al contains 41 amino acids residues 
(Rosengarth et al., 2001) with the complete protein consisting of 346 amino acids. 
Figure 1.4. shows the three-dimensional structure of ANX-Al. ANX-Al is found in 
large amounts in human neutrophils, accounting for approximately 24% of the total 
cytosolic protein (Francis et al., 1992). This protein is also expressed by other cells 
including monocytes and some subsets of lymphocytes though in smaller amounts 
(Morand et aL, 1995). 
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Figure 1.4. Three-dimensional structure of Annexin 1. The protein core consists 
of four repeats each made up of five (x-helices: repeat I is depicted in red, repeat 11 in 
green, repeat III in blue and repeat IV in purple. The N-terminal domain of 41 amino 
acids is depicted in yellow. Diagram adapted from Rosengarth et al., 2001. 
Although ANX-Al has been shown to be abundant in the cytoplasm of several cell 
types its exact location is unclear. In a kidney cell line ANX-A I has been shown to 
localise around endosomal membranes, especially those of early endosomes, in a Ca" 
dependent manner (Seemann et al., 1996). Differentiated U937 cells (cell line with a 
macrophage phenotype) have been shown to contain ANX-Al protein distributed 
throughout the cell although mostly localised to the cytoplasm. The protein did not 
seem associated with any particular organelle in these cells. However, when the cells 
had ingested non-pathogenic bacteria (E. coli) or yeast, ANX-A 1 localised. around the 
phagosome (Harricane et al., 1996). In human neutrophils, at high Ca2' concentrations, 
ANX-A I has been found associated with azurophilic granules, specific granules and 
secretory vesicles as well as free in the cytoplasm (Sjolin et al., 1994). 
Another interesting point is that ANX-Al does not contain a signal sequence for 
secretion via the classical secretory pathway. However it can be selectively released 
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from cells, for example high concentrations are secreted by cells of the human prostate 
gland (Christmas et al., 1991). More recently ANX-Al secretion has been 
demonstrated in the colon of human patients with ulcerative colitis (Vergnolle et al., 
2004). 
The distribution of ANX-Al gene expression in mice has been indirectly analysed by 
the use of ANX-Al knockout mice in which the targeting vector contains the Lac-Z 
gene. They were used, with P-galactosidase as a substrate, to reveal sites of ANX-Al 
gene expression. ANX-Al is differentially expressed in organs of the mouse. It is 
strongly expressed in the stomach, lung, spleen, ovary and uterus and expressed at 
intermediate levels in the kidney, thymus and heart. It was found at lower levels in 
thyroid, pancreas and testes and no ANX-Al gene expression was found in the brain 
cortex, liver and adrenal gland (Hannon et al., 2002). 
1.2.3. Glucocorticoids and Annexin 1: Anti-Inflanumtory Actions 
The steroid hormones (progestagens, glucocorticoids, mineralocorticoids, androgens 
and oestrogens) are derived from cholesterol and figure 1.5. is a brief summary diagram 
of the actions of these hormones. Glucocorticoids (GC), which are produced by the 
adrenal gland via actions of the hypothalamo-pituitary-adrenocorticaI (HPA) axis, have 
since 1949 been used for their anti-inflammatory actions. Figure 1.6 (a) is a diagram to 
show the synthesis and release of GC. Figure 1.6 (b) shows how GC can affect target 
cells and modulate protein synthesis. Endogenous GC is carried in the plasma bound to 
corticosteroid binding protein (CBP) or albumin (which also carries exogenous GQ. 
The GC diffuses into target cells where it can bind to a GC receptor (GR) which is 
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found in the cytoplasm in a complex with two molecules of heat shock protein, hsp90- 
The hsp9O molecules prevent the GR moving into the nucleus until the GR binds GC, 
which then causes hsp9O to dissociate leading to the exposure of nuclear localisation 
signals. Once this occurs the GC-GR complex is activated and it then forms a dimer 
which translocates to the cell nucleus. In the nucleus the complex binds to a GC 
recognition sequence (GC response element, GCR) located in the 5'-upstrearn promoter 
region of glucocorticoid-responsive genes. Once the complex has bound to a GRE, the 
GC produces its effects by altering the rate of transcription to induce or repress the 
gene. GR can also interact directly with transcription factors such as AP- I (activating 
protein-1) and NF-KB (nuclear factor KB) as well as having other important 
cytoplasmic interactions. As the GR interacts with the transcription factors this 
prevents both the transcription factor and the GR interacting with DNA reducing the 
response to them (Barnes, 1998). 
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Figure I. S. Steroid hormones and their actions. The five major classes of steroid 
hormones are shown in boxes with examples given in red. All are derived from cholesterol. 
A brief summary of action is given in blue for each steroid. Adapted from Berg el al., 2002. 
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A series of investigations were carried out in the first half of the 1970's to investigate 
how GC reduced the inflammatory response. In vitro it had been noted that these 
hormones could prevent the generation of inflammatory mediators of the eicosanoid 
family by reducing the supply of the substrate arachidonic acid. A protein factor 
induced by steroids that inhibited P'A2 activity to bring about the reduction of 
eicosanoid generation was discovered (Flower & Blackwell, 1979). A number of other 
groups at the time also identified steroid-modulated anti-phospholipase proteins and 
named them lipomodulin, macrocortin and renocortin. Eventually careful comparison 
of conditions of their generation and their properties led all groups to the conclusion 
that despite discrepancies in the molecular weights of these proteins, they were in fact 
functionally identical and actually active fragments of the same precursor which had 
undergone proteolysis. A unified nomenclature was agreed and the name 'lipocortin' 
introduced (Di Rosa et al., 1984). The protein was cloned, and both the rat (Pepinsky 
et al., 1986) and human (Wallner et al., 1986) sequence established. The protein has 
since been fully characterised and renamed annexin I (ANX-Al) (Ahluwalia, 1996; 
Perretti & Flower, 2004). 
GC induce the expression and secretion of ANX-Al in several cell types. In the 
hamster, dexamethasone (DEX), a synthetic GC, causes an increase in cell associated 
ANX-Al levels in all types of peripheral blood leukocytes with a more marked 
response in the neutrophil (Mancuso et al., 1995). Interestingly, in human volunteers, 
hydrocortisone administration causes a significant increase in levels of both 
intracellular and cell surface ANX-Al (Goulding et al., 1990). This effect is not 
confined to humans as was shown by the fact that the levels of ANX-Al are decreased 
in rat peritoneal cells by the administration of a GC receptor antagonist, RU486 (Peers 
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et al., 1993). Accordingly, adrenal ectomi sed rats also show a decrease in ANX-A I 
mRNA and protein in the lung (Vishwanath et al., 1992). As ANX-A I is strongly 
induced by GC it led to the suggestion that ANX-A I could act as a cellular mediator of 
-the anti- inflammator actions of GC (Flower, 1988). This effect was originally y In 
attributed to the capability of ANX-A I to inhibit PLA, activity. This inhibition would 
block arachidonic acid production and the downstream eicosanoid production. As 
eicosanoids have an important role in pain, fever and inflammation it was thought that 
ANX-Al's ability to inhibit release/synthesis of these mediators was mediating the anti- 
inflammatory effects of the GC. Figure 1.7 shows the effect of GC and ANX-A I on 
the generation of eicosanoids from membrane phospholipids. 
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Figure 1.7. The effect of glucocorticoids and ANX-A I on eicosanoid formation. Figure 
adapted from Nussey & Whitehead, 2001, Rang et al., 2003. 
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Many experiments have been carried out to examine the role of endogenous ANX-Al 
and the effects of exogenous ANX-Al and its N-terminal derived peptides in 
inflammation. Table 1.1. summarises the findings of a number of these experiments. 
Some of these studies will be described in more detail in the following sections. 
Table 1.1. The anti-inflammatory effects of ANX-Al in models of inflammation. 
i. c. v., intracerebroventricular injection, i. p., intraperitoneal, i. pI. intraplantar injection, 
I/R, ischaemia-reperfusion, i. s., intrascrotal, ix., intravenous, ix. m., intravital 
microscopy 
Endogenous ANX-Al 
Model/Species Inflammogen Treatment Results Reference 
Air pouch 11,1P Endogenous Reverses effects of (Perretti & 
Mouse ANX-Al GC: DEX-induced Flower, 
neutralised inhibition of PMN 1993) 
migration blocked 
Air pouch Zymosan Endogenous Prolongs (Perretti et 
Mouse ANX-Al inflammation al., 1996a) 
neutralised 
Skin oedema Zymosan- Endogenous Increases the (Peffetti et 
Mouse activated ANX-Al oedema response al., 1996a) 
serum (ZAS) neutralised 
Cheek pouch fMLP Endogenous Reverses effects of (Mancuso 
(i. v. m. ) ANX-Al GC: DEX-induced et al., 
Hamster neutralised detachment and 1995) 
emigration delay in 
blocked 
Peritonitis Zymosan Endogenous Reverses effects of (Getting el 
Mouse ANX-Al GO DEX-induced al., 1997) 
neutralised inhibition of PMN 
and monocyte 
recruitment blocked 
Peritonitis Glycogen Endogenous Reverses effects of (Teixeira et 
Mouse ANX-Al GC: DEX-induced aL, 1998) 
neutralised inhibition of PMN 
recruitment blocked 
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Pain Carrageenin Endogenous Reverse effects of (Ferreira et 
Rat TNF-a ANX-Al GC: DEX-induced al., 1997) 
IL'IP neutralised anti-hyperalgesic 
effects blocked 
Arthritis model Adjuvant Endogenous Reverse effects of (Yang et 
Rat ANX-Al GC: DEX-induced al., 1999) 
neutralised reduction on arthritis 
index, paw volume 
and cell influx 
blocked 
Arthritis model Carrageenin Endogenous Reverse effects of (Yang et 
Rat ANX-Al GC: DEX-induced aL, 1997) 
neutralised inhibition of PMN 
recruitment blocked 
Exogenous ANX-AI: hrANX-AI (full length protein) 
Model/Species Inflammogen Treatment Results Reference 
Air pouch IL'IP hrANX-Al Reduces PMN (Perretti et 
Mouse (i. v. ) accumulation in air aL, 1993; 
pouch Perretti & 
Flower, 
1993) 
Mesentery US hrANX-AI Attenuates LPS- (Allcock et 
(i. v. m. ) (i. v. ) induced cell aL, 2001) 
Rat adhesion and 
emigration 
Mesentery Zymosan hrANX-AI Reduced extent of (Lim et aL, 
(i. v. m. ) (S. C. ) zymosan-induced 1998) 
Mouse cell adhesion and 
emigration 
Mesentery Zymosan hrANX-Al Caused adherent cell (Urn et aL, 
(i. v. m. ) (i. v. ) detachment 1998) 
Mouse 
Paw oederna Carrageenin hrANX-Al Inhibited (Cirino et 
Rat (i. pl. ) carrageenin-induced aL, 1989a) 
paw oederna 
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Exogenous ANX-Al: Peptide Ac2-26 
Model/Species Inflammogen Treatment Results Reference 
Air pouch II. -IP Ac2-26 Reduces PMN (Perretti et 
Mouse migration into air al., 1993) 
pouch 
Cheek pouch fMLP Ac2-26 Mimicked GC (Mancuso 
(i. v. m. ) (DEX) i. e. increased et al., 
Hamster emigration time 1995) 
Mesentery Zymosan AC2-26 Reduced extent of (Lim et al., 
(i. v. m. ) (S. C. ) zymosan-induced 1998) 
Mouse cell adhesion and 
emigration 
Mesentery IL'IP AC2-26 Reduced IL- I (Cuzzocrea 
(i. v. m. ) induced cell et al., 
Rat adhesion and 1997) 
emigration 
Mesentery I/R of Ac2-26 Reduces I/R-induced (Gavins et 
O. V. m. ) mesenteric (i. v. ) cell adhesion and al., 2003) 
Mouse vessels emigration, induces 
adherent cell 
detachment 
Peritonitis Zymosan Ac2-26 Reduces zymosan- (Getting et 
Mouse (S. C. ) induced PMN influx al., 1997) 
into cavity 
Circulatory I/R of Ac2-26 Reduces the I/R- (Cuzzocrea 
shock splanchic (S. C. ) induced decrease in et al., 
organs (i. v. ) blood pressure/ 1997) 
decrease leukocyte 
accumulation in 
intestines 
Pain Carrageenin Ac2-26 Reduced the (Ferreira el 
Rat TNF-a (i. pl. ) intensity of aL, 1997) 
II'lp hyperalgesia 
Arthritis model Carrageenin Ac2-26 Reduces (Yang et 
Rat (i. v. ) carrageenin-induced aL, 1997) 
recruitment of PMN 
into joint 
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Exogenous ANX-Al: Fragment 1-188 
Model/Species Inflammogen Treatment Results Reference 
Air pouch IL'IP Fragment Reduces IL. - I (Peffetti et 
Mouse 1-188 induced PMN al., 1993) 
(i. v. ) accumulation in air 
pouch 
Fever IL'IP Fragment Reduces IL- I (Carey et 
Rat 2-188 induced increase in al., 1990) 
Ox. v. ) colonic temperature 
Brain Occlusion of Fragment Inhibition of (Relton et 
Rat MCA 1-188 (i. c. v. ) neuronal damage al., 1991) 
(infarct size) and 
oedema 
Endogenous ANX-Al 
The effects of endogenous ANX-Al were first examined by passive immunisation 
experiments using neutralising anti-serum or monoclonal antibodies. Application of 
the cytokine IL-1 into an experimental air pouch caused leukocyte emigration, as a 
basic model of leukocyte accumulation and inflammation. DEX is anti-inflammatory 
in this model by inhibiting the influx of cells into the air pouch. When endogenous 
ANX-Al is blocked by a passive immunisation protocol with a neutralising sheep 
serum the anti-migratory effects of i. v. DEX are blocked (Perretti & Flower, 1993). 
This suggests that endogenous ANX-Al has a specific role in DEX-induced inhibition 
of cell migration. These anti-migratory actions of ANX-Al are unlikely to be due to 
the blockade of inflammatory mediator generation. This was shown again using an IL- 
lp-induced inflammation in a mouse air pouch model. The use of drugs that block 
eicosanoid producing pathways downstream of arachidonic acid (indomethacin, the 
31 
cyclooxygenase (COX) inhibitor and BWA4C, the selective 5-lipoxygenase inhibitor) 
do not have an anti-migratory effect in this model (Perretti & Flower, 1993). 
So, these results challenged the previous idea that PLA2inhibition by ANX-A I was the 
sole mechanism for the anti-inflammatory actions of the glucocorticoids. Recently it 
has become clear that it is likely that many of the anti-inflammatory actions of ANX- 
Al are due to interference with granulocyte recruitment, migration and/or activation, at 
sites of inflammation brought about by other mechanisms. 
From Table 1.1 it can be seen that in a variety of models of acute inflammation, 
performed in different species and with different inflammogens, anti-annexin 
antibodies have been reported to reverse the anti-inflammatory effects of the GC in 
vivo. Altogether these experiments indicate an important role for endogenous ANX-A I 
in GC-induced inhibition of leukocyte recruitment and consequent tissue damage. 
To examine more closely the ability of GC and endogenous ANX-Al to influence 
leukocyte movement, intravital microscopy studies were carried out initially in the 
hamster cheek pouch model. When fMLP was used as an inflammatory stimulus to 
activate the hamster cheek pouch microcirculation there was a reduction in rolling 
velocities of WBC and an increase in the number of adherent and emigrating cells (i. e. 
an easily quantifiable inflammation). DEX was shown to have no effect on cell rolling 
and adhesion, however it influenced the fate of adherent cells such that a higher 
proportion detached from the vessel wall and returned to the blood flow, rather than 
emigrating through the wall into the surrounding tissue (Mancuso et al., 1995). Cells 
that did emigrate took longer to do so. The use of an anti-ANX-Al serum 24 hr before 
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DEX challenge reversed (almost to control levels) the delay in emigration and caused 
less cells to detach from the vessel wall. So DEX brings about this anti-inflammatory 
effect by affecting the leukocyte transmigration process and this seems to be mediated 
by endogenous ANX-Al. 
Interestingly this relationship was not restricted to the neutrophils, as seen with 
experiments conducted to study endogenous ANX-Al and its role in the anti-migratory 
action of GC on monocyte recruitment. In a model of murine peritonitis induced by 
zymosan DEX could reduce 24 hr monocyte recruitment in a dose-dependent fashion. 
Passive immunisation against full length hrANX-AI rendered the steroid inactive in 
reducing cell recruitment (Getting et al., 1997). This suggests that DEX may act via 
ANX-Al on monocyte recruitment in the same way as it does in neutrophils. Indeed, 
when U937 cells were transfected with an ANX-Al cDNA to augment protein 
expression a reduced degree of transmigration towards SDF-la/CXCL12 was 
measured (Perretti et al., 2002). The most recent data indicate that endogenous ANX- 
Al is capable of inhibition of monocyte emigration reinforcing the previous in vivo 
study conducted in the mouse. 
As GC have been shown to inhibit recruitment of eosinophils (Teixeira et al., 1995) a 
study was carried out to evaluate the role of endogenous ANX-A I in the recruitment of 
this cell type. DEX could inhibit both acute and delayed-onset recruitment of 
eosinophils from the circulation into sites of cutaneous inflammation (in a mouse model 
of allergic reaction in the skin) however this effect was shown to be independent of 
ANX-Al (Teixeira et al., 1998). So although endogenous ANX-Al can be clearly 
demonstrated to have a role in mediating the anti-migratory effects of DEX with 
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respect to neutrophil and monocyte recruitment this is not the mechanism that DEX 
utilises to inhibit eosinophil recruitment. 
ExogenousANX-Al 
After the cloning and sequencing of ANX-A I, human recombinant ANX-Al (hrANX- 
Al) was available in substantial amounts. The protein could be administered 
exogenously and was clearly shown to mimic several of the anti-inflammatory effects 
of GC in a variety of models (Table 1.1. ). As each annexin possesses a unique N- 
terminus it is thought that this might confer specificity of activity. Thus, peptides have 
been synthesised and tested, the idea being that they may be easier to prepare and 
administer compared to handling of the full-length protein. Many studies have shown 
that peptide Ac2-26 (corresponding to 25 amino acids of the 41 amino acid N-terminus) 
and a truncated version of ANX-Al, fragment 1-188, are effective at inhibiting 
leukocyte recruitment mimicking the effects of hrANX-A I (see Table 1.1. ). Although 
fragment 1-188 was shown to exhibit anti-migratory action in an IL. -lp air pouch model 
it was not as efficacious as the full length protein (fragment 1-188 inhibited IL-lp- 
induced neutrophil accumulation by a maximum of 49% whereas full length hrANX- 
Al inhibited accumulation by almost 90%) (Perretti & Flower, 1993). Peptide Ac2-26 
also inhibited leukocyte migration in the ILlP air pouch model, with a similar efficacy 
to whole length hrANX-AI (around 90% inhibition of leukocyte recruitment) although 
it was approximately two orders of magnitude less potent than the full length parent 
protein (Perretti et al., 1993). This study also suggested that the peptide was acting via 
the same mechanism as the native ANX-Al as when inactive ANX-Al was given 
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intravenously (which did not alter ILAP-induced neutrophil migration) it completely 
blocked the effect of the peptide (Perretti et al., 1993). 
One important finding of these original studies was that both hrANX-A1 and peptide 
Ac2-26 could cause adherent cells to detach from activated endothelium such that, 
rather than emigrate, these cells returned to the blood stream. This was shown in both 
the inflamed hamster cheek pouch (Mancuso et al., 1995) and in the mouse mesentery 
after inflammation induced by zymosan (Lim et al., 1998) and during the course of this 
thesis, by I/R (Gavins et al., 2003). This suggests that exogenous ANX-Al could be 
reducing cell emigration to the site of inflammation by causing detachment of adherent 
cells. As discussed before, endogenous ANX-Al could also be acting in this manner 
(Mancuso et al., 1995). 
ANX-A I has also been demonstrated to have a role in another facet of inflammation, 
that is, pain. In a model of mechanical hyperalgesia (rat paw pressure test) DEX was 
shown to reduce the hyperalgesic effects of agents such as carrageenin, TNF-ct and IL- 
lp. Passive immunisation against ANX-Al abolished the anti-hyperalgesic effect of 
DEX in this model. Hyperalgesic responses could also be inhibited by pre-treatment 
with peptide Ac2-26 (Ferreira et al., 1997). More recently, administration of the 
peptide has been shown to inhibit nociceptive behaviour in the mouse formalin paw 
test: injection of formain into hind paw causes a biphasic response consisting of licking 
and biting the paw. Peptide Ac2-26 could inhibit the later phase of the nociceptive 
response (Pieretti et al., 2004). 
35 
1.2.4. Mechanisms of Action 
Experimental work using FACS analysis, confocal microscopy and western blotting has 
shown that in human neutrophils, ANX-A I was mainly found intracellularly with only 
small amounts on the cell surface. Neutrophil adhesion to endothelial monolayers 
(stimulated by either fMLP, IL-8 or PAF) causes intracellular ANX-Al to be 
translocated to the cell surface (much larger amounts of intact, 37 kDa ANX-Al could 
now be detected) where it is kept in a Ca' dependent manner (Oliani et al., 2001; 
Perretti et al., 1996b). After adhesion, neutrophils lost a majority (>50%) of their 
staining for cell-associated ANX-Al. ANX-Al could now be detected in the 
supernatant from the adherent cells, although this was not the intact 37 kDa protein but 
a cleaved form of the protein that was only 33 kDa in size. So the surface bound ANX- 
Al on adherent cells is subjected to proteolysis and a 33 kDa 'clipped' form of the 
protein is released into the media (Perretti et al., 1996b). These data suggest that 
externalised ANX-Al may be involved in the negative regulation of neutrophil 
migration. The idea of a specific 'lipocortinase' has also been suggested, which might 
'clip' the N-terminal region of ANX-Al releasing the inactive 33 kDa form (Peffetti et 
al., 1996b). The enzyme(s) responsible for this action has yet to be identified. 
However several enzymes have been shown to cleave the N-terminal region of ANX- 
Al including elastase (Huang et al., 1987; Smith et al., 1990), calpain (Ando et al., 
1989; Liu et al., 1995), cathepsin D (Ando et al., 1989) and plasmin (Huang et al., 
1987) though it is not yet defined which one is present in the microenvironment of the 
adherent neutrophil thus which one would be biologically relevant. 
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Experiments were then performed to look at the cellular distribution of ANX-Al in 
emigrating cells during an actual inflammatory response. A model of acute peritonitis 
in the rat was induced by i. p. injection of carrageenin for 4 hr. Mesenteries were 
stained and neutrophils in the vasculature and tissues were examined. ANX-Al was 
found in the nucleus, cytoplasm and plasma membrane of intravascular neutrophils. 
The majority of ANX-Al in the plasma membrane of adherent cells is the intact, 37 
kDa form of the protein (Oliani et al., 2001) backing up what was found in vitro 
(Peffetti et al., 1996b). Cells that had emigrated from the vessels were found to contain 
mainly the clipped 33 kDa isoform of the protein and this was located in vacuoles. 
This has led to the proposal that in vivo endogenous ANX-A I acts as an autocrine 
inhibitor that controls the emigration process in pathophysiological situations 
(membrane bound ANX-Al affects adherent cells from which it is secreted). The 
proteolytic cleavage of ANX-Al that can occur on the cell surface may regulate the 
action of this protein and may be somehow involved in the regulation of the cell 
emigration process. 
It is still unclear how ANX-Al is released from neutrophils as the protein lacks a signal 
sequence which would be necessary to target ANX-Al to the classical secretory 
pathway. An in vitro study has established that in resting human neutrophils there is 
co-localization of ANX-A I with gelatinase granules (but not with secretory vesicles or 
lysosomes) a large proportion of which is found in the matrix of the granules. On 
adhesion (of neutrophils to monolayers of endothelial cells) there is an externalization 
of ANX-Al and it is found in a punctate pattern on the neutrophil surface (Perretti et 
al., 2000). In vivo, it was demonstrated that adherent cells (in the vasculature) had co, 
localization of ANX-Al and gelatinase and once cells had emigrated (found outside of 
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the vasculature) only a very low amount of gelatinase was found, indicating that 
exocytosis of this enzyme had occurred (Oliani et al., 2001). As gelatinase granules are 
mobilised during neutrophil extravasation (Boffegaard & Cowland, 1997) this may be a 
mechanism for externalising a large proportion of ANX-A I from activated neutrophils. 
Experiments were suggesting that leukocytes might contain binding sites for ANX-A I 
on their surface and that these were mediating the effects of exogenous ANX-Al. A 
study was carried out to assess binding of human ANX-Al to cells although this used 
an indirect method to quantify binding in which binding of ANX-Al was detected 
using a specific mAb and flow cytometric analysis. Human monocytes, but not 
lymphocytes, were shown to exhibit Caý'-dependent, trypsin-sensitive ANX-Al 
binding and two specific binding sites were found using immunoprecipitation studies 
(Goulding et aL, 1996). As specific proteinaceous binding sites for ANX-A I are found 
on the surface of human monocytes and neutrophils (Euzger et al., 1999) a recent 
breakthrough in the field is the proposition that ANX-A I is likely to be an agonist at 
the formyl peptide receptor (FPR), the prototype of the family of seven transmembrane 
domain G-protein-coupled receptors. The first study used an N-terminal derived 
peptide of ANX-Al, Ac9-25, and found that it was triggering signalling pathways in 
neutrophils (Walther et al., 2000). This was an in vitro study and a variety of 
experiments demonstrated that Ac9-25 was acting on FPR in a similar manner to 
another ligand of the receptor, fMLP. The transcellular Ca' signals, which are initiated 
when fMLP binds to its receptor, FPR, were also increased when Ac9-25 was added to 
cells. Activation of chemoattractant receptors by their agonists can lead to 
heterologous and homologous desensitisation i. e. the down-regulation of cell responses 
to a second challenge by an agonist. This desensitisation of Ca' mobilisation was seen 
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not only in response to fMLP, but also Ac9-25. Peptide Ac9-25 caused desensitisation 
of Ca' mobilisation in neutrophils and stopped them responding to chemotactic 
gradients. These authors proposed that this mechanism could possibly have a role in 
decreasing cell emigration. Antagonists of fMLP were also shown to abolish the 
inhibitory effect of Ac9-25 on neutrophil transendothelial migration using a two- 
chamber system (Walther et al., 2000). Application of antagonists of FPR, in a model 
of mouse peritonitis, blocked the anti-inflammatory properties of Ac2-26 and Ac2-12. 
Indication for binding of ANX-Al to murine FPR was obtained by a set of ex-vivo 
experiments with FPR knockout mice (Perretti et al., 2001). However, this issue is not 
as clear-cut as first thought and FPR may not be the only receptor involved in the 
biological action of ANX-Al. In fact a variant of FPR termed FPR-like I (FPRLI), 
may also be involved in the anti-inflammatory mechanism of ANX-A I (Gavins et al., 
2003). 
1.2.5. ANX-Al Knockout Mce 
ANX-Al knockout (ANX-Al') mice have been recently generated in our laboratory 
(Hannon et al., 2002). The mice were produced using a dual-purpose vector which 
both inactivates the ANX-A I gene and can report on the activity of the promoter with 
Lac-Z staining. The mice produced were healthy, viable and reproduced normally, 
with the mutated gene being passed on in the Mendelian fashion. Although the ANX- 
A 1' mice were generated prior to the start of this PhD no research was published on the 
topic until 2002. Since then a small number of papers have been published beginning 
to report on the phenotype of ANX-AV- mice (Hannon et al., 2002) (Wells et al., in 
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press) and their inflammatory responses (Hannon et al., 2002; Roviezzo et al., 2002; 
Yang et al., 2004; Yona et al., 2004). 
The initial paper on the ANX-A 1' mice (Hannon et al., 2002) has shown that the mice 
displayed altered levels of other annexins. In particular, annexins 2,4,5 and 6 were 
up-regulated in the lung of the ANX-A 1-1- mice, whereas higher levels of 2 and 4 were 
found in the thymus of male mice with no difference in the female thymus. A strong 
up-regulation of COX-2 and cPLA2was seen in the lung and thymus of ANX-Al 4- 
mice irrespective of the sex. As many studies have shown the anti-inflammatory 
effects of ANX-Al in models of acute inflammation these were the first types of 
studies to be carried out with the ANX-A I' mice to examine the effects of removing 
the ANX-Al gene. Previous studies have shown that administration of the exogenous 
ANX-Al mimetic, Ac2-26, can reduce neutrophil influx into the peritoneal cavity 
inflamed with zymosan (Getting et al., 1997). Conversely, blockade of endogenous 
ANX-Al reverses the anti-inflammatory actions of DEX in this model (Getting et al., 
1997). When the ANX-Al'- mice were studied it was shown that the mice had a 
significantly greater cell emigration into the peritoneal cavity at all of the time-points 
examined (2,4 and 24 hr) when compared to the wild type (ANX-Ar"). Heterozygote 
mice showed intermediate levels of emigration between the ANX-Al' and the ANX- 
Al"- at the early time-points (2 and 4 hr) but more similar emigration numbers to the 
ANX-AI'+ at the 24 hr time-point (Hannon et al., 2002). An increased IL-Ip 
production by ANX-A I' mice was also noted after 2 hr zymosan peritonitis. ANX-A I- 
" mice were found to be resistant to the anti-inflammatory effects of GC (DEX) in this 
model. Whereas DEX could reduce neutrophil migration in the peritoneal cavity of 
ANX-Al' mice by almost 50%, the GC could only reduce emigration in the 
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ANX-AI4- mice by 22% and this difference was not significant. This data reinforces 
the idea that endogenous ANX-Al may play a tonic inhibitory role in acute 
inflammation. 
A second model of acute inflammation was studied in the ANX-A I'- mice. An increase 
in paw inflammation in response to carrageenin-induced inflammation was also found. 
In particular, although ANX-Al-- mice showed a similar time course for carrageenin- 
. induced paw swelling they displayed an enhanced sensitivity and had greater swelling 
at most of the time-points examined (Hannon et al., 2002). This fits with previous, 
similar studies showing that, in a model of carrageenin-induced paw swelling in the rat, 
exogenous ANX-A 1 could inhibit paw oedema (Cirino et al., 1989b). 
A third study has utilised the ANX-Al' mice to monitor chronic inflammation. A 
model of antigen-induced arthritis (AIA) was used in which ANX-Al" mice show 
significant inflammation of the knee joint as demonstrated by a number of 
histopathologic features including pannus formation, synovitis (synovial lining 
hypercellularity), exudation of inflammatory cells into the joint space, cartilage damage 
and also bone damage. In this model, ANX-Al' mice showed exacerbation of AIA 
with a greater degree of synovitis, exudation of inflammatory cells and bone damage. 
As is seen in the previous study, the anti-inflammatory actions of GC are markedly 
attenuated in these mice. In the ANX-Al" mice DEX significantly reduced overall 
severity of AIA by 31% whereas ANX-Al' mice were relatively insensitive to DEX, 
with an overall severity inhibition of 13% (Yang et al., 2004). These data suggest that 
endogenous ANX-Al also has a role in more chronic models of inflammation. 
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Most recently the characterisation of macrophages from ANX-Al'- mice has been 
studied (Yona et aL, 2004). They have been shown to have defects in the phagocytosis 
process that is dependent on the stimulus used. For example, peritoneal macrophages 
from ANX-Al' mice had a reduction in the phagocytosis of non-opsonised, but not 
opsonised, zymosan or IgG complexes. Macrophages from ANX-Al' mice did not 
appear to be morphologically different to macrophages from the ANX-Al", however 
they were shown to ingest or associate with significantly lower numbers of zymosan 
particles compared to the ANX-Al". This suggests a role for endogenous ANX-Al 
during macrophage phagocytosis, at least under certain conditions. 
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1.3. Scope of the thesis 
1.3.1. Aims 
This thesis focuses on two main models of acute inflammation in the mouse with 
particular attention to the leukocyte recruitment process in ANX-Al' mice. The aims 
of this thesis were: 
To use a simple model of acute inflammation (peritonitis) to assess leukocyte 
recruitment. The technique was modified by the addition of a cell staining 
protocol so that flow cytometry could be utilised to identify recruited cell 
populations in a more objective way to simple cell counting. This model could 
then be used to compare leukocyte recruitment between the ANX-Al-'- and 
ANX-Al" mice. 
2. To learn the technique of intravital microscopy in the mouse cremaster muscle 
(from a visit to Dr. Granger's Laboratory in Louisiana, USA) with the intention 
being to set up and apply this technique to the current problem under 
investigation. 
3. To determine if exogenous ANX-Al has a role to play in leukocyte recruitment 
in the cremaster muscle intravital preparation. 
4. To utilise intravital microscopy of the mouse cremaster muscle to dissect the 
recruitment process and to determine if differences existed between the ANX- 
Al"' and ANX-Al' mice. 
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5. To examine leukocyte recruitment in transgenic ANX-Al over-expressing mice 
to complement data obtained in the ANX-A l- mice. 
1.3.2. Hypothesis 
The hypothesis this project has explored is that major alterations in the inflamed 
microcirculation of ANX-AV- mice will occur. Based on previous pharmacological 
studies it is likely these mice will have an exacerbated inflammatory response when 
compared to their equivalent ANX-Al" mice. 
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Methods 
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2. Methods 
Two main models were used in this study to assess leukocyte recruitment in 
inflammation: mouse peritonitis and intravital microscopy of the mouse cremaster. 
Leukocyte transmigration can be studied in vivo using a number of different techniques. 
The most common method is to quantify the migration of leukocytes into a body cavity 
such as the peritoneal cavity, or the pleural cavity, after the local administration of a 
pro-inflammatory stimulus such as zymosan, thioglycollate (non-specific) or ILAP 
(specific inflammatory mediator). This study makes use of both zymosan- and ILAP- 
induced peritonitis with the addition of a cell staining protocol so that flow cytometry 
could be utilised to identify the recruited cell populations. This technique provided 
valuable information on leukocyte recruitment to sites of inflammation however it did 
not identify the different stages of leukocyte recruitment. So, a technique of intravital 
microscopy of the mouse cremaster muscle was also used, to visualise potential 
alterations in the leukocyte recruitment process in the microcirculation of ANX-AI-1- 
mice. 
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2.1. Flow Cytometry 
2.1.1. Animals 
ANX-AI-1- and ANX-Al"' animals were recently generated in our own laboratory 
(Hannon et al., 2002) on a C57BU6 background. The animals were viable, healthy and 
bred normally. No differences were found between the ANX-A I' and the ANX-A14- 
animals with respect to their appearance, behaviour or weight (Hannon et al., 2002). 
Transgenic ANX-A I over-expressing (ANX-A I') mice and negative littermate control 
(ANX-AlLm) mice were generated at Imperial College by Dr. Nic Wells and were a gift 
to the department. Transgenic mice were created on a C57BUIO x. CBA/Ca 
background using a transgene containing murine ANX-Al cDNA with a chicken beta- 
actin promoter and cytornegalovirus enhancer. Over-expression of ANX-Al does not 
appear to produce obvious effects on development or survival of these mice. 
All mice were maintained on a standard chow pellet diet with tap water ad libitum. 
Animals were housed in cages in a room with controlled lighting (lights on 8: 00 to 
20: 00 hr) in which the temperature was maintained at 21-23T. Male and female 
animals were used and weighed between 25 and 35 g. Animal work was performed 
according to Home Qffice regulations (guidance from the Animals (Scientific 
Procedures) Act, 1986). 
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2.1.2. Model of Mouse Peritonitis 
The peritoneal cavity was used as a site for the administration of inflammatory stimuli. 
Leukocytes were then collected in lavage fluids at selected time-points (4 or 24 hr). 
Z mosan Preparation Y 
Zymosan type A (500 mg) was mixed with 50-200 ml of phosphate buffered saline 
(PBS) and boiled (and continually stirred) in a conical flask for approximately 30 min. 
After cooling on ice the suspension was washed 3 times by centrifugation in PBS at 
400 g for 15 min at 4T. The resulting pellet was re-suspended in 10 ml PBS (500 mg 
zymosan in 10 ml PBS) and aliquoted into sterile eppendorf tubes at 100-500 jil 
volumes. These were then centrifuged at 400 g for 3 min and the supernatant 
discarded. The zymosan was then stored at -20T until required. 
Zymosan-Induced Peritonitis 
Peritonitis was induced in mice using an i. p. injection of 1 mg zymosan in 0.5 ml sterile 
PBS. The dose of zymosan chosen was used in previous experiments performed in our 
laboratories and has been shown to cause a marked degree of leukocyte extravasation 
(Getting et al., 1997; Hannon et al., 2002; Perretti et al., 1992)After the injection mice 
were left for selected time-points (4 and 24 hr) before being killed by carbon dioxide 
(C02) exposure and the leukocytes collected as described below (section 2.1.3. ). Cells 
were also collected from untreated animals as controls. Figure 2.1. is a summary of the 
time-points examined. 
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IL-Ifl-Induced Petitonitis 
Peritonitis was induced in mice using an i. p. injection of 10 ng IL-lp in 0.5 ml sterile 
PBS. The dose of ILAP given has been used in previous experiments performed in our 
laboratory (Ajuebor et al., 1998b). After the injection mice were left for selected time- 
points (Figure 2.1. ) before being killed by C02 exposure and the leukocytes collected 
by the method described below (See section 2.1.3. ). 
-24 hr 
injection 
-4 hr 
injection 
no 
injection 
(0 hr) 
t 
Cells collected 
by lavage 
Figure 2.1. A summary of peritonitis time-points examined. Injection was 
either 10 ng IL- IP in 0.5 ml sterile PBS or I mg zymosan in 0.5 ml stefile PBS. 
2.1.3. Collection of Peritoneal Lavage Fluids 
Immediately after the animals were killed by CO, exposure, a small incision was made 
in the fur at the abdominal midline, the skin removed from either side and the 
peritoneal cavity exposed. The cavity was then injected with 3 ml of PBS containing 3 
mM ethylenediaminetetra-acetic acid sodium salt (EDTA) and 25 U/ml heparin. The 
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cavity was gently massaged to ensure any loosely adherent cells were recovered and 
then the cavity was opened by a small incision in the abdominal muscle. The lavage 
fluid was collected using aI ml Pasteur pipette. Usually 1.5-2.5 ml of lavage fluid 
could be recovered. Samples were placed into polypropylene tubes and kept on ice. 
Differential Cell Counting 
Turk's solution (0.01% crystal violet in acetic acid) was prepared by dissolving 50 mg 
of crystal violet in 3% acetic acid (500 ml). An aliquot (100 [d) of the lavage fluid was 
then diluted in 900 [tl of Turk's solution for cells to be counted. The samples were 
vortexed and 10 [d of the stained cell solution was placed in a Neubauer 
haernocytometer to count total cell numbers. All cells located in the central triple ruled 
area of the haemocytometer chamber (25 small squares) were counted. Total cell 
numbers were counted. Identification of the different leukocyte populations was also 
performed. PMN were identified by the multi-lobed nucleus, the visible cytoplasm and 
also the strong uptake of dye. Monocytes and macrophages contain a single kidney 
shaped nucleus and a larger cytoplasm and cells stained a paler blue. Lymphocytes 
contain a large round nucleus and only a small cytoplasm and these cells also stain a 
dark blue (see figure 2.2. ). The number of cells recovered from the peritoneal cavity of 
each mouse could then be calculated using the following formula: 
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Number of cells counted in central triple ruled area (25 small squares) x 10' (dilution 
factor on slide) x 10 (dilution in Turk's) = number of cells per ml of fluid 
Number of cells per ml of fluid x volume of liquid recovered = number of cells 
recovered from animal 
Neutrophil Monocyte Lymphocyte 
Figure 21. Cell types found in the lavage fluids by a peritoneal cavity wash. 
Photos obtained from www. vh. org 
2.1.4. Antibodies 
A mixture of antibodies was used to label the cells collected from the peritoneal cavity. 
Figure 2.3. is a table showing details of these antibodies and the cell markers they 
recognise. Figure 2.4. is a diagram explaining the differential staining of peritoneal 
cells. 
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Abbreviation Ab clone Details Conjugated? Ab specificity Cells 
number recognized by 
the AN 
CDI Ib Ab mino Rat anti- Biotin Recognizes Monocytes, 
mouse conjugated the 170kDa am PMN and NK 
CD11b chain of Mac-I cells 
mAb (CD II b/CD 18, 
aMP2 integrin) 
Gr-I Ab RB6-8C5 Rat anti- Fluorescein Recognizes the Granulocytes 
mouse isothiocyanate LY-6G (Gr-l- (neutrophils and 
Ly-6G (FITC) myeloid eosinophils) 
(Gr-1) conjugated differentiation 
and Ly- antigen), a 21- 
6C mAb 25-kDa GPI 
anchored protein 
F4/80 Ab CIAM Rat anti- R. Recognises Murine 
mouse Phycoerythrin mouse F4/80 macrophages 
F4/80 (PE) conjugated antigen, a 160- from sites 
antigen kDa including 
glycoprotein peritoneal cavity 
expressed by and blood 
murine monocytes 
macrophages 
and blood 
monocytes 
Isotype control A95-1 Rat Biotin Isotype-matched 
IgG2b. ic conjugated negative control 
isotype for CDI lb Ab 
standard 
Figure 2.3. Summary of antibodies used to stain peritoneal cells. 
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Streptavidin 
tricolor 
Gr-I 
C011b 
CbIIb 
d Biotin abelled 
anti-CUllb mAb 
F4/80 
PE conjugated 
anti F4/80 mAb 
Neutrophil zv"ý 
FITC conjugated Monocytic cell 
anti Gr-1 mAb 
Figure 2.4. Diagram showing fluorescent labelling of peritoneal cells. 
2.1.5. Cell Staining 
After differential cell counting, lavage fluids were centrifuged at 400 g for 10 min, the 
supernatant collected into eppendorfs and frozen at -80'C for later analysis of mediator 
concentrations. The resulting pellet was re-suspended in FACS wash (PBS containing 
0.2% bovine serum albumin (BSA) and 0.1% sodium azide (NaN3)) to make cells up to 
a concentration of 4x 107 cells/ml. Aliquots of cells (10 [d) were seeded onto a 96- 
well plate (spare cells were spun down and the resulting pellets frozen at -80'C for later 
analysis of protein concentrations by western blotting). A 1: 1 mixture of 50 ýd 
blocking IgG (human y globulin, 6 mg/mI, made up in FACS wash) and either the 
CDI Ib antibody or the isotype control, both at a final concentration of 5 [tg/mI were 
placed on the cells. These concentrations were used as they have been previously 
optimised by another group who demonstrated the technique to this department 
(Henderson et al., 2001). The plate was put on ice and incubated for 30 min. Three 
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washes with FACS wash were then carried out. This involved adding 100 td of wash 
buffer to each well and centrifuging at 400 g for I min. The supernatant was discarded 
and then the plate tapped to re-suspend the cells. Two more washes were carried out in 
the same way but using 200 141 of FACS wash. The second incubation consisted of 
1: 1: 1 mixture of Gr-I-FITC, F4/80-PE and Streptavidin Tricolour at final 
concentrations of 1.67 pg/ml, 1.00 gg/ml and 0.33 [ig/ml respectively. The 
concentrations of Gr-I-FITC and F4/80-PE were optimized in a preliminary study 
using a range of concentrations (0-10 pg/ml) and described in results section 3.1.1. The 
concentration of Streptavidin Tricolour was used as previously optimized by another 
group (Henderson et al., 2001). The antibodies were added to the cells, which were 
then incubated, covered and on ice, for 30 min. Cells were again washed three times 
with FACS wash. The cells were re-suspended with 200 [tl FACS wash and then fixed 
with 200 [t]. of cold cell fixative (CelIFIX", 1/10 dilution of stock). The flow 
cytometric analysis either followed immediately after this step or the next morning 
(tubes were stored wrapped in foil, overnight in the fridge). The cell staining steps are 
summarized in figure 2.5. 
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INCUBATION 1 
WELL BIgG Antibody 
Main wells 50111 50 1A biotin CD 11 b 
Unstained well 50 Itl 50 ltl FACS wash 
Isotype control 50 jAl 50 ld isotype control 
FITC only Single 50 lil 50 ttl FACS wash 
PE only colour 50 R1 50 lil FACS wash 
Tricolour only controls 50 p] 50 ttl biotin CD IIb 
INCUBATION 2 
Well FITC PE Tricolour FACS wash 
Main wells 50 RI 50 [d 50 Id 
Unstained well 150 RI 
Isotype control 50 ttl 50 [d 50 lil 
FrrC only 50 td 100 [d 
PE only 50 td 100 ttl 
Tricolour only 50 ttl 100 RI 
Figure 2.5. Summary of cell staining steps for flow cytometry protocol. Final 
concentrations of reagents: biotin CD11b, isotype control :5 tig/ml, BlgG (blocking IgG, 
human y globulin): 3 mg/ml, FITC conjugated Gr-l: 1.67 [tg/ml, PE conjugated F4/80: I 
Vg/ml, streptavidin tricolour (secondary for CD II b): 0.33 ttg/ml. 
2.1.6. Flow Cytometric Analysis 
Analysis of single cell suspensions by flow cytometry was completed using a FACScan 
flow cytometer (Becton Dickinson). Contaminants (red blood cells, dead cells, and 
debris) were gated out at the time of analysis, using forward and side scatter gating. 
FITC fluorescence was detected through the FL-I channel; PE florescence through the 
FL-2 channel and Tricolour was assessed using the FL-3 channel. Data was acquired 
and analysed using the CellQuest@) application on a Power Macintosh G3 computer. 
For each sample a minimum of 10,000 events were analysed. Gates were constructed 
around two populations, the FL-I positive events (Gr-I positive) and around FL-2 
positive events (F4/80 positive events). The criteria examined were the percentage of 
total events each population contained and also the level of CD IIb expression found in 
each of these populations. Figure 2.6 is a representative dot plot from the FACS 
machine after treatment with an inflammogen in a wild type mouse. This dot plot is 
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separating events based on the scatter in the FLI and FL2 channels, FLI being the 
channel for Gr- I and FL2 the channel for F4/80. Three distinct populations are seen 
and gated so that the percentage of total events in each cloud can be determined. The 
Gr- I positive events are neutrophils, the F4/80 positive events are monocytic cells and 
the events that are negative for both Gr-I and F4/80 are mainly lymphocytes, with 
some dead cells and cell debris though most of this would have gated out at the time of 
data acquisition. 
Monocytic 
cells 
ýR I 
cli _j LL 
C, 
12-f 100 
Neutrophils 
Lymphocytes/cell 
debris 
-1-61 -'''' -'1'62 ''--"1 '63 ---- 1 -64 
FL 14A 
Figure 16. Representative dot plot from the FACS machine. Figure 
showing the events separated on the basis of Gr- I and F4/80 Ab staining. Three 
distinct populations are -seen: green, Gr-l positive events (ncutrophils), orange, 
F4/80 positive events (monocytic cells) and black, lymphocytcs and some cell 
debris. 
F4/80 posith e Ae 
Gr-1 positive 
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2.2. In Vitro Techniques: Protein and Mediator Generation in Peritoneal Samples 
2.2.1 Bradford Assay for Protein 
Cell pellets collected during peritonitis experiments were frozen at -80*C. Analysis of 
protein content was made with the widely used Bradford assay (Bradford, 1976). The 
samples were thawed at 4*C and then immediately re-suspended in protease inhibitory 
buffer (complete mini EDTA-free protease inhibitory cocktail tablet made up in 7 ml 
distilled H20 (dH20)). Each sample was then sonicated for 15 sec. A series of 
solutions with known protein concentrations were then prepared using BSA made up in 
dH20 (concentration range 0-0.5 mg/ml). 10 [d of each standard and cell pellet 
samples were added in triplicate to a 96 well plate. 200 jil of Bradford reagent (1: 5 
dilution of commercially available stock solution diluted in dH20) was added to every 
well. The optical densities were then measured using a spectrophotometer at a 
wavelength of 570 nm. The absorbance readings from the standard samples were used 
to construct a standard curve. This curve could then be used to determine the protein 
concentration of unknown samples using their measured absorbency values. Figure 2.7 
shows a representative standard curve constructed for a Bradford assay from standard 
samples. 
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0.5- 
0.4- 
0.3- 
.c 1.0 
0.2- 
0.1- 
0.0-- 
0.0 
Protein concentration (mg/ml) 
Figure 2.7. Standard curve for a Bradford assay. The curve can then be used to 
calculate the amount of protein in an sample of unknown protein concentration. 
2.2.2. Sample Preparation for Western Blotting 
Once the protein concentration of samples was known they were diluted to 2 mg/mI by 
dilution with protease inhibitory buffer. 2x Laemmli sample buffer was then added to 
samples at a 1: 1 ratio to yield aIx Laemmli buffer comprising 50 mM Tris HCI (pH 
6.8), 100 mM dithiothretol (DTT), 2% sodium dodecyl sulphate (SDS), 0.1% 
bromophenol. blue and 10% glycerol (Laemmli et aL, 1970). Samples were then boiled 
for 5 min. Prepared samples contained a final concentration of I mg/mI protein and 
were stored at -20*C- 
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2.2.3. SDS-PAGE (SDS Polyacrylamide Gel Electrophoresis) Western Blotting 
Western blotting samples and prestained protein markers (broad range) were thawed at 
room temperature and markers boiled for 5 min. Samples were then loaded onto a 10% 
polyacrylamide gel comprising 3.3 ml protogel polyacrylamide, 2.5 ml resolving buffer 
(1.5 M Tris HCI pH 8.8), 2.9 ml dH2O, 50 [d ammonium persulphate and 10 ttl Temed 
and topped with a 49/o stacking gel comprising 0.8 ml protogel polyacrylamide, 1.25 ml 
stacking buffer (0.5 M Tris HCI pH 6.8), 2.5 ml dH, O, 50 [tl ammonium persulphate 
and 10 1AI Temed. Using a BioRad Mini-PROTEAN@ III Electrophoresis system and a 
running buffer (25 mM Trizma Tris base, 192 mM glycine. and 0.1% SDS in dH20)the 
gels were stacked and run at IOOV until dye front reached the bottom of the gel 
(approximately I hr). The proteins in the gel were then transferred onto a nitrocellulose 
membrane (Hybond-C extra) via a system of wet transfer under 100 mA (taking 
approximately I hr) using transfer buffer (25 mM Tris base, 192 mM glycine and 20% 
methanol in dH20)* 
Following wet transfer the membrane was incubated overnight in a blocking solution of 
5% milk in TBS-T (50 mM Tris HCI, 150 mM NaCI and 0.1% Tween 20 in dH20) at 
4T to prevent non-specific binding. The membrane was then washed 3 times (each 
wash 15 min) in TBS-T followed by incubation with a primary antibody (for ANX-Al 
detection: 1: 1000 rabbit anti-ANX-Al antibody in TBS-T containing 5% milk, for cx- 
tubulin detection: 1: 5000 mouse anti-a-tubulin antibody in TBS-T containing 5% milk) 
for I hr at room temperature. The membrane was then washed 3 times (each wash 15 
min) and incubated at room temperature for a further I hr with a peroxidase conjugated 
secondary antibody (ANX-Al secondary: 1: 2000 peroxidase conjugated goat anti- 
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rabbit antibody, (x-tubulin secondary: 1: 2000 peroxidase conjugated goat anti-mouse 
antibody). The membrane was washed as before. Membranes were then incubated for 
1 min with enhanced chemiluminescence (ECL) reagent (1: 1 mixture of two 
commercially available ECL reagents) before exposure to photographic film for 
approximately I min followed by developing and chemical fixation. Densitometric 
analysis was performed using the public domain NIH Image program (developed at the 
U. S. National Institutes of Health; http: //rsb. info. nih. gov/nih-image/). 
2.2.4. ELISA (Enzyme-Linked Immunosorbent Assay) 
Ninety six well plates were coated with capture antibody (TNF ELISA: anti-mouse 
TNF antibody, KC ELISA: anti-mouse KC antibody) diluted in coating buffer (83 mM 
Na2HP04,134 mM NaH2PO4 in dH20, pH 6.5), sealed with parafilm and incubated 
overnight at 40C. Following incubation plates were washed 3 times with wash buffer 
(PBS containing 0.05% Tween-20). After each wash the plate was inverted and blotted 
on paper towels to remove residual buffer. Next the plates were blocked to prevent 
non-specific binding using 200 [tI assay diluent per well (PBS containing 10% FCS, pH 
7.0) and incubated at room temperature for I hr. The plates were washed as before. 
Standards and samples (supernatants from peritonitis experiments, stored at -800C, 
allowed to thaw at room temperature) were added to the wells (100 [LI per well), the 
plates sealed and incubated at room temperature for 2 hr. Standards were prepared 
from a Iyophilized sample reconstituted with I ml of deionised H20 and stored in 50 [LI 
aliquots at -80*C. For each experiment an aliquot was thawed at room temperature and 
then prepared into a series of standards made with assay diluent (range 0-1000 pg/ml). 
Assay diluent alone was used as the zero standard (0 pg/ml). After incubation of 
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samples and standards with the capture antibody the plates were washed as before but 
for a total of 5 washes. Detection antibody (biotinylated anti-mouse TNF/KQ and 
enzyme reagents (avidin-horseradish peroxidase conjugate) were added next for aI hr 
incubation at room temperature. Following the incubation the plates were washed for a 
total of 7 times and 100 [LI of substrate solution (1: 1 solution of tetramethylbenzidine 
and hydrogen peroxide) was added to each well, and incubated for 30 min at room 
temperature in the dark. Finally 50 [d of stop solution (I M sulphuric acid ASOO) was 
added to each well. The optical densities were measured using a spectrophotometer at 
a wavelength of 450 nrn within 30 min of addition of the stop solution. The absorbance 
readings from the standard samples were used to construct a standard curve on a 
logarithmic axis. This curve could then be used to determine the protein concentration 
of unknown samples using their measured optical densities. Figure 2.8 shows a 
representative standard curve obtained during an ELISA experiment for KC detection. 
I 
4. 
Q 
C 
0.0 
10 100 1000 
KC concentration (pg/ml) 
Figure 2.8. Standard curve for a KC ELISA. The curve is constructed from 
samples of known protein concentration. 
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2.3. Intravital Microscopy 
2.3.1. Anhnals 
ANX-Al"' and ANX-Al' animals were generated in our own laboratory. FPR""' mice 
were also bred on-site (breeding pairs donated by P. M. Murphy and J. L. Gao, NIH, 
Maryland, USA). C5713IJ6 mice were purchased from B&K Universal and housed for 
a minimum of I week before being used for experiments. All animals were maintained 
on a standard chow pellet diet with tap water ad libitum. Animals were housed in cages 
in a room with controlled lighting (lights on 8: 00 to 20: 00) in which the temperature 
was maintained at 21-231C. Male animals were used and weighed between 20 and 35 
g. Animal work was performed according to Home Office regulations (guidance from 
the Animals (Scientific Procedures) Act, 1986). 
2.3.2. Cremaster Muscle Preparation for Intravital. Microscopy 
Male mice were anaesthetised with one of two anaesthetic mixtures; either diazepam (6 
mg/kg) subcutaneously in the neck followed immediately with an intramuscular 
injection of HypnormTm (0.7 mg/kg fentanyl citrate and 20 mg/kg fluanisone) in the 
thigh muscle, or a mixture of xylazine (7.5 mg/kg) and ketamine (150 mg/kg) made up 
in sterile H20 and mixed before being injected i. p. In some cases the right jugular vein 
was cannulated for administration of saline, drugs and FITC-labelled albumin during 
the experiment. The neck area was shaved with electric clippers and the skin over the 
area removed. The salivary gland was moved to one side and the jugular vein was 
isolated from surrounding fat and tissues using tweezers. Using a silk suture the vein 
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was tied off proximally and a suture was loosely placed further down. A small incision 
was made in the vessel with micro scissors and the cannula (polyethylene tubing 
(PEIO) connected to aI ml syringe) placed in and tied in place with silk suture. Next, 
the anterior aspect of the scrotum was gently shaved and all loose hair removed with a 
small piece of sticky tape. The mouse was placed onto the viewing stage. This was a 
specially made Perspex viewing stage consisting of a base plate with a central area 
containing a raised circular area (diameter: 24 mm, height: 15 mm) topped with a 
permanently attached glass cover slip. The central area has a raised edge to contain the 
buffer (which drips onto the preparation to keep it warm and moist). Excess buffer is 
drained away by suction (See Figure 2.9. ). The stage was placed onto a heating pad to 
maintain body temperature at 37T. An incision was made in the skin and fascia over 
the ventral aspect of the right scrotum. Care was taken not to touch the underlying 
tissue with any instruments used. Irrigation of exposed tissue started (as soon as tissue 
was exposed) with bicarbonate buffered solution (BBS). This solution consisted of 132 
mM NaCl, 5 mM KCI, 2 mM CaCl2, I mM MgSO4.20 mM NaHCO3 made up in 
distilled water and heated to 37*C. This solution was regularly applied to the exposed 
tissue to keep it moist. The incision was extended up above the inguinal fold and to the 
distal end of the scrotum. The underlying connective tissue fascia was then carefully 
separated from around the cremaster sack avoiding touching the cremaster muscle. At 
this point the animal was positioned using a gel heating pack (to keep animal warm) in 
a supine position with the cremaster sack resting on the central glass region of the 
stage. A suture was used in the distal end of the cremaster sack to hold down and 
slightly extend the end of the sack. Using a cauteriser a line was scored down the 
centre of the cremaster sack and also from left to right along the top edge of the sack. 
The cauteriser was allowed to completely pierce the tissue at one point and then 
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scissors were placed in here and the scored lines cut along gently. The cremaster then 
started to lie flat on the glass stage. Four hooks (bent 6 gauge needles) attached to 
threads and taped down were used along the edges of the tissue (two on each side) to 
hold the cremaster down onto the glass stage. The small vessel connecting the testicle 
and cremaster was sealed using the cauteriser and then scissors used to cut the last 
remaining connections between the testicle and the cremaster muscle. The testicle was 
laid out to the side so as little as possible was covering the cremaster muscle. The 
preparation was then ready to view under the microscope. Figure 2.10. is a 
photographic summary of cremaster preparation. The preparation on the stage was then 
mounted on a Zeiss Axioskop 'FS' microscope with a water immersion objective lens 
(magnification of x 40; Carl Zeiss Ltd, Welwyn Garden City, UK) and an eyepiece (x 
10 magnification; Carl Zeiss Ltd) was used to observe the microcirculation. The 
preparation was trans-illuminated with a 12-V, 100-W halogen light source. An optical 
Doppler Velocimeter (Microcirculation Research Institute, Texas A&M University, 
Dallas, Texas, USA) was attached to measure centre line RBC velocity. A Hitachi 
charge-coupled device colour camera (model KPC571; Tokyo, Japan) acquired images 
that were displayed onto a Sony Trinitron colour video monitor (model PVM 1440QM) 
and recorded on a Sony super-VHS video cassette recorder (model SVO-9500 MDP) 
for subsequent off-line analysis. A video time-date generator (model VTG-33; Tokyo, 
Japan) projected the time, date and stopwatch function, onto the monitor. The setup 
was connected so that warm BBS continuously dripped onto the tissue at a rate of 2 
ml/min and was then removed using suction. Figure 2.11. shows the microscope set-up. 
The open cremaster muscle preparation was originally described in the early 1970's 
(Baez, 1973) for the rat and then the mouse. It has now been used extensively and 
reported in over 230 papers (PubMed search as of September 2004). 
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Figure 2.9. Diagram showing the specially designed Perspex stage used in this thesis. 
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Figure 2.10. Photographic summary of the cremaster muscle preparation in mice. 
(a) The mouse taped to Perspex stage and skin removed from right scrotum to show 
testicle and surrounding cremaster (b) Cremaster and its contents after it is freed from 
surrounding fat and tissues (c) Cremaster and its contents extended and placed onto 
glass stage (d) Cremaster showing lines to be cut along (e) Cremaster sack after 
cutting and pins inserted to hold it in place (f) Testicle moved to side and cremaster 
ready for trans-i II umi nation and observation. 
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Figure 2.11. Intravital Microscopy Set Up. 
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2.3.3. PAF-Induced Inflammation 
The cremaster preparation was allowed a 30 min stabilization period and recordings 
were not made until after this time, although during this period the preparation was 
examined under the microscope to find a vessel for recording. Post-capillary venules 
with a diameter between 20 and 40 [tm were chosen, in which 100 [LI length of vessel 
could clearly be seen. Also another criteria was a wall shear rate (WSR) of -500 sec-1 
or greater. The venule fitting the above parameters and with the smallest number of 
adherent and emigrated leukocytes at the end of the 30 min stabilization period was 
chosen to record. A5 min recording was made and at the end of the recording the RBC 
velocity was measured using the Doppler velocimeter, and diameter noted. The 
number of cells that had emigrated into the surrounding tissue (50 [Im either side of the 
100 gm venule section) were counted in real-time (i. e. after recording the vessel not 
during off-line analysis). After this recording, superfusion of the tissue was continued 
with either normal BBS (vehicle control animals) or with a PAF solution (I or 100 nM) 
made up in BBS. The concentration of PAF to be used was determined by experiments 
carried out previously in our laboratory (Tailor et al., 1997) and by others (Zimmerman 
et al., 1994). Recordings (5 min) were made every 15 min from the start of this 
superfusion with the same parameters measured as before and continued for 90 min. 
The video recordings were used subsequently for off-line analysis (see section 2.3.6). 
Figure 2.12. is a summary of recordings made during PAF experiements. 
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Figure 2.12. Summary of recordings made during PAF intravital experiments. 
In the case of experiments designed to analyse cell detachment, after a 30 min 
stabilisation period a continuous video recording was made of a single vessel for 60 
min during superfusion of the cremaster with I nM PAR All analysis of these vessels 
was carried out off-line as described in section 2.3.6. 
2.3.3.1. Effect of Ac2-26 in the Cremaster Muscle Inflamed with PAF 
Male mice were first cannulated and then prepared for intravital microscopy of the 
cremaster muscle (see section 2.3.2. ). After a 30 min stabilisation period and a basal 
recording (5 min) animals were either administered 200 [tg peptide Ac2-26 (in 200 ld 
PBS) or 200 IAl PBS alone via the cannula in the jugular vein (i. v. ). Superfusion of the 
cremaster with a 100 nM PAF solution (made up in BBS) was then started. Recordings 
(5 min) were made every 15 min from the start of this superfusion with the same 
parameters measured as before and continued for 90 min. The video recordings were 
used subsequently for off-line analysis (see section 2.3.6). 
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2.3.4. Zymosan-Induced Inflammation 
Zymosan was used to inflame the cremaster muscle using a new technique adapted by 
the laboratory following a demonstration by another group (Young et al., 2002). Male 
mice were administered 30 [tg Alexa-Fluor 488-conjugated zymosan bioparticles in 
400 [d sterile saline by intrascrotal (i. s. ) injection. Control groups were injected with 
i. s. saline (400 [d). These injections were performed under anaesthetic (either xylazine 
and ketamine (as above) or using inhaled halothane gas at a concentration of -3%) 
following which the animal was allowed to recover. Later (approximately 4.5 hr after 
injection of zymosan), the mice were re-anaesthetised and the cremaster muscle 
prepared for intravital microscopy using the technique described above (section 2.3.2. ). 
The cremaster preparation was allowed a 30 min stabilization period and recordings 
were not made until after this time, although during this period the preparation was 
examined under the microscope to find the vessels of choice to record. Post-capillary 
venules were chosen that had a diameter between 20 and 40 [Lm, in which 100 [tl length 
of vessel could clearly be seen and with a WSR of -500 s-' or greater. One to three 
post-capillary venules were chosen for analysis from each mouse. A5 min recording 
was made of each vessel and at the end of each recording the RBC velocity was 
measured using the Doppler velocimeter, and diameter noted. The number of cells that 
had emigrated into the surrounding tissue was counted (50 [tm either side of the 100 
[Lm venule section). A further experiment was carried out in which emigration was 
quantified at different distances from the vessel wall (0-50 [tm, 50-100 [Lm and 100-150 
tLm: this was on both sides of the 100 jim length of vessel analysed). 
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In some cases a slightly different technique was used to that previously described 
following the method of another group (Young et al., 2002). Briefly, after the animals 
were anaesthetised an incision was made across the bottom of the scrotal sack. Using 
gentle pressure the testicle was pushed down from the body cavity into the sac and out 
of the incision. Tweezers were used to pull away any fat clinging to the outside of the 
cremaster. The cremaster was then pinned to the stage using L-shaped pins and cut 
along the centre as previously described so the whole muscle could be pinned out flat to 
the stage. After a 10 min stabilization period post-capillary venules of 20-40 pm in 
diameter and 100 pm long were chosen. Leukocyte emigration was quantified in real- 
time per field of view (for 1-3 fields of view per vessel) in 1-3 vessels per animal. 
Figure 2.13 is a summary of the time course of this experiment. In some cases 
phagocytosis by emigrated leukocytes was also determined in real-time. This was done 
by direct observation and quantification of leukocytes under both bright light and 
fluorescence to see if the visible particles of zymosan were contained in the emigrated 
leukocyte. Data was normalised against the number of emigrated cells and so 
expressed as index of phagocytosis (%). 
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Figure 2.13. Summary of protocol for zymosan-induced inflammation in the 
cremaster muscle. 
2.3.5. Post-Capillary Venule Leakage 
In some cases post-capillary venule leakage was measured at the end of the experiment. 
FITC-labelled albumin (0.25 g/kg) dissolved in sterile saline was injected via the 
cannular in the jugular vein (approximately 100 [d per mouse). The FITC-albumin was 
allowed to circulate for 5 min before recording for 30 sec under a fluorescent light with 
an excitation filter of 450-490 nm and an emission filter of 525-620 nm. This was 
recorded for later off-line analysis (see section 2.3.6). 
2.3.6. Off-line Analysis of Video Recordings 
Cell adhesion, rolling velocity andflux: Cell adhesion was quantified by counting the 
number of adherent cells per 100 ýLrn vessel length (adherent cells were stationary for 
30 sec or longer) during each 5 min recording. Leukocyte rolling velocity was 
calculated by counting the time taken for a cell to travel a fixed length of the vessel and 
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expressed in [tm/sec (average of 10 cells). Leukocyte flux was calculated as the 
number of cells passing a fixed point in the vessel per min (averaged over 3 min). 
Wall Shear Rate: WSR (sec-') was calculated using the mean RBC velocity (V.. = 
centreline velocity/1.6) and the Newtonian definition, WSR = 8000 x (V.. / diameter). 
Figure 2.14. is a summary of the measurements made from each vessel. 
Post-capillary venule leakage: Post-capillary venule leakage was measuring using 
mean fluorescence intensity measured on a Pentium 3 PC with video analysis software 
(Image-Pro Plus, Media Cybernetics, USA). Florescence was measured inside the 
vessel (Hi. ), 10 [trn away from the outside of the vessel (Fl.,,, ), and also in the 
background (13k). Each measurement was made 3 times per vessel recording. The 
following formula was used to calculate index of albumin leakage (%): 
[(Fl.,, t-Bk)/ (Hi,, -Bk)] x 100 
Detachment: Continuous video recordings (60 min) were used to examine the fate of 
adherent leukocytes. Using a method adapted from a previous study (Lim et al., 1998) 
the fate of adherent cells was observed in 10 min periods over a total of 60 min. Each 
adherent cell was monitored to see if it detached or emigrated. The time taken for 
detachment of adherent cells was also recorded. 
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Figure 2.14. Summary diagram of measurements made. 
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2.4. Statistical Analysis 
Data are expressed as mean: t standard error of the mean (SEM) for n mice. In the case 
of peritonitis experiments, each value was measured in duplicate or triplicate. Analysis 
was caffied out on a Macintosh (model G4) using GraphPad Prism (GraphPad 
Software Inc, USA). Data were first tested for normality. Normally distributed data 
were analysed using appropriate (one-way or two-way) analysis of variance (ANOVA) 
dependent on number of variables in each experiment. This was followed by a 
Bonferroni's Multiple Comparison Test (a post hoc test), and aP value of less than 0.05 
was considered significant. 
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2.5. Materials 
Material Supplier 
Acetic acid 
Alexa-Fluor 488-conjugated zymosan 
bioparticles 
Ammonium persulphate (APS) 
Annexin I antibody (rabbit anti ANX- 
Al) 
Annexin I peptide (Ac2-26) 
Biotin-conjugated rat anti mouse CDI Ib 
monoclonal Ab 
Biotin-conjugated rat IgG2b, K 
monoclonal Ig isotype control 
Bovine serum albumin (BSA) 
Bradford Reagent 
Bromophenol blue 
Calcium chloride (CaCl2) 
Cell FIX' 
Complete, Mini, EDTA-free protease 
inhibitor cocktail tablets 
Crystal violet 
Diazepam 
Dithioretol (DTT) 
ECL' western blotting detection 
reagent 
BDH, Leicestershire, UK 
Molecular Probes (Invitrogen, 
Renfrewshire, UK) 
Bio Rad, Hertfordshire, UK 
Zymed (Cambridge Bioscience, 
Cambridgeshire, UK) 
Advance Biotechnology Centre, Imperial 
College School of Medicine, London, UK 
Pharmingen (BD Biosciences, Oxfordshire, 
UK) 
Pharmingen (BD Biosciences, Oxfordshire, 
UK) 
Sigma-Aldrich, Dorset, UK 
Sigma-Aldrich, Dorset, UK 
Sigma-Aldrich, Dorset, UK 
Sigma-Aldrich, Dorset, UK 
BD Biosciences, Oxfordshire, UK 
Roche Diagnostics, Sussex, UK 
Sigma-Aldrich, Dorset, UK 
Roche, Hertfordshire, UK 
Sigma-Aldrich, Dorset, UK 
Amersham Bioscience, Buckinghamshire, 
UK 
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Ethylenediaminetetraacetic acid (EDTA) Sigma-Aldrich, Dorset, UK 
sodium salt 
F4/80 antibody: PE conjugated (rat anti 
mouse) 
FITC-conjugated rat anti-mouse Gr- I 
monoclonal Ab 
Foetal calf serum (FCS) 
Serotec, Oxfordshire, UK 
Pharmingen (BD Biosciences, Oxfordshire, 
UK) 
Gibco (Invitrogen, Renfrewshire, UK) 
Gas: nitrogen carbon dioxide mix 
Glycerol 
Heparin (sodium) 
Human y Globulin 
Hydrochloric acid (HCI) 
BOC gases, Lancastershire, UK 
BDH, Leicestershire, UK 
Leo Laboratories, Buckinghamshire, UK 
Sigma-Aldrich, Dorset, UK 
BDH, Leicestershire, UK 
Hyperfilm' ECL Amersham Bioscience, Buckinghamshire, 
UK 
Hypnorm' Janssen, Buckinghamshire, UK 
Ketamine (Ketaset) 
Magnesium sulphate (MgSO4) 
Mersilk 6-0 suture thread 
Milk powder (Non fat) 
Mouse KC ELISA set 
Mouse TNF ELISA set 
Murine recombinant IL-IP 
Fort Dodge Animal Health, Hampshire, UK 
Sigma-Aldrich, Dorset, UK 
Johnson and Johnson (3S Healthcare, 
London, UK) 
Safeway, London, UK 
R&D Systems, Oxfordshire, UK 
BD Biosciences, Oxfordshire, UK 
PeproTech, London, UK 
Nitrocellulose membrane (Hybond" -C 
extra) 
Amersham Bioscience, Buckinghamshire, 
UK 
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PAF (C16 form: C26H54NO7P) I 
Peroxidase-conjugated goat anti rabbit 
Peroxidase conjugated goat anti mouse 
immunoglobulin 
Phosphate buffered saline (PBS) tablets 
Polyethylene tubing (for cannulation) 
Potassium Chloride 
Protogel (30% acrylamide/0.8% 
bisacyrlamide solution) 
Prestained protein marker 
Protogel resolving buffer (pH 8.8) 
Protogel stacking buffer (pH 6.8) 
Sodium Azide (NaN3) 
Sodium Bicarbonate (NaHC03) 
Sodium Chloride (NaCI) 
Sodium dihydrogen orthophosphate 
dihydrate (NaH2PO4) 
Sodium dodecyl sulphate (SDS) 
Sodium hydroxide (NaOH) 
di-Sodium hydrogen orthophoshate 
dihydrate (Na2HP04) 
Streptavidin Tri-color conjugate 
Sterile saline 
Sulphuric acid (H2SO4) 
Suture thread 
Temed 
Trizma@ base 
Trizma@ Hydrochloride 
Tubulin antibody (mouse monoclonal 
anti-a tubulin Ab) 
Tween 20 (Polyoxyethylene sorbitan 
Sigma-Aldrich, Dorset, UK 
Dako, Cambridgeshire, UK 
Dako, Cambridgeshire, UK 
Sigma-Aldrich, Dorset, UK 
BD Biosciences, Oxfordshire, UK 
BDH, Leicestershire, UK 
National Diagnostics, Yorkshire, UK 
New England Biolabs, Leicestershire, UK 
National Diagnostics, Yorkshire, UK 
National Diagnostics, Yorkshire, UK 
Sigma-Aldrich, Dorset, UK 
BDH, Leicestershire, UK 
BDH, Leicestershire, UK 
BDH, Leicestershire, UK 
Sigma-Aldrich, Dorset, UK 
Sigma-Aldrich, Dorset, UK 
BDH, Leicestershire, UK 
Caltag Laboratories, Northamptonsire, UK 
Sigma-Aldrich, Dorset, UK 
BDH, Leicestershire, UK 
Pearsalls, Somerset, UK 
National Diagnostics, Yorkshire, UK 
Sigma-Aldrich, Dorset, UK 
Sigma-Aldrich, Dorset, UK 
Sigma-Aldrich, Dorset, UK 
Sigma-Aldrich, Dorset, UK 
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monolaurate) 
Xyazine (Rompun) Bayer, Suffolk, UK 
Zymosan type A Sigma-Aldrich, Dorset, UK 
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3. Results 
3.1. Peritonitis Model 
As very few experiments had been carried out on the ANX-AI-1- mice prior to the start 
of this PhD the first set of experiments that were completed used a simple model of 
acute inflammation, the zymosan peritonitis model. As the main aim of this thesis was 
to examine leukocyte recruitment during inflammation, this was an ideal model for 
monitoring leukocyte trafficking in response to inflammatory stimuli. The zymosan 
peritonitis model had been previously well characterised in mice and was known to 
produce reliable and reproducible results. An additional step was added into the 
protocol, staining of the peritoneal cells with specific markers, so that flow cytometry 
could be utilised to identify the recruited cell populations. 
3.1.1. Determination of Antibody Concentrations for Staining Mouse Peritoneal 
Cells 
Preliminary studies were carried out to determine the optimum concentrations of 
antibodies to use to stain the cells collected from the peritoneal cavities of mice. 
The titration curve for the Gr-I Ab is shown in figure 3.1. The experiment used a 
pooled sample of peritoneal cells obtained from peritoneal washes of 3x C57BU6 
mice (25-27g) that were treated i. p. with I mg zymosan (in 0.5 ml sterile PBS) 4 hr 
prior to the peritoneal wash. Each concentration of Gr-I Ab was tested in duplicate. 
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The graph shows that the optimum concentration of antibody was 1.67 [tglml. Higher 
concentrations of Ab offer no further advantage in terms of the levels of detection. 
The titration curve for the F4/80 Ab is shown in figure 3.2. The experiment used a 
pooled sample of peritoneal cells obtained from the peritoneal washes of 2x TO mice 
(32-35g) that were not treated with an inflammogen. This was because the IP4/80 Ab 
stains monocytic cells that are found in a normal, untreated peritoneal cavity. Each 
concentration of Ab was tested in duplicate. There was a concentration dependent 
increase in F4/80 expression. Using this preliminary data it was decided that the final 
concentration of antibody to use to treat cells in further experiments would be I lAg/ml 
as this concentration gave a significant signal above background. A concentration of 5 
[tg/ml may gain a stronger signal but was considered to be too expensive for routine 
work. 
The concentrations of CD IIb antibody, isotype control and streptavidin tricolour were 
previously optimised by another group and were adapted by us (Henderson et al., 
2001). ILAP and zymosan doses were chosen as they have been successfully used in 
previous experiments performed in our laboratory (Ajuebor et al., 1998; Perretti et al., 
1992). 
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Figure 3.1. Titration curve for calculating the optimum concentration of 
Gr-I Ab to stain mouse neutrophils. C5713L/6 mice were treated with I mg 
zymosan for 4 hr. Peritoneal cells were stained with Gr- I Ab (0-10 [tg/ml) and 
fluorescence measured. Values are mean±sem of triplicate analysis of n=3 
mice, P<0.05 vs. time 0. 
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Figure 3.2. Titration curve for calculating the optimum concentration of 
F4/80 Ab to stain mouse mononuclear cells. Peritoneal cavities of TO mice 
were lavaged and peritoneal cells collected were stained with 174/80 Ab (0-5 
[tg/ml) and fluorescence measured. Values are mean±sem of triplicate analysis 
of n=2 mice, ý`P<0.05 vs. time 0. 
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3.1.2. Comparison of Methods used to Quantify Different Cell Populations: Flow 
Cytometry Protocol versus Light Microscopy Manual Counting 
ANX-Al' and ANX-Al' animals were treated with zymosan (I mg in 0.5 ml sterile 
PBS i. p. ). Peritoneal cavities were lavaged 4 hr later; peritoneal samples were collected 
and stained. Fluorescence in the samples was measured in the FACS machine and the 
percentage of events that were attributable to neutrophils and monocytic cells, as 
assessed using the specific antibodies as markers for these cell types, was measured. 
Figure 3.3. is a comparison of results obtained by this method of distinguishing 
neutrophils and monocytic cells and the more widely used technique of visual cell 
counting using Turk's staining and a haernocytometer. Both graphs show the 
percentage of neutrophils found in the peritoneal cavity after 4 hr treatment with 
zymosan. When analysed no significant difference was found between results of cell 
counting and results obtained from the FACS machine so this was deemed a suitable 
method to quantify the cells infiltrating the peritoneal cavity. The benefits of this 
technique over basic cell counting are that it can also be used to assess the levels of 
other cell markers on each cell population (such as CD11b). Also the possibility of 
human error in distinguishing cell types is minimised using this technique. 
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Figure 3.3. Comparison between data obtained by a simple cell count 
using a haemocytometer (a) and a count using the flow cytometer and 
nuorescently labelled cells (b). ANX-Al+'+ 0 and ANX-Al-'- . mice were treated i. p. for 4 hr with zymosan. Peritoneal cells were collected by lavage 
and either (a) differential cell counts were carried out on cells stained with 
Turk's solution or (b) the cells were stained with the appropriate fluorescent 
Abs for flow cytometric analysis. 
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4 hr zymosan 
3.1.3. Zymosan Peritonitis in ANX-Al' and ANX-Al' Mice 
ANX-Al"' and ANX-Al-l- mice were either treated i. p. with I mg zymosan (in 0.5 ml 
sterile PBS) or left as untreated controls. At selected time-points (4 or 24 hr) mice 
were killed and peritoneal cells collected and stained for flow cytometric analysis as 
described previously. 
3.1.3.1. Gr-I and F4/80 Positive Events 
Figure 3.4 shows the levels of Gr-I positive events found in the peritoneal cavity after 
zymosan treatment. Significantly higher levels of Gr-I positive events (neutrophils) 
were found in the peritoneal cavity after 4 hr treatment with zymosan in both the ANX- 
AI'4' and ANX-Al' mice when compared to 0 hr. However, in the ANX-Al-'- there 
were significantly higher numbers of Gr-I positive events (neutrophils) compared to 
the ANX-Al' at the 4 hr time-point (ANX-Al-": 25.54: 0.10 (n=7) vs. ANX-AI4-: 
63.46: 0.48 (n=8), p<0.05). At 24 hr the levels of Gr-I positive events were decreased 
in the ANX-Al'" (not significantly different to 0 hr) however in the ANX-AI4- there 
were still significantly higher levels found at 24 hr compared to 0 hr. 
When the F4/80 positive events (monocytic cells) in the peritoneal cavity were 
examined a different pattern was seen. Lower levels of F4/80 positive events 
(monocytic cells) were found in the peritoneal cavity after 4 hr treatment with zymosan 
in both the ANX-Al' and ANX-Al-1- mice compared to corresponding control 
animals. However, in the ANX-Al'4- mice there were significantly lower numbers of 
F4/80 positive events (monocytic cells) when compared to the ANX-Al"' animals at 
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the 4 hr time-point (ANX-A I"': 14.97. t5.80 vs. ANX-A I-'-: 0.32. tO. 12, n=8, P<0.05). 
This is seen in figure 3.5. In the ANX-A I "' mice, the percentage of F4/80 positive 
cells increased at 24 hr back to basal levels (i. e. 24 hr value not significantly different 
to 0 hr value). In the ANX-A I -'- however, the percentage increased from that at 4 hr 
but did not returned back to basal levels. 
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Figure 3.4. Gr-I positive events during zymosan peritonitis in ANX-Al' 
and ANX-AIII+ mice. ANX-Al"' M and ANX-Al' mice were treated 
with zymosan (i. p. ). At selected time-points cells were collected by lavage, 
stained with fluorescent Ab and analysed in the flow cytometer. Values are 
mean±sem of n=7-8 mice per group, P<0.05 vs. corresponding time 0, 
T<0.05 ANX-Al' vs. ANX-Al"' at same time-point. 
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Figure 3.5. F4/80 positive events during zymosan in ANX-Al` and ANX- 
All/' mice. ANX-Al"I and ANX-Al' mice were treated with 
zymosan (i. p. ). At selected time-points cells were collected by lavage, stained 
with fluorescent Ab and analysed in the flow cytometer. Values are 
mean±sem of n=8 mice per group, P<0.05 vs. corresponding time 0, 
I! $P<0.05 ANX-Al' vs. ANX-Al"'at same time-point. 
3.1.3.2. CD11b Expression on Gr-1 and F4/80 Positive Populations 
The level of CD IIb expression was measured on both the Gr- I positive population and 
the 174/80 positive population collected from the peritoneal cavity of ANX-Al' and 
ANX-A I" mice treated with zymosan for 4 hr or left as untreated controls. The levels 
of CDI Ib were measured as mean fluorescence intensity (MFI). 
Figure 3.6. shows CD IIb expression on Gr- I positive cells (neutrophils). As shown 
there was no significant difference in CD IIb levels found on neutrophils after 4 hr 
zymosan treatment between ANX-A I "' and ANX-A I -- mice. 
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Figure 3.7. shows CD IIb expression on F4/80 positive cells (monocytic cells). As 
shown CD IIb expression did not change significantly in monocytic cells after 4 hr 
zymosan treatment and as found with the neutrophils, there was no significant I- 
difference in CDI lb expression between ANX-Al"' and ANX-Al' mice. 
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Figure 3.6. C D111b expression on Gr-1 positive cells (neutrophils) 
collected after zymosan peritonitis in ANX-API and ANX-All mice. 
ANX-A I +'+ 0 and ANX-A I -'- ,--' mice were 
treated with zymosan (i. p. ) for 4 
hr. Cells were collected by lavage, stained with fluorescent Ab and analysed in 
the flow cytometer. Values are mean±sem of n= 4 mice per group. 
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Figure 3.7. C DIM expression on F4/80 positive cells (monocytic cells) 
collected after zymosan peritonitis in ANX-Al-/- and ANX-All. ANX- 
AI "' and AN X-A I -'- mice were treated with zymosan (i. p. ). At selected 
time-points cells were collected by lavage, stained with fluorescent Ab and 
analysed in the flow cytometer. Values are mean±sern of n=4 mice per group. 
3.1.3.3. ANX-Al Expression in Peritoneal Cells 
ANX-A I -'and ANX-A I"' mice were either treated with I mg zymosan i. p. for 4 hr or 
left as untreated controls. Cells collected from the peritoneal cavity were frozen at - 
80'C and later thawed for western blot analysis. 
Figure 3.8(a) shows the levels of ANX-A I expression by peritoneal cells of untreated 
ANX-Al-'- and ANX-Al" mice (these would mainly be resident macrophages as 
determined by flow cytometry). ANX-Al was clearly expressed by cells collected 
from ANX-Al"' mice and was absent from the ANX-Al-'- cell lysates. Levels of 
tubulin are shown below to demonstrate equal protein loading. Figure 3-8(b) is a 
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graphic representation of this data using densitometric analysis normalised with 
reference to tubulin. 
The samples obtained from mice treated for 4 hr with zymosan were also blotted for 
ANX-Al and this is shown in figure 3.9(a). Again there was clear expression of ANX- 
Al in the samples from ANX-Al"' mice and no expression by the ANX-AI-1- mice. 
The tubulin blot is shown beneath. Densitometric analysis was carried out on the blots 
and is shown in figure 3.9(b). 
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Figure 3.8. ANX-Al expression on peritoneal cells collected from 
untreated (basal) ANX-Al' and ANX-AI+'+ mice. Peritoneal cavities of 
untreated ANX-Al"' and ANX-Al' and mice were lavaged, cell 
lysates were analysed by western blotting for ANX-A I and tubulin expression 
(a) Western blot results (b) Densitometry data from western blots. Values are 
mean±sem of n=4 mice per group. 
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Figure 3.9. ANX-Al expression on peritoneal cells collected after 
zymosan peritonitis in ANX-AI-1- and ANX-All mice. ANX-Al"'Mand 
ANX-Al-'- -. mice were treated with zymosan (I. p. ) for 4 hr, collected cells 
were later analysed by western blotting for ANX-Al and tubulin expression 
(a) Western blot results (b) Densitometry data from western blots. Values are 
mean±sem of n=4 mice per group. 
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3.1.3.4. CYtokine Release by Peritoneal Cells 
ANX-AV- and ANX-Al' mice were treated with 1 mg zymosan i. p. for 4 hr or left 
untreated as controls. Mice were killed and peritoneal exudates were spun down by 
centrifugation; the resulting supernatants were frozen at-80*C and later thawed for 
ELISA assays. 
Figure 3.10(a) shows TNF-(x release by peritoneal cells from untreated (0 hr) and 4 hr 
zymosan treated mice. The levels of TNF-a released by cells into the peritoneal cavity 
were unchanged at 4 hr compared to basal in both the ANX-Al"' and the ANX-Al-- 
animals. No difference was seen between the ANX-Al"' and the ANX-Al-- mice at 
either of the time-points examined. 
Figure 3.10(b) shows KC levels found in the peritoneal cavities of untreated (0 hr 
zymosan) and 4 hr zymosan treated mice. The levels of KC increased significantly 
from basal by 4 hr in ANX-Al"' mice (0 hr: 8.93: 6.18 pg/ml vs. 4 hr: 46.11: 04.63 
pg/ml, n=4, P<0.05). The same pattern was seen in the ANX-AI4- mice (Ohr: OtO 
pg/ml vs. 4 hr: 52.91-tI5.48 pg/ml, n=4, P<0.05). No differences were found with 
respect to KC release between the genotypes under basal conditions or after 4 hr 
zymosan treatment. 
94 
40 
30 
20 
F- 
to 
0 
75 
ýz 
50 
25 
0 
04 
Time post zymosan injection (hr) 
Figure 3.10. Cytokine release by cells into the peritoneal cavity during 
zymosan peritonitis in ANX-Al"I and ANX-AI-I mice. ANX-AIII-I (solid 
bars) and ANX-A I` (clear bars) mice were either left as untreated controls (0 
hr) or treated with zymosan (i. p. ) for 4 hr. Measurement of cytokine release (a) 
TNF-cE (b) KC was made using an ELISA kit. Values are mean±sem of n=4 
mice per group, ' P<0.05 vs. corresponding time 0. 
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3.1.4. Interleukin lp Peritonitis 
As the experiments with zymosan had produced interesting results another 
inflammogen, IL- I P, was tested in the peritonitis model, This was also a model that had 
been previously used and characterised in our department (Ajuebor et al., 1998). 
3.1.4.1. Gr-1 and F4/80 Positive Events 
ANX-Al-'- and ANX-Al' animals were treated i. p. with 10 ng IL-lp (in 0.5ml sterile 
PBS) for different time periods, animals killed by C02 exposure then peritoneal 
samples were collected and stained. The samples was analysed in the FACS machine 
and the percentage of events arising from neutrophils and monocytic cells were 
measured, using the specific antibodies as markers for these cell types. 
Figure 3.11 shows the Gr-I positive events (neutrophils) found in the peritoneal cavity 
after treatment with ILAP. Higher levels of Gr-I positive events (neutrophils) were 
found in the peritoneal cavity after 4 hr treatment with IL-lP in both the ANX-Al"' 
and ANX-Al' mice. These numbers returned to basal levels after 24 hr treatment in 
both the ANX-Al' and the ANX-AI-- animals. This is similar to the pattern seen with 
zymosan treatment. However when using IL-lp no significant difference between 
ANX-Al' and ANX-Al-l- mice was seen at any of the time-points. 
The 174/80 positive events (monocytic cells) found after IL-IP treatment are displayed 
in figure 3.12. Treatment with ILAP for 4 or 24 hr had no effect on levels of 
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monocytic cells found in the peritoneal cavity. No difference was seen in monocytic 
cell numbers between the two ANX-A I genotypes. 
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Figure 3.11. Gr-I positive events during IL-10 peritonitis in ANX-Al' 
andANX-AI'mice. ANX-Al"' M and ANX-Al' __j mice were 
treated 
with ILAP (i. p. ). At selected time-points cells were collected by lavage, 
stained with fluorescent Ab and analysed in the flow cytometer. Values are 
mean±sem of n=8 mice per group, P<0.05 vs. corresponding time 0, n. s, no 
significant difference. 
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Figure 3.12. F4/80 positive events during IL-10 peritonitis in ANX-API- 
and ANX-Al"/+ mice. ANX-AIIII and ANX-Al-1- mice were treated 
with IL-lp (i. p. ). At selected time-points cells were collected by lavage, 
stained with fluorescent Ab and analysed in the flow cytometer. Values are 
mean±sern of n=8 mice per group. 
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3.1.4.2. CD11b Expression on Gr-I and F4/80 Positive Populations 
The level of CD11b expression was measured on both the Gr-I positive population and 
the F4/80 positive population of cells collected from ANX-AI4- and ANX-Al. "' mice 
treated with IL- I P. 
Figure 3.13. shows CD11b expression on Gr-I positive cells (neutrophils) collected 
from 4 hr treated mice. As the graph shows there was no significant difference in 
CD11b levels between ANX-Al"' and ANX-AI-1- mice. CD1lb expression could not 
be measured on 0 hr or 24 hr samples as the numbers of neutrophils found at those 
time-points were too low to get an accurate result. 
Figure 3.14. shows CD11b expression on F4/80 positive cells (monocytic cells). As 
with CD11b expression on Gr-1 positive cells it can be seen that no significant 
differences were seen between the ANX-AI'4" and the ANX-Al-1- mice. No changes in 
CD IIb expression were seen over the time course of the peritonitis experiment in either 
the ANX-AI'4' or the ANX-A V- mice. 
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Figure 3.13. CD111b expression on Gr-1 positive cells (neutrophils) after 
IL-10 peritonitis in ANX-Al' and ANX-Al" mice. ANX-Al"' M and 
ANX-Al-'- --] mice were treated with IL-lp (i. p. ) for 4 hr. Cells were 
collected by lavage, stained with fluorescent Ab and analysed in the flow 
cytometer. Values are mean±sem of n=7-8 per group. 
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Figure 3.14. CD111b expression on F4/80 positive cells (monocytic cells) 
after IL-10 peritonitis in ANX-AI-I and ANX-Al-11 mice. ANX-Al"' J, 
and ANX-A I -'- mice were treated with zymosan (i. p. ). At selected time- 
points cells were collected by lavage, stained with fluorescent Ab and analysed 
in the flow cytometer. Values are mean±sem of n=8 mice per group. 
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3.1.5. Zymosan Peritonitis in Male Transgenic ANX-Al Over-Expressing Mice 
During the course of this study transgenic animals that were genetically modified to 
over-express ANX-Al became available (a kind gift from Dr. Wells, Imperial College, 
London) and so the same experiments that had been carried out in the ANX-AV- mice 
could be completed in these mice. Transgenic over-expressing (ANX-AITG) mice and 
the corresponding negative littermate control (ANX-Al') mice were used. The 
zymosan peritonitis model was chosen as this gave interesting results in the ANX-Al-'- 
animals. The majority of experiments were carried out in male animals but as some 
females were also available, a few experiments were also performed in these mice. 
3.1.5.1. Gr-1 and F4/80 Positive Events 
Figure 3.15. shows the Gr-1 positive events (neutrophils) found in the peritoneal cavity 
after treatment with I mg zymosan in both ANX-AI'G and ANX-AILM male mice. In 
both genotypes there was a significant increase in numbers of Gr-I positive events after 
4 hr zymosan treatment. However, in the ANX-AITGmice the levels of Gr-1 positive 
events were significantly lower than in the ANX-AIL" mice (ANX-AILM: 26.50: t4.53, 
n= II vs. ANX-A ITG: 12.98---4.36, n=10, P<0.05). No significant difference was found 
between ANX-Al' and ANX-AITGmice that were untreated controls. 
Figure 3.16. shows the 174/80 positive events (monocytic cells) found in the peritoneal 
cavity after treatment with zymosan in male ANX-Al"' and ANX-A ITG mice. In the 
ANX-AlLm mice there was a significant decrease in numbers of 174/80 positive events 
after 4 hr zymosan treatment. In the ANX-Al"' mice the levels of 174/80 positive 
100 
events did not decrease at the 4 hr time-point and were not significantly different to 
basal values. However there was no significant difference between the ANX-A I Lm and 
the ANX-Al" mice at this time-point. The graph also shows there was no significant 
difference between the ANX-AlLm and ANX-A ITG mice with respect to the untreated 
controls (0 hr time-point). 
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Figure 3.15. Gr-I positive events during zymosan peritonitis in male 
ANX-AlT"' and ANX-Al"I mice. Male ANX-AILM 0 and ANX-A I TG ý: ] 
mice were treated with zymosan (i. p. ) for 4 hr. Cells were collected by lavage, 
stained with fluorescent Ab and analysed in the flow cytometer. Values are 
mean±sem of n=10-1 I mice per group, ' P<0.05 vs. corresponding time 0, 
IIIP<0.05 ANX-A I'G vs. ANX-A I Lm at same time-point. 
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Figure 3.16. F 4/80 positive events during zymosan peritonitis in male 
ANX-AJTG and ANX-AJLM mice. Male ANX-A I I-m and ANX-A ITG 
mice were treated with zymosan (i. p. ) for 4 hr. Cells were collected by lavage, 
stained with fluorescent Ab and analysed in the flow cytometer. Values are 
mean±sem of n=10-1 I mice per group, P<0.05 vs. corresponding time 0. 
3.1.5.2. CD11b Expression on Gr-1 and F4/80 Positive Populations 
The level of CD IIb expression was measured on both the Gr- I positive population and 
the 174/80 positive population of cells collected after treatment of ANX-A IT' and ANX- 
AI LM mice with zymosan. 
Figure 3.17. shows CID 11 b expression on Gr- I positive cells (neutrophils) 4 hr post 
zymosan injection. There were significantly higher levels of CDI lb expressed on Gr-I 
positive cells from ANX-A I LM mice compared to cells from ANX-A I TG mice (ANX- 
A ILM : 296. -t85 vs. ANX-A I TG: 107: 0 1, n=7, P<0.05). 
CDI Ib expression on 174/80 positive cells (monocytic cells) is shown in figure 3.18. 
No significant changes in CD11b expression were seen over the course of the 
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peritonitis experiment in ANX-AILM or ANX-A ITG mice. No significant difference 
was seen between ANX-AlLm and ANX-A I TG mice at either of the time-points 
examined (0 hr and 4 hr). 
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Figure 3.17. CD11b expression on Gr-I positive cells (neutrophils) after 
zymosan peritonitis in male ANX-A ITG and ANX-Al"' mice. Male ANX- 
A ILM E and ANX-A ITG [-] mice were treated with zymosan (i. p. ) for 4 hr. 
Cells were collected by lavage, stained with fluorescent Ab and analysed in the 
flow cytometer. Values are mean±sem of n=7 mice per group, IIIP<0.05 
ANX-A ITG vs. ANX-A I LM . 
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Figure 3.18. CD11b expression on F4/80 positive cells (monocytic cells) 
after zymosan peritonitis in male ANX-AlT(, and ANX-AILM mice. ANX- 
AILM and ANX-A I TG mice were treated with zymosan (i. p. ) for 4 hr. 
Cells were collected by lavage, stained with fluorescent Ab and analysed in the 
flow cytometer. Values are mean±sem of n=10-1 I mice per group. 
3.1.5.3. ANX-Al Expression in Peritoneal Cells 
Male ANX-A ITG and ANX-A l'-m mice were treated with I mg zymosan i. p. (in 0.5 ml 
sterile PBS) for 4 hr or left untreated as controls. Cells collected from the peritoneal 
cavity were frozen at -80'C and later thawed for Western blot analysis. 
Figure 3.19(a) shows the levels of ANX-Al expression by peritoneal cells from 
untreated (control) ANX-Al"' and ANX-AILM mice (these cells would mainly be 
resident macrophages). ANX-Al was found to be present in cells from both ANX- 
Al""' and ANX-Al"m mice. It was visually unclear if there was a difference in 
expression of the protein in either genotype so figure 3.19(b) shows a densitometric 
analysis of the blot. Data shown are normalised so expressed as a percentage of 
tubulin, see figure 3.19(a). The data from the densitometric analysis does not show 
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more ANX-Al expression in the macrophages of ANX-AITG mice compared to the 
ANX-Al' mice. This was unexpected due to the fact that over-expression of ANX- 
Al was noted in other body tissues (unpublished data from group who generated the 
mice). 
Cell pellets from mice treated with zymosan for 4 hr were also blotted for ANX-A I 
expression and this blot is shown in figure 3.20(a) along with the blot for tubulin from 
these samples. There was clearly ANX-Al expression in both genotypes. Some 
samples show the typical ANX-Al double band and some do not but this does not seem 
to be connected to which genotype the samples are obtained from. Figure 3.20(b) is an 
attempt to see if a correlation exists between the band density obtained from the 
western blot and the amount of Gr-I positive events found in the peritoneal cavity of 
the same mice. Even though only a few samples could be assessed it shows a 
correlation exists between the two variables, i. e. the samples with less Gr-I positive 
events had a lower optical density (and a single band on the western blot) 
Figure 3.20(c) is a graphical representation of the data from the blot. There was no 
difference in the optical density of bands from either genotype and therefore ANX-Al 
expression between the ANX-AlTGand ANX-AlLm mice on cells from the inflamed 
peritoneal cavity. 
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Figure 3.19. ANX-Al expression on cells from peritoneal cavities of 
IT( , untreated (basal) male ANX-A ' and ANX-Al'-" mice. Peritoneal 
cavities of untreated male ANX-A I TG and ANX-AIIII ý mice were 
lavaged, cell lysates were analysed by western blotting for ANX-Al and 
tubulin expression (a) Western blot results (b) Densitometry data from western 
blots. Values are mean±sern of n=3-6 mice per group. 
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Figure 310. ANX-Al expression on cells from peritoneal cavities of 
zymosan treated ANX-AIT(; and ANX-AIIII mice. Male ANX-A 11" and 
ANX-A I I" E mice were treated with zymosan (I. p. ) for 4 hr, collected cells 
were later analysed by western blotting for ANX-Al and tubulin expression. 
(a) Western blot results (b) Correlation between band optical density and % 
Gr- I positive events in these samples (c) Densitometry data from western 
blots. Values are mean±sem of n=6 mice per group. 
107 
. 10 -I 
3.1.5.4. Cytokine Release by Peritoneal Cells 
By analogy to the experiments with ANX-AI-- mice, the levels of cytokines in the 
peritoneal cavities of ANX-AITG and ANX-Al' mice were also measured. 
Figure 3.21(a) shows TNF-a release by peritoneal cells from untreated (0 hr) and 4 hr 
zymosan treated mice. No difference was seen in TNF-(x release with 4 hr zymosan 
treatment in either the ANX-AlLm or the ANX-AITG mice. As can be seen from the 
graph there was also no significant difference in TNF-(x release between the two 
genotypes. 
Figure 3.21(b) shows KC release from peritoneal cells. There was a significant 
increase in KC release into the supernatant from mice treated with zymosan for 4 hr. 
This was seen in both genotypes (ANX-AlLm; 0 hr: 19.89. t4.46 pg/ml, n=4 vs. 4 hr: 
69.98±10.05 pgIml, n=7, P<0.05 ANX-AITG; 0 hr: 22.68±4.28 pg/ml vs. 4 hr: 
81.40: 07.47 pg/ml, n=7, P<0.05). No significant difference was found between the 
ANX-A I Lm and the ANX-A I' mice with respect to KC release. 
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Figure 3.21. C ytokine release by cells into the peritoneal cavity during 
zymosan peritonitis in ANX-AlLm and ANX-AjTG mice. Male ANX-A I" 
(solid bars) and ANX-AITG (clear bars) mice were either left as untreated 
controls (0 hr) or treated with zymosan (i. p. ) for 4 hr. Measurement of 
cytokine release (a) TNF-(x (b) KC was made using an ELISA kit. Values are 
mean±sem of n=8 mice per group, T<0.05 vs. corresponding time 0. 
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3.1.6. Zymosan Peritonitis in Female ANX-Al' Mice 
3.1.6.1. Gr-1 and F4/80 Positive Events 
In the initial studies with the ANX-AI4- mice (Hannon et al., 2002) there was an 
indication of a sexual dimorphism in the extent of PMN emigration. It was decided a 
worthwhile experiment would be to examine the response of the female ANX-AITG 
mice. This was tested in the zymosan peritonitis model. 
Treatment with I mg zymosan lead to a significant increase in the percentage of Gr-1 
positive events found in the peritoneal cavities of both ANX-AlLm (0 hr: 0.13: tO. 05, 
n=8 vs. 4 hr: 18.11±2.32, n=6, P<0.05) and ANX-AlTG (0 hr: 0.15±0.06, n=8 vs. 
22.03±3.61, n=7, P<0.05) female mice (Figure 3.22). However, no significant 
differences were found in levels of Gr-I positive events when the ANX-AILM mice 
were compared to the ANX-A ITG mice at either the 0 hr or the 4 hr time-point. 
Figure 3.23 shows that the levels of F4/80 positive events found in the peritoneal cavity 
after 4 hr treatment with zymosan were significantly decreased when compared to the 
levels found in untreated control mice (0 hr zymosan) in ANX-AIL" mice (0 hr: 
24.41: t4.45, n=8 vs. 4hr: 2.95±1.39, n=6, P<0.05). The same pattern was seen in ANX- 
AITGmice (0 hr: 22.39±5.35, n=8 vs. 4 hr: 1.86±0.69, n=7, P<0.05). No significant 
difference was seen between the female ANX-AlLm and ANX-AIG mice at either 0 hr 
or 4 hr. 
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Figure 3.22. Gr-1 positive events during zymosan peritonitis in female 
ANX-AJTG and ANX-AJLM mice. Female ANX-A I LM 0 and ANX-A I TG -j 
mice were treated with zymosan (i. p. ) for 4 hr. Cells were collected by lavage, 
stained with fluorescent Ab and analysed in the flow cytometer. Values are 
mean±sem of n=6-8 mice per group, ' P<0.05 vs. corresponding time 0. 
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Figure 3.23. F4/80 positive events during zymosan peritonitis in female 
ANX-A ITG and ANX-AIIII mice. Female ANX-A I LM and ANX-A I 
mice were treated with zymosan (i. p. ) for 4 hr. Cells were collected by lavage, 
stained with fluorescent Ab and analysed in the flow cytometer. Values are 
mean±sem of n=6-8 mice per group, P<0.05 vs. corresponding time 0. 
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3.1.6.2. CD I lb Expression on Gr- I and F4/80 Positive Populations 
The level of CD IIb expression was measured on both the Gr- I positive population and 
the F4/80 positive population of cells collected from female ANX-A ITG and ANX- 
AI LM mice treated with zymosan. 
In contrast to the results obtained with male ANX-A I TG mice (lower CD IIb on PM N 
of ANX-A I" mice compared to ANX-A I LM mice), CD IIb expression on Gr- I positive 
cells (neutrophils) after 4 hr zymosan treatment was not significantly different between 
ANX-A I Lm and ANX-A ITG female mice (Figure 3.24). 
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Figure 3.24. CD11b expression on Gr-1 positive cells (neutrophils) after 
zymosan peritonitis in female ANX-AJTG and ANX-AjLM mice. Female 
ANX-A I I-m 0 and ANX-A I" E mice were treated with zymosan (i. p. ) for 4 
hr. Cells were collected by lavage, stained with fluorescent Ab and analysed 
in the flow cytometer. Values are mean±sem of n=6-7 mice per group. 
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Figure 3.25 shows CD11b expression on 174/80 positive events (monocytic cells). 
Expression was not altered by 4 hr treatment with zymosan in either the ANX-A I LM or 
the ANX-A I TG mice. CD IIb expression was not significantly different between the 
genotypes basally (0 hr) or after 4 hr zymosan treatment. 
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Figure 3.25. CD11b expression on F4/80 positive cells (monocytic cells) 
after zymosan peritonitis in female ANX-AITG and ANX-Al" mice. 
Female ANX-All-11 and ANX-A I TG mice were treated with zymosan 
(i. p. ) for 4 hr. Cells were collected by lavage, stained with fluorescent Ab and 
analysed in the flow cytometer. Values are mean±sem of n=6-7 mice per 
group. 
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3.1.6.3. ANX-Al Expression in Peritoneal Cells 
Female ANX-Al' and ANX-AILm mice were treated i. p. with I mg zymosan (in 0.5 
ml sterile PBS) for 4 hr or left untreated as controls. Peritoneal cells collected from the 
peritoneal cavity were frozen at -80*C and later thawed for western blot analysis. 
Figure 3.26(a) shows the levels of ANX-Al expression in peritoneal cells collected 
from untreated female ANX-A1TG and ANX-AILM mice (mainly resident 
macrophages). ANX-Al protein was detected in cell lysate samples from both ANX- 
AITGand ANX-Al' female mice. All samples tested displayed double bands however 
the top band (intact ANX-AI) was expressed to a different extent in individual mice. 
The blot for tubulin is also shown in figure 3.26(a). Figure 3.25(b) is graphical 
representation of the band optical densities normalised with reference to tubulin, and as 
can be seen there was no difference in the ANX-Al expression between ANX-AILM 
and ANX-A ITGfemale mice under basal conditions. 
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Figure 3.26. ANX-Al expression on on cells from peritoneal cavities of 
untreated (basal) female ANX-Al' and ANX-AIIII mice. Peritoneal 
cavities of untreated female ANX-A I TG and ANX-All-m mice were 
lavaged, cell lysates were analysed by western blotting for ANX-Al and 
tubulin expression (a) Western blot results (b) Densitometry data from western 
blots. Values are mean±sem of n=4 mice per group. 
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3.1.6.4. Cytokine Release by Peritoneal Cells 
Figure 3.27(a) shows TNF-cc release by peritoneal cells from untreated (0 hr) and 4 hr 
zymosan treated female mice. As is shown in the graph there was no change detected 
in TNF-a release by peritoneal cells in response to treatment with zymosan for 4 hr. 
There was no significant difference in TNF-a release between the female ANX-AILM 
and ANX-A I'G mice at either 0 hr or 4 hr. 
Figure 3.27(b) shows that in female ANX-AITr' mice the level of KC released from 
peritoneal cells increased after 4 hr zymosan treatment (0 hr: 19.26: f-. 3.33 vs. 4 hr: 
38.85: t8.66, n=8, P<0.05). This was similar to the result obtained from male ANX- 
A ITG mice. However, in the female ANX-Al' mice no increase was seen in the 4 hr 
supernatants (0 hr: 25.59±4.29 vs. 4 hr: 28.42--4.74, n=8, P>0.05) which is in contrast 
to the pattern seen in male ANX-A ITG mice. 
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Figure 3.27. Cytokine release by cells into the peritoneal cavity during 
zymosan peritonitis in female ANX-Al WT and ANX-AlTI mice. Female 
ANX-Al"' (solid bars) and ANX-AITG (clear bars) mice were either left as 
untreated controls (0 hr) or treated with zymosan (i. p. ) for 4 hr. Measurement 
of cytokine release (a) TNF-ct (b) KC was made using an ELISA kit. Values 
are mean±sem of n=8 mice per group, P<0.05 vs. corresponding time 0. 
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3.2. Intravital Microscopy of the Cremaster Muscle 
Before embarking on a set of complex and time-consuming experiments the effect, if 
any, of peptide Ac2-26 on leukocyte recruitment in the cremaster muscle preparation 
had to be assessed. As this had not previously been described, PAF superfusion (100 
nM) was chosen to inflame the cremaster muscle. This concentration was chosen as it 
causes significant and reproducible inflammation in the rat mesentery (Tailor et aL, 
1997) and in the mouse cremaster (Henninger et al., 1997). Superfusion was chosen as 
the method of administration rather than local intrascrotal injection of an inflammogen 
due to its relative ease as well as animal licensing restrictions at that time. Another 
important benefit of this model is the fact that a vessel is chosen in an untreated animal 
and then monitored over the course of the developing inflammatory response so as well 
as having an internal control, the time course of the response could also be measured. 
3.2.1. Effect of AcI-26 in the Cremaster Muscle Preparation 
C57BU6 mice were prepared for intravital microscopy of the cremaster muscle and 
after a 30 min stabilisation period were either treated with 200 [tg peptide Ac2-26 (in 
200 IAI PBS) or 200 IAI PBS alone via a cannula in the jugular vein (i. v. ). The cremaster 
was then superfused with 100 nM PAF for a total of 90 min. 
Rolling Velocity 
The effect of Ac2-26 on leukocyte rolling velocity is shown in figure 3.28. The data 
are presented as a percentage of the rolling velocity measured at time 0 (basal) for 
clarity. In PBS treated (vehicle control) mice the rolling velocity of leukocytes was 
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significantly reduced over the 90 min time course of 100 nM PAF superfusion from 30 
min onwards. In the mice treated with peptide Ac2-26 there was also a reduction in 
cell rolling velocity over the PAF time course and this was significant at 30,60,75 and 
90 min. There were no significant differences between the two treatment groups at any 
of the time-points measured. 
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Figure 3.28. Effect of Ac2-26 on cell rolling velocity as assessed in the 
inflamed cremaster muscle of C57BL/6 mice. C57BL/6 mice were prepared 
for intravital microscopy. Mice were treated with either PBS N or 200 g Ac2- 
26 Fý (time 0) and then superfused with 100 nM PAF. Rolling velocity is 
shown as % of basal rolling velocity (basal rolling velocity in PBS and Ac2-26 
treated mice was 41±8 and 89±20 Rm/sec respectively). Values are mean±sem 
of n=4 mice per group, T<0.05 vs. corresponding time 0. 
Cell Flux 
Figure 3.29. shows the effect of 100 nM PAF on cell flux in vehicle control (PBS 
treated) and peptide Ac2-26 treated mice. In the vehicle control group cell flux was not 
significantly altered over 90 min of PAF superfusion. The same was seen in the 
peptide treated group. There were also no significant differences between the treatment 
groups at any of the time-points measured. The large error bars on the graph show that 
cell flux was highly variable in both the peptide treated and vehicle control animals. 
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Figure 3.29. Effect of Ac2-26 on cell flux as assessed in the inflamed 
cremaster muscle of C57BL/6 mice. C57BL. /6 mice were prepared for 
intravital microscopy. Mice were treated with either PBS 0 or 200 ýtg Ac2- 
26 F-] (time 0) and then superfused with 100 nM PAF. Cell flux was 
measured as the number of cells passing a fixed point in the vessel/min. 
Values are mean±sem of n=4 mice per group. 
Adhesion 
Figure 3.30 shows that cell adhesion was increased in a time-dependent manner when 
the cremaster muscle was superfused with 100 nM PAR In the vehicle control animals 
the number of adherent cells was significantly higher than the basal level (0 min) from 
45 min of PAF superfusion onwards. The treatment of mice with Ac2-26 caused no 
significant change in adhesion which still increased in a time-dependent manner in 
these mice (also significant from 45 min onwards). No significant differences were 
seen between the two treatments at any of the time-points measured. 
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Figure 3.30. Effect of Ac2-26 on cell adhesion as assessed in the inflamed 
cremaster muscle of C57BL/6 mice. C57BL/6 mice were prepared for 
intravital microscopy. Mice were treated with either PBS 0 or 200 [Lg Ac2- 
26 Fý (time 0) and then superfused with 100 nM PAR Adhesion is measured 
as the number of cells stationary for >30 sec. Values are mean±sem of n=4 
mice per group, P<0.05 vs. corresponding time 0, n. s, no significant 
difference between KO vs. WT at same time-point. 
Emigration 
PAF also caused a time-dependent increase in the number of cells that emigrated from 
the vessel into the surrounding tissues in vehicle control mice. The profile of this 
response is shown in figure 3.3 1, showing a significant increase compared to basal 
from 30 min onwards. In animals treated with Ac2-26 there was a significant 
attenuation of this increase. Numbers of emigrated cells were significantly lower in 
peptide treated mice compared to the vehicle control at 75 and 90 min time-points. 
Calculated inhibitions of 43% and 54% were obtained for the peptide Ac2-26 group at 
75 and 90 min PAF superfusion. The degree of inhibition becomes even more marked 
if calculations are made on net values, i. e. subtracting the spontaneous emigration 
measured before PAF superfusion which gives a calculated inhibition of 67% and 79% 
respectively. Another way of assessing this event was by comparing the areas under 
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the curve, showing that overall the treatment with Ac2-26 causes a 35% decrease in cell 
emigration. It can be also be seen that the number of emigrated cells in the peptide 
treated animals was not increased from basal (0 min) at any of the time-points 
measured. 
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Figure 3.31. Effect of Ac2-26 on cell emigration as assessed in the 
inflamed cremaster muscle of C57BL/6 mice. C57BL/6 mice were prepared 
for intravital microscopy. Mice were treated with either PBS 0 or 200 [tg 
Ac2-26 F-I (time 0) and then superfused with 100 nM PAR Emigration is 
measured as number of cells either side of 100 [trn vessel. Values are 
mean±sem of n=4 mice per group, : P<0.05 vs. corresponding time 0, yP<0.05 
KO vs. WT mice at same time-point, n. s, no significant difference. 
Haemodynamic parameters 
The haemodynamic parameters measured in post-capillary venules of mice inflamed 
with 100 nM PAF are shown in table 3.1. Superfusion with 100 nM PAF had no 
significant effects on RBC velocity or WSR over the 90 min time course. The 
treatment of mice with Ac2-26 did not cause any significant changes to these 
parameters either. 
122 
0 15 30 45 60 75 90 
PAF Superfusion (min) 
Summary 
The superfusion of 100 nM PAF in C57BU6 mice caused a significant and measurable 
inflammation in the cremaster muscle. An effect on cell flux was not apparent, 
however there was a significant decrease in cell rolling velocity associated with a time- 
dependent increase in cell adhesion and emigration. The effect of PAF on cell rolling 
velocity was maximal from 30 min onwards, the increase in adhesion was maximal at 
45 min and the maximum increase in emigration occurred at 75 min. After these time- 
points there was no further increase, at least during the time frame examined. 
The administration of the ANX-Al mimetic, peptide Ac2-26 had no effect on cell 
rolling and adhesion however it caused a marked attenuation of cell emigration, 
particularly evident at the later time-points of PAF superfusion. 
Treatment n Vessel RBC WSR 
diameter velocity (sec-) 
(ILM) (mm/sec) 
100 nM PAF 4 28.90: t 3.39 0 2.68 :t0.52 480: t 92 
+ PBS 15 2.60: t 0.57 457: t 89 
(Vehicle control) 30 2.55 :t0.5 8 443 :t 93 
45 2.60: t 0.63 452: t 97 
60 2.85 t 0.80 492 t 122 
75 2.48 -t 0.44 435: t 72 
90 2.33 t 0.46 406 t69 
100 nM PAF 4 36.46: t 2.25 0 3.85 :t0.94 530: t 133 
+ Ac2-26 15 3.33 :t0.54 453 t 68 
30 3.18: t 0.67 434: t 91 
45 3.65 t 0.89 496: t 121 
60 3.23 :t0.91 447: t 131 
75 3.33 :t0.88 463: t 128 
90 2.53: t 0.21 351 :t 37 
Table 3.1. Effect of Ac2-26 on haemodynamic parameters of 100 nM PAF 
inflamed cremasteric venules of C57BU6 mice. C57BU6 mice were 
prepared for intravital microscopy. Mice were treated with either with either 
PBS (200 tLI) or Ac2-26 (200 [tg in 200 Id PBS) Lv. (after time 0 recording). 
The tissue was then superfused with 100 nM PAR Vessel diameter and RBC 
velocity were measured and WSR calculated. Values are meantsem of n=4 
mice per group. 
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3.2.2. Effect of PAF on Leukocyte Recruitment in ANX-Al"" and ANX-Al"'* Mice 
Once it had been established that the microcirculation of the cremaster was susceptible 
to the effects of ANX-Al by using the peptido-mimetic Ac2-26, then the first series of 
experiments were to examine leukocyte-endothelium interactions in ANX-AI4- and 
ANX-Al"' mice when no inflammatory stimulus was used. The response measured 
under these conditions is prompted by the trauma produced by the tissue manipulation 
during exposure of the cremaster muscle. 
3.2.2.1. Basal leukocyte recruitment 
ANX-AI4- and ANX-A 1'4' mice were prepared for intravital microscopy of the 
cremaster muscle. To assess basal levels of leukocyte recruitment a suitable vessel was 
chosen and then recorded for 90 min of the experiment. During this time the tissue was 
superfused with BBS to keep the conditions as physiological as possible 
Rolling Velocity 
Figure 3.32 shows cell rolling velocity in both the ANX-Al"' and ANX-AI-1- mice 
under basal conditions. The data are presented as a percentage of basal rolling velocity. 
As can be clearly seen the cell rolling velocity in ANX-Al' mice was quite consistent 
over the time course of the experiment. The same pattern was seen in the ANX-AI-/- 
mice and the rolling velocity neither increased nor decreased significantly over the 90 
min. No significant difference was seen between the two genotypes. 
124 
200 
150 
ei ce 
loo 
50 
0 
Figure 3.32. Basal cell rolling velocity as assessed in the cremaster muscle 
of ANX-AI-I and ANX-AI+'+ mice. ANX-Al+'+ 0 and ANX-Al' mice 
were prepared for intravital microscopy. The tissue was superfused with 1313S 
for 90 min. Rolling velocity is shown as % of basal rolling velocity (basal 
rolling velocity in ANX-Al+` and ANX-Al' mice was 60±18 and 47±5 
[tm/sec respectively). Values are mean±sem of n=6 mice per group. 
Cell Flux 
Cell flux is measured as the number of cells passing a fixed point in the vessel per min. 
The basal cell flux in ANX-Al" and ANX-Al-'- mice is shown in figure 3.33. As it 
can be seen, the cell flux in both the ANX-Al"' and the ANX-Al-'- mice was quite 
consistent over the time course of the experiment. However, the values obtained for 
each mouse analysed were quite variable as shown by the relatively large error bars. 
There was no difference in the extent of cell flux when ANX-A]"' animals were 
compared to ANX-A I -'- mice at any of the time-points measured. 
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Figure 3.33. Basal cell flux as assessed in the cremaster muscle of ANX- 
Al' and ANX-All mice. ANX-Al"' M and ANX-Al-'- mice were 
prepared for intravital microscopy. The tissue was superfused with BBS for 90 
min. Cell flux was measured as the number of cells passing a fixed point in 
the vessel/min. Values are mean±sem of n=6 mice per group. 
Adhesion 
The basal levels of cell adhesion in the ANX-Al-'- and the ANX-Al+'+ mice are shown 
in figure 3.34. Between 3 and 4 adherent cells were found consistently over the time 
course in both the ANX-Al"' and ANX-Al-'- mice and these levels did not 
significantly increase or decrease over the 90 min time course. No significant 
difference was seen when comparing the two genotypes. 
Emigration 
Basal cell emigration shows a similar pattern to cell adhesion however, with a smaller 
proportion of emigrated cells compared to adherent cells. The number of emigrated 
cells was consistent over the time course in both the ANX-A I"'* and ANX-A I -'- mice. 
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No significant difference was seen between the ANX-Al"' and ANX-Al-'- mice. This 
is shown in figure 3.35. 
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Figure 3.34. Basal cell adhesion as assessed in the cremaster muscle of 
ANX-Al' and ANX-AIII mice. ANX-Al"' M and ANX-Al' mice 
were prepared for intravital microscopy. The tissue was superfused with BBS 
for 90 min. Adhesion is measured as number of cells stationary for >30 sec. 
Values are mean±sem of n=6 mice per group. 
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Figure 3.35. Basal cell emigration as assessed in the cremaster muscle of 
ANX-Al-1- and ANX-All mice. ANX-Al+'+ 0 and ANX-Al-1- mice 
were prepared for intravital microscopy. The tissue was superfused with 1313S 
for 90 min. Emigration is measured as number of cells either side of 100 [tm 
vessel. Values are mean±sem of n=6 mice per group. 
Haemodynamic parameters 
The haemodynamic parameters measured in untreated post-capillary venules are shown 
in table 3.2. No significant differences were seen between the genotypes with respect 
to either RBC velocity or WSR at any of the time-points. These parameters were not 
significantly altered over the time course of the experiment in either the ANX-A I"' or 
the ANX-A I -'- mice. 
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Genotype Treatment n Vessel 
diameter 
(ILM) 
RBC 
velocity 
(mm/sec) 
WSR 
(see") 
ANX-A I' Vehicle control 6 32 ± 1.53 0 2.52 ± 0.37 385 ±47 
15 2.97 ± 0.39 466 ±69 
30 2.62 ± 0.31 404 ±42 
45 2.73 ± 0.27 425 ± 44 
60 2.63 ± 0.26 411 ±47 
75 2.62 ± 0.34 411 ± 50 
90 2.60 ± 0.29 404 ± 36 
ANX-Al' Vehicle control 6 29: t 2.90 0 2.87: t 0.36 496 t46 
15 3.27: t 0.24 575 t 54 
30 2.93: t 0.35 509: t 47 
45 2.92 ± 0.28 512 ± 40 
60 2.60 ± 0.39 440 ± 30 
75 2.57: t 0.33 436 ± 25 
90 2.58: t 0.32 438 ± 20 
Table 3.2. Haemodynamic parameters in vehicle control (basal) 
cremasteric venules of ANX-AII*'+ and ANX-AI-I" mice. ANX-All and 
ANX-All mice were prepared for intravital microscopy. The tissue was 
superfused with BBS for 90 min. Vessel diameter and RBC velocity were 
measured and WSR calculated. Values are meantsern of n=6 per group. 
Summary 
When quantifying basal leukocyte recruitment in ANX-A 1'4- and ANX-A 1 4' a low level 
of cell adhesion and emigration could be measured but did not significantly increase 
over the 90 min time course of the experiment. Rolling velocity and cell flux were also 
unchanged and constant over the time course however these numbers were more 
variable than those obtained with cell emigration and adhesion. The preparation proved 
to be quite stable and apart from the initial mild activation due to tissue manipulation 
and maintaining the mouse on the stage produced no further activation. So, the next 
experiments examined the response of ANX-Al-- mice to an inflammatory stimulus. 
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3.2.2.2. Effect of High Dose (100 nM) PAF 
To examine the recruitment of leukocytes under inflammatory conditions PAF was 
chosen as an inflammatory stimulus. This agonist was chosen for the reasons outlined 
above (section 3.2. ) and also because PAF is a direct acting feukocyte activator (the 
PAF receptor is found on blood leukocytes). This means that other cell types in the 
surrounding tissues (for example, tissue macrophages) should not be activated by PAF 
offering some degree of selectivity. Initial experiments were carried out to investigate 
potential defects in the leukocyte migration process due to absence of ANX-A I. 
ANX-Al-'- and ANX-AI'4' mice were prepared for intravital microscopy of the 
cremaster muscle. A suitable vessel was chosen, superfused with a 100 nM PAF 
solution, and then recorded for 90 min of the experiment to assess leukocyte 
recruitment under inflammatory conditions. 
Rolling Velocity Figure 3.36 shows the rolling velocity in ANX-Al-1- and ANX-Al"' 
mice during 90 min of 100 nM PAF superfusion. The data are presented as a 
percentage of the basal rolling velocity (time 0). The ANX-Al' mice showed a 
significant decrease in cell rolling velocity over the time course which was significant 
from 30 min onwards. In the ANX-Al-- mice, the rolling velocity also decreased. This 
was significant from 15 min onwards. No significant differences were found between 
the ANX-A 1'4' and the ANX-Al' animals at any of the time-points examined. 
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Figure 3.36. Effect of 100 nM PAF on cell rolling velocity as assessed in 
the cremaster muscle of ANX-All and ANX-All mice. ANX-Al+'+ M 
and ANX-Al' Fý mice were prepared for intravital microscopy. The tissue 
was superfused with 100 nM PAF for 90 min. Rolling velocity is shown as % 
of basal rolling velocity (basal rolling velocity in ANX-AI'+ and ANX-Al' 
mice was 60±16 and 73±11 Rm/sec respectively). Values are mean±sem of 
n=6 mice per group, : P<0.05 vs. corresponding time 0. 
Cell Flux 
Cell flux in 100 nM PAF inflamed cremaster muscles of ANX-Al-'- and ANX-Al"' 
mice is shown in figure 3.37. In the ANX-Al" mice a similar pattern to rolling 
velocity findings was seen, that is, a significant decrease in cell flux was measured over 
the time course which became significantly different from basal (0 min) from 30 min 
onwards (although it slightly increases again at 90 min). In the ANX-A I -- animals the 
cell flux does not follow the same pattern as the ANX-Al" mice. Although the cell 
flux decreased significantly at 15 min it then increased again. It remained variable over 
the time course and was not significantly different from basal for the duration of the 
experiment. The cell flux was significantly different in the ANX-Al-'- animals 
compared to the ANX-A I" animals at 45,60 and 75 and 90 min. 
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Figure 3.37. E ffect of 100 nM PAF on cell flux as assessed in the 
cremaster muscle of ANX-Al' and ANX-Al"I mice. ANX-Al"' 0 and 
ANX-Al' Fj mice were prepared for intravital microscopy. The tissue was 
superfused with 100 nM PAF for 90 min. Cell flux was measured as the 
number of cells passing a fixed point in the vessel/min. Values are mean±sem 
of n_-6 mice per group, ' P<0.05 vs. corresponding time 0, yP<0.05 ANX-A I 
vs. ANX-Al" at same time-point, ns, no significant difference. 
Adhesion 
Adhesion of leukocytes induced by 100 nM PAF is shown in figure 3.38. In the ANX- 
Al" mice cell adhesion increased in a time-dependent manner. There were 
significantly higher numbers of adherent cells compared to basal (0 min) from 30 min 
onwards. A similar PAF induced time-dependent increase in cell adhesion was 
observed in the ANX-Al-/- mice which was also significant from 30 min onwards. No 
significant difference was calculated between the ANX-Al" and the ANX-Al' 
animals except at the 75 min time-point where significantly higher cell adhesion was 
attained in the ANX-Al"' compared to the ANX-Al' mice (75 min; ANX-Al": 
13.00-t 1.53 vs. ANX-A I -'-: 9.00-t 1.10, n=6, P<0.05). 
132 
%J ------ 
0 15 30 45 60 75 90 
20 
15 
10 
Z5 
01 1ý 
0 15 30 45 60 75 90 
Superfusion (min) 
Figure 3.38. Effect of 100 nM PAF on cell adhesion as assessed in the 
cremaster muscle of ANX-API and ANX-All mice. ANX-Al" 0 and 
ANX-Al' R mice were prepared for intravital microscopy. The tissue was 
superfused with 100 nM PAF for 90 min. Adhesion is measured as number of 
cells stationary for >30 sec. Values are mean±sem of n=6 mice per group, 
*P<0.05 vs. corresponding time 0, zj, P<0.05 ANX-Al' vs. ANX-Al" at same 
time-point, n. s, no significant difference. 
Emigration 
Following PAF superfusion cell emigration increased significantly in a time-dependent 
manner in both the ANX-Al" and the ANX-Al-'- mice. In the ANX-Al"' animals this 
was significant from 45 min and in the ANX-Al-'- mice from 60 min. Emigration 
shows a very similar pattern to that found with cell adhesion, that is, with no difference 
seen between the genotypes throughout the time course. At the later time-points (60, 
75 and 90 min) consistently lower emigration was found in the ANX-Al-'- mice 
however this did not reach statistical significance at the 5% level. This is shown in 
figure 3.39. 
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Figure 3.39. Effect of 100 nM PAF on cell emigration as assessed in the 
cremaster muscle of ANX-AI-I and ANX-Al+'+ mice. ANX-Al+'+ 0 and 
ANX-Al-1- F-I mice were prepared for intravital microscopy of the cremaster 
muscle. The tissue was superfused with 100 nM PAF for 90 min. Emigration 
is measured as number of cells either side of 100 [tm vessel. Values are 
mean±sem of n=6 mice per group, ý. ': P<0.05 vs. corresponding time 0, n. s, no 
significant difference between ANX-A I` vs. ANX-A 1 +11 at same time-point. 
Haemodynamic parameters 
The haemodynamic parameters measured in post-capillary venules inflamed with 100 
nM PAF are shown in table 3.3. RBC velocity and WSR were not significantly altered 
over the time course of the experiment in either the ANX-A I "' or the ANX-A I -- mice. 
No significant differences were seen between the genotypes with respect to either RBC 
velocity or WSR at any of the time-points measured. 
Summary 
When the cremaster microcirculation of ANX-Al"' mice was activated with 100 nM 
PAF over a 90 min time course, there was significantly decreased cell rolling velocity 
and cell flux and increased cell adhesion and cell emigration. The data are essentially 
similar to those obtained in C57BL/6 mice as described in section 3.1 with no 
134 
0 15 30 45 60 75 90 
Superfusion (min) 
difference evident between ANX-AI'4' mice and C57131-16 mice with respect to cell 
rolling velocity, cell adhesion and cell emigration. The cell flux was found to be 
slightly different between these two sets of mice with a sharper decrease in flux and 
less variability in cell flux in the ANX-Al"' mice compared to C57BU6 mice. A 
similar pattern was seen in the ANX-AI4- mice as in the ANX-Al' mice when cell 
rolling velocity, adhesion and emigration was assessed whereas cell flux did not 
decrease to the same extent as in the ANX-Al"' animals. 
Significant differences were not seen between the genotypes with respect to cell rolling 
velocity, adhesion or flux however, at the later time-points of the experiment there was 
significantly higher cell flux in the ANX-Al' mice compared to the ANX-Al"" mice. 
Genotype Treatment n Vessel 
diameter 
(tun) 
RBC 
velocity 
(mm/sec) 
WSR 
(sec-') 
ANX-Al+'+ 100 nM PAF 6 32± 0.94 0 3.07 ± 0.44 488 * 78 
15 2.53 ± 0.26 406 ± 51 
30 2.73 * 0.27 432 ± 53 
45 2.92: t 0.32 467 ± 64 
60 2.38 t 0.23 378 * 43 
75 2.70: t 0.19 427 ± 42 
90 2.66: t 0.26 408: t 50 
ANX-Al' 100 nM PAF 6 35: t 1.77 0 4.30: t 0.73 603 t 82 
15 3.70 -t 0.56 518 :t 56 30 4.07: t 0.75 566; t 81 
45 3.63 ± 0.43 511 * 43 
60 3.30 ± 0.30 466: t 26 
75 3.60 ± 0.54 502 ± 53 
90 3.15 :t0.55 455 ± 76 
Table 3.3. Haemodynamic parameters of 100 nM PAF inflamed 
cremasteric venules of ANX-All and ANX-AIl- mice. ANX-All and 
ANX-All mice were prepared for intravital microscopy of the cremaster 
muscle. The tissue was superfused with 100 nM PAF for 90 min. Vessel 
diameter and RBC velocity were measured and WSR calculated. Values are 
mean±sem. of n=6 mice per group. 
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3.2.2.3. Effect of Low Dose (I iiM) PAF 
In preliminary studies carried out in our department in parallel to these in vivo 
experiments, cells taken from ANX-Al-4- mice were more susceptible to in vitro 
activation when a low concentration of PAF was used, namely 1 nM. Therefore 
investigations using this lower dose of PAF in the cremaster preparation were carried 
out in order to highlight any potential changes between the genotypes. The 
experiments were carried out as before however this time the microcirculation was 
superfused with I nM PAF for up to 90 min. 
Rolling Velocity 
Figure 3.40 shows rolling velocity in ANX-AI-1- and ANX-AI4' mice after treatment 
with I nM PAR The data are presented as a percentage of basal cell rolling velocity (at 
time 0). The lower concentration of PAF (I nM) was unable to significantly reduce 
cell rolling velocity in the ANX-AI'* mouse as it did in the case with 100 nM PAF 
(see figure 3.36). A similar pattern was seen in the ANX-AI-1- mice at the start of 
superfusion, however at the later time-points (75 and 90 min) the rolling velocity was 
reduced significantly compared to basal. Thus, using the lower dose of PAF, a 
difference due to absence of the ANX-A I gene began to emerge. 
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Figure 3.40. Effect of I nM PAF on cell rolling velocity as assessed in the 
cremaster muscle of ANX-AI-' and ANX-All mice. ANX-A I+'+ N and 
ANX-Al' 
- mice were prepared 
for intravital microscopy. The tissue was 
superfused with I nM PAF for 90 min. Rolling velocity is shown as % of 
basal rolling velocity (basal rolling velocity in ANX-Al" and ANX-Al' 
mice was 50±15 and 75±20 [tm/sec respectively). Values are mean±sem of 
n=6 mice per group, P<0.05 vs. corresponding time 0. 
Cell Flux 
The values for cell flux measured during superfusion with I nM PAF is shown in figure 
3.41. In contrast to the results obtained in ANX-Al"' mice treated with 100 nM PAF 
(figure 3.37), superfusion with I nM PAF did not modify the cell flux over the 90 min 
treatment. The same holds true for the ANX-A I -'- mice though in this case this was not 
very different to the cell flux produced by 100 nM PAF treatment. 
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Figure 3.41. Effect of 1 nM PAF on cell flux as assessed in the cremaster 
muscle of ANX-Al-I and ANX-Al"I mice. ANX-A I "' N and ANX-A I -- 
mice were prepared for intravital microscopy. The tissue was superfused 
with I nM PAF for 90 min. Cell flux was measured as the number of cells 
passing a fixed point in the vessel/min. Values are mean±sem of n=6 mice per 
group. 
Adhesion 
The cell adhesion induced by I nM PAF is shown in figure 3.42. In ANX-A I"' mice 
there was a time-dependent increase in cell adhesion over the time course which 
follows the profile obtained with the higher concentration of PAF, with a significant 
increase from 45 min onwards. However, it must be noted that lower numbers of 
adherent cells were found with I nM PAF compared to 100 nM PAR For instance, at 
the 60 min time-point, 7.00: tO. 45 adherent cells were found in response to I nM PAF 
whereas 11.33. t2.03 cells were found in response to 100 nM PAF (see figures 3.38 and 
3.42). ANX-A I -'- mice also showed a time-dependent increase in cell adhesion over 90 
min which was significantly different to time 0 from 30 min onwards. This is similar to 
the response to 100 nM PAR However, in contrast to the ANX-Al" mice, emigration 
was not reduced in response to the lower dose of PAR As an example, at the 60 min 
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time-point, 7.83.0.33 cells could be counted in response to I nM PAF and 9.00: 0.27 
cells were adherent after 100 nM PAR 
No significant difference was found between the ANX-A I "' and ANX-A I -- mice with 
respect to I nM PAF induced cell adhesion despite a tendency towards higher values in 
the latter genotype. This increase did not reach statistical significance at the 5% level. 
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Figure 3.42. E ffect of 1 nM PAF on cell adhesion as assessed in the 
cremaster muscle of ANX-Al' and ANX-Al"I mice. ANX-A I` M and 
ANX-Al-1- mice were prepared for intravital microscopy. The tissue was 
superfused with I nM PAF for 90 min. Adhesion is measured as number of 
cells stationary for >30 sec. Values are meantsem of n=6 mice per group, 
: '. ýP<0.05 vs. corresponding time 0, n. s, no significant difference between ANX- 
AI` vs. ANX-A I" at same time-point. 
Emigration 
Figure 3.43 reports the effect of I nM PAF on leukocyte emigration in ANX-A I -I- and 
ANX-Al"' mice. Again, there was a time-dependent increase in cell emigration in 
both ANX-Al"' and ANX-Al-'- mice. In the ANX-Al"' there was significantly higher 
numbers of cells (compared to basal) from 30 min onwards. The numbers of emigrated 
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cells were significantly lower than those found to be emigrating in response to 100 nM 
PAR For instance, at the 60 min time-point 5.00: tO. 45 emigrated cells were found in 
response to I nM PAF whereas 11.67: t2.23 cells were counted in response to 100 nM 
PAR In the case of the ANX-AI-1- animals, there was also a time-dependent increase in 
cell emigration in response to I nM PAF and this was significant from 15 min onwards. 
As was found in the case of cell adhesion, although the ANX-Al 4' mice showed a 
significantly lower degree of cell emigration in response to the lower dose of PAF this 
was not replicated in the ANX-AI4- mice. For example, at the 60 min time-point, 
7.50: tO. 56 emigrated cells were found in response to I nM PAF and 8.50: tl. 88 cells 
emigrated in response to 100 nM PAF (not significant, compare figure 3.39 and 3.43). 
When comparing the response of ANX-Al' and ANX-AI'4' mice to I nM PAF 
superfusion it can be seen that there were significantly higher numbers of emigrated 
cells in the ANX-AI4- mice compared to the ANX-AI'4' mice. This difference was 
evident as early as 30 min from the start of PAF superfusion. At 30 min 46% more cell 
emigration was calculated in ANX-A14- mice compared to ANX-Al' mice, this 
difference increases to over 50% more cell emigration in the ANX-Al-'- mice at the 60 
min time-point. When comparisons were made on net values (subtracting the 
spontaneous emigration measured before PAF superfusion) the greater extent of 
emigration in the ANX-AI4- mice becomes even more evident, for example, at 30 min, 
75% more cell emigration was measured in the ANX-Al' mice compared to the ANX- 
AI'4* mice. When comparing the total overall increase in cell emigration, by 
examining area under the curve, 39% higher emigration could be calculated in ANX- 
AV- mice compared to ANX-Al' mice. 
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Figure 3.43. E ffect of 1 nM PAF on cell emigration as assessed in the 
cremaster muscle of ANX-AI-1- and ANX-All mice. ANX-A I "' 0 and 
ANX-A I` mice were prepared for intravital microscopy. The tissue was 
superfused with I nM PAF for 90 min. Emigration is measured as number of 
cells either side of 100 [tm vessel. Values are mean±sem of n--6 mice per 
group, P<0.05 vs. corresponding time 0, yP<0.05 ANX-A I` vs. ANX-A I 
at same time-point, n. s, no significant difference. 
Albumin Leakage 
As a significantly higher number of cells emigrated at 45 and 60 min in the ANX-A I -/- 
mice in response to I nM PAF compared to ANX-A I" mice, this later time-point was 
chosen to examine leakage of albumin into the surrounding tissue. Animals superfused 
with I nM PAF for 60 min were injected with FITC labelled albumin, and after 5 min a 
vessel was recorded for later analysis of albumin leakage. No significant difference in 
fluorescence leakage was found between the ANX-Al"' and ANX-Al-'- mice and this 
is shown in figure 3.44. 
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Figure 3.44. Effect of 1 nM PAF on albumin leakage as assessed in the 
cremaster muscle of ANX-AI-I and ANX-All mice. ANX-A I"' M and 
ANX-Al-l-, mice were prepared for intravital microscopy of the cremaster 
muscle. The tissue was superfused with I nM PAF for 60 min. At 60 min 
FITC labelled albumin was injected 5 min prior to analysis of albumin leakage. 
Values are mean±sem of n=4-5 mice per group. 
Haemodynamic parameters 
The haemodynamIC parameters were measured in post-capillary venules treated with I 
nM PAF and are shown in table 3.4. No significant differences were seen between the 
genotypes with respect to either RBC velocity or WSR at any of the time-points. These 
parameters were not significantly altered over the time course of the experiment in 
either the ANX-A I "' or the ANX-A I -- mice. 
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Genotype Treatment n Vessel RBC WSR 
diameter velocity (sec-') 
OLM) (mm/sec) 
ANX-Al' I nM PAF 6 32: t 2.55 0 2.68 :t0.35 432t 37 
15 2.98: t 0.31 497: t 61 
30 2.88 :t0.34 474: t 51 
45 2.65. t 0.36 425 ± 44 
60 2.96. t 0.28 459 ± 55 
75 2.90: t 0.35 444 ± 46 
90 3.10 :t0.52 467: t 64 
ANX-AI'l- I nM PAF 6 30: t 1.65 0 2.93 t 0.34 492: t 46 
15 2.88 :t0.39 481 :t 50 
30 2.45: t 0.32 419: t 57 
45 2.55: t 0.34 439: t 63 
60 2.48 -t 0.34 
425 :t 61 
75 2.48: t 0.32 420: t 51 
90 2.57: t 0.36 432: t 56 
Table 3.4. Haemodynamic parameters in I nM PAF inflamed cremasteric 
venules of ANX-Al"I* and ANX-A14"mice. ANX-AI4+ and ANX-Al-1- mice 
were prepared for intravital microscopy. The tissue was superfused with I nM 
PAF for 90 min. Vessel diameter and RBC velocity were measured and WSR 
calculated. Values are mean: rsem of n=6 mice per group. 
Summary 
In the ANX-Al' mouse superfusion with I nM PAF seemed to be unable to produce 
significant changes in cell rolling and cell flux however the numbers of adherent and 
emigrated cells did increase in a time-dependent manner over the 90 min time course. 
Although the adhesion and emigration response to 1 nM PAF was significant it was not 
as marked as when mice were treated with the high dose, WOW, of PAF showing that 
the response was also concentration-dependent. 
When examining cell rolling velocities in ANX-Al' mice a slight effect could be noted 
which was evident at the later time-points. This indicates that a difference due to the 
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absence of the ANX-Al gene was now beginning to emerge. A time-dependent 
increase in cell adhesion and emigration was produced but in contrast to the ANX-Al' 
mice these responses were not reduced versions of the 100 nM PAF response. Cell 
adhesion and emigration was much higher after I nM PAF treatment, so much so that 
differences were not found between the I nM and 100 nM PAF superfused ANX-Al' 
animals. Due to this a significantly higher degree of cell emigration was observed in 
the ANX-Al' mice compared to the ANX-AI'4' mice. A role for ANX-Al is now 
emerging in this more moderate model of inflammation. 
3.2.2.4. Effect of I nM PAF on Leukocyte Recruitment: Cell Detachment Study 
Experiments using I nM PAF had shown that leukocyte emigration was greater in 
ANX-AI'4- mice compared to ANX-Al' mice but that cell adhesion was not 
significantly affected. This may suggest an effect of endogenous ANX-Al in the fate 
of the adherent leukocyte (as in the hamster cheek pouch microcirculation (Mancuso et 
al., 1995)). So, the next set of experiments were designed so the cremaster muscle was 
superfused for up to 60 min with I nM PAF and, at 10 min intervals, cell detachment 
was monitored using a method adapted from a previous study (Lim et al., 1998). 
Adherent cells that detach 
Figure 3.45 shows the numbers of adherent cells that detach. These are cells that are 
adherent for a minimum of 30 sec but then return to the main blood flow after this time 
rather than emigrating. The vessels were analysed in 10 min intervals over the 60 min 
time course. In the ANX-Al' mice the numbers of cells that detach were quite 
constant over 60 min even though the values were quite variable (large error bars). In 
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the ANX-Al-'- mice a similar trend was seen however, lower cell detachment was 
detected in the ANX-Al-- mice compared to the ANX-Al" mice at the 0 min time- 
point, i. e. before superfusion with PAF began although due to the small numbers of 
cells involved, this was not statistically significant. No significant differences were 
found between the ANX-A I "'and the ANX-A I -'-mice over the time course assessed. 
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Figure 3.45. Effect of I nM PAF on adherent cell detachment as assessed 
in the cremaster muscle of ANX-Al-I and ANX-Al"I mice. ANX-Al'I'M 
and ANX-Al' mice were prepared for intravital microscopy. The tissue 
was superfused with I nM PAF for 60 min. Cells counted were those that were 
adherent for >30 sec and then detached and returned to the blood flow. Values 
are mean±sern of n=4 mice per group. 
Figure 3.46 shows the above data as a percentage of adherent cells that detach. This 
shows that in ANX-A I"' mice the percentage of cells that detach trends to be stable 
over the 60 min time course. In the ANX-Al-'- animals a significantly lower percentage 
of adherent cells detach at the 0 min time-point. Once superfusion began this effect 
was lost and for the rest of the time-course the percentage of detaching cells were not 
found to be significantly different between the genotypes. 
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Figure 3.46. E ffect of 1 nM PAF on adherent cell detachment 
(percentage) as assessed in the cremaster muscle of ANX-Al' and ANX- 
API+ mice. ANX-Al WT M and ANX-Al' mice were prepared for 
intravital microscopy. The tissue was superfused with I nM PAF for 60 min. 
Cells counted were those that were adherent for >30 sec and then detached and 
returned to the blood flow (expressed as a percentage of total adherent cells). 
Values are mean±sern of n=4 mice per group, 1,, P<0.05 ANX-A I` vs. ANX- 
AI -- at same ti me-poi nt. 
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Figure 3.47 is a graph to show the length of time it took for adherent cells to detach. 
The line represents 30 sec as this is the minimum length of time for a stationary cell to 
be classified as adherent. There was no significant change over the time course in the 
time taken for a cell to detach. No difference between the ANX-Al"' and ANX-Al-'- 
mice was observed. 
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Figure 3.47. Effect of 1 nM PAF on adherent cell detachment time as 
assessed in the cremaster muscle of ANX-Al-' and WT mice. ANX-A I"' 
M and ANX-A I -'- mice were prepared for intravital microscopy. The tissue 
was superfused with I nM PAF for 60 min. Cells counted were those that were 
adherent for >30 sec and time taken to detach and return to the blood flow was 
measured. Values are meantsem of n=4 mice per group. 
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3.2.3. Effect of Zymosan on Leukocyte Recruitment in ANX-Al-l' and ANX-Al"" 
Mice 
Next a series of experiments were performed in the cremaster muscle preparation using 
zymosan as an inflammogen. As zymosan-induced peritonitis promoted significantly 
higher levels of neutrophil emigration in the ANX-AI'4- mice the leukocyte recruitment 
process was examined in more detail using the mouse cremaster microcirculation. As 
fluorescently labelled zymosan was used the percentage of emigrated cells that had 
phagocytosed zymosan was also measured in the ANX-Al' and the ANX-Al' mice 
to determine if differences could be observed with respect to this important function of 
emigrated neutrophils. 
ANX-Al-'- and ANX-Al'4' mice were treated i. s. with fluorescently labelled zymosan 
(30 [tg in 400 jil sterile saline). Cremaster muscle preparations were carried out so that 
various vessels could be chosen and recorded 6 hr post zymosan injection. The first 
study was conducted in the laboratory of Dr. S. Nourshargh. The cremaster muscle was 
prepared using a slightly different protocol as described in the methods section (2.3.4). 
Cell emigration was analysed as well as the percentage of emigrated cells that had 
phagocytosed zymosan. 
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Emigration 
In the first set of experiments cell emigration was assessed in animals treated i. s. with 
either zymosan or saline for 6 hr. Figure 3.48 shows the number of emigrated cells 
counted in ANX-Al' and ANX-AI+'+ mice after treatment with zymosan. Thenumber 
of emigrated cells were counted in 1-3 fields of view for 1-3 vessels per animal. In the 
saline injected animals (vehicle control) there were very low numbers of cell 
emigration and no significant difference observed between ANX-AI+'+ and ANX-AV- 
mice. After 6 hr zymosan treatment significant numbers of cells had emigrated into the 
tissues surrounding vessels in both the ANX-AI+'+ and ANX-Al-4- mice (ANX-Al+'+; 
saline: 3.52±0.60 vs. 6 hr zymosan: 26.52±2.47, n=3, P<0.05, ANX-AI'4-; saline: 
2.37±2.47 vs. 6 hr zymosan: 40.81--2.38, n=3, p<0.05). When comparing the ANX- 
Al+'+ to the ANX-AI4- mice, significantly higher numbers of cells were found to have 
emigrated in ANX-A14- mice after 6 hr zymosan treatment compared to ANX-Al"'+ 
mice (ANX-A I': 26.52±2.47 vs. ANX-Al-1-: 40.81±2.38, n=3, P<0.05). 
Phagocytosis 
Figure 3.49 shows the percentage of emigrated cells that were found to have 
phagocytosed zymosan particles. The data is presented as index of phagocytosis as this 
normalises the phagocytosis for the number of emigrated cells that are in the tissue. No 
significant difference was found in the percentage of emigrated cells that had 
phagocytosed zymosan when comparing the ANX-AI-1- to the ANX-Al"' mice. 
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Figure 3.48. E ffect of zymosan on cell emigration as assessed in the 
cremaster muscle of ANX-Al-' and ANX-All mice. ANX-A I I" and 
ANX-Al-1- mice were injected i. s. with either saline (400 IAI: Ohr zymosan) 
or zymosan (30 [Lg in 400 [d saline). Later mice were prepared for intravital 
microscopy so measurements were made at 6 hr post injection. Emigration 
was measured as number of cells per field of view (f. v). 3 f. v were analysed 
per vessel; 1-3 vessels were chosen per mouse. Values are mean±sem of n=3 
mice per group, : '.: P<0.05 vs. corresponding time 0, ii, P<0.05 ANX-Al' vs. 
AN X-A I "I at same ti me-poi nt. 
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Figure 3.49. Effect of zymosan on phagocytosis by emigrated cells as 
assessed in the cremaster muscle of ANX-AI-1- and ANX-All mice. 
ANX-Al"' and ANX-Al-'- mice were injected with 30 Rg fluorescent 
zymosan (i. s. ). 6 hr post-zymosan emigrated cells (see above) were analysed 
for phagocytosis (number of emigrated cells containing fluorescent particles 
per field of view). Data was normalised for number of emigrated cells so 
expressed as index of phagocytosis (%). Values are meantsem of n=3 mice per 
group. 
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The second study was conducted in our department and the cremaster microcirculation 
was prepared as in the previous PAF experiments. For this second study the usual 
parameters of cell rolling velocity, cell flux, cell adhesion and emigration were 
measured as previously described. In this second study emigration was assessed 
directly next to the post-capillary venule under investigation, i. e. up to 50 [Lm either 
side of the 100 [tm vessel length. 
Rolling Velocity 
Zymosan treatment had no significant effects on cell rolling velocity in ANX-Al"' or 
ANX-A14- animals. This is shown in figure 3.50. No significant differences were 
found between the ANX-AI'4' and the ANX-A14- animals with respect to rolling 
velocity after saline (vehicle control) treatment or after 6 hr zymosan treatment. 
Cell Flux 
Similarly to the rolling velocity results, zymosan had no effect on cell flux in vessels of 
either zymosan or saline treated animals at this time-point. This is shown in figure 
3.51. No significant differences were found between the genotypes after saline (vehicle 
control) or zymosan treatment for 6 hr. 
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Figure 3.50. Effect of zymosan on cell rolling velocity as assessed in the 
cremaster muscle of ANX-AI-' and ANX-AIII mice. ANX-A I "' and 
ANX-A I -- mice were injected i. s. with with either saline (400 1. & Ohr 
zymosan) or zymosan (30 ýtg in 400 [d saline). Later mice were prepared for 
intravital microscopy so measurements were made at 6 hr post injection. 
Rolling velocity is measured as [Lm/sec. Values are mean±sem of n=4 mice 
per group. 
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Figure 3.51. Effect of zymosan on cell flux as assessed in the cremaster 
muscle of ANX-AI-I and ANX-AI+'+ mice. ANX-All"A, and ANX-AI-1- 
mice were injected i. s. with with either saline (400 ýtl: Ohr zymosan) or 
zymosan (30 [tg in 400 [d saline). Later mice were prepared for intravital 
microscopy so measurements were made at 6 hr post injection. Cell flux was 
measured as the number of cells passing a fixed point in the vessel/min. 
Values are mean±sem of n=4 mice per group. 
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Adhesion 
Figure 3.52 shows the effect of zymosan on adhesion of leukocytes in ANX-Al-1- and 
ANX-AI*" animals. A low level of cell adhesion was measured in the saline treated 
(vehicle control) animals. This occurred in both the ANX-Al'4' and the ANX-AVL 
animals with no difference seen between the genotypes. Zymosan induced a significant 
number of cells to become adherent within the vessels of ANX-Al '4+ and ANX-A 1 4- 
mice. Again, no difference was found between the genotypes with respect to cell 
adhesion after 6 hr zymosan treatment. 
Emigration 
In the second set of experiments cell emigration was measured as outlined earlier. 
Figure 3.53 shows the results of this experiment. In the saline injected animals (vehicle 
control) there were low numbers of emigrated cells and no significant difference 
observed between ANX-Al' and ANX-Al-- mice. After 6 hr zymosan treatment 
significant numbers of cells had emigrated in both the ANX-Al+1+ and ANX-Al 4- mice 
compared to saline treated animals (ANX-Al+'+; saline: 1.83*039 vs. 6 hr zymosan: 
9.67: tl. 43, ANX-Alý'; saline: 2.19±0.40 vs. 6 hr zymosan: 9.88-tl. 23, n=4, P<0.05). 
When comparing ANX-AI'4+ to ANX-AI-1- mice no significant difference could be seen 
after 6 hr zymosan treatment. 
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Figure 3.52. E ffect of zymosan on cell adhesion as assessed in the 
cremaster muscle of ANX-Al-I and ANX-All mice. ANX-Al+'+ and 
ANX-A I -- mice were injected with with either saline (400 [d: Ohr zymosan) 
or zymosan (30 ýtg in 400 ýd saline). Later mice were prepared for intravital 
microscopy so measurements were made at 6 hr post injection. Adhesion is 
measured as number of cells stationary for >30 sec. Values are mean±sem of 
n=4 mice per group, P<0.05 vs. corresponding time 0. 
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Figure 3.53. E ffect of zymosan on cell emigration as assessed in the 
cremaster muscle of ANX-Al-1- and ANX-A114" mice. ANX-Al"' and 
ANX-A I -'- mice were injected with with either saline (400 [d: Ohr zymosan) 
or zymosan (30 [tg in 400 [d saline). Later mice were prepared for intravital 
microscopy of the cremaster muscle so measurements were made at 6 hr post 
injection. Emigration is measured as the number of cells either side of 100 
[Lm vessel. Values are mean±sem of n=4 mice per group, P<0.05 vs. 
corresponding time 0. 
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The first zymosan study indicated a difference in cell emigration between the ANX- 
Al"* and the ANX-A14- mice. In this experiment emigration was examined per field of 
view and these were further into the tissue than when emigration was assessed in the 
second zymosan study (where emigration was measured directly next to the vessel). As 
there was no difference between the genotypes in the second experiment it is possible 
this was due to a difference in the distance that the cells emigrated in the two 
genotypes. So a further experiment was performed where emigration distance was 
taken into account as Previously performed in the department (Tailor et al., 1997). 
Emigration Distance 
Emigration was measured in animals treated with zymosan for 6 hr. Cells at different 
distances from the vessel wall (0-50 [im, 50-100 [tm and 100-150 [tm) on both sides of 
100 [Lm vessel length were counted. The results are in figure 3.54. In the ANX-Al""' 
mice the numbers of cells that had emigrated significantly decreased with the distance 
from the vessel. There were fewer cells in the 50-100 tLm section and 100-150 [Lm 
section compared to the 0-50 [tm section (0-50 tLm: 9.50±0.87,50-100 tim: 5.04±0.71, 
100-150 tLm: 3.08±0.99, n=4). In the ANX-Al' animals however, the numbers of 
emigrated cells were still high in the 50-100 [tm section although when 100-150 [Lm 
was examined there were fewer cells (0-50 pm: 9.33±0.74,50-100 pm: 6.42±0.44,100- 
150 [tm: 5.63±0.14, n=4). However, the number of cells at this distance (100-150 ttm) 
was significantly higher in ANX-AI-1- mice compared to ANX-Al"' mice. Overall, 
significantly higher numbers of emigrated cells (0-150 [Lm) were found in the ANX-Al- 
/- mice compared to the ANX-AI*" mice (ANX-Alý-: 17.63±2.08 vs. ANX-AI4-: 
21.38±0.95, n=4, P<0.05). In any case this difference was more modest than that 
measured in study 1. 
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Figure 3.54. Effect of zymosan on cell emigration distance as assessed in 
the cremaster muscle of ANX-Al' and ANX-All mice. ANX-Al+'+", ", ýý 
and ANX-A I mice were injected with 30 [tg zymosan (i. s. ). Later mice 
were prepared for intravital microscopy so measurements were made at 6 hr 
post injection. Emigration was measured as number of cells at different 
distances either side of 100 [tm vessel; 0-50,50-100 and 100-150 ýtm. Values 
are mean±sem of n=4 mice per group, ": P<0.05 vs. corresponding emigration at 
0-50 [tm, y P<0.05 ANX-A I` vs. ANX-A I` at same distance. 
Haemodynamic parameters 
Table 3.5. shows the haemodynamic parameters measured in the ANX-Al-'- and ANX- 
Al" animals treated with saline or zymosan for 6 hr. The RBC velocity was not 
significantly different between the treatment groups or the genotypes. However, a 
significantly higher WSR was found in the saline treated ANX-Al' animals compared 
to the saline treated ANX-Al" animals (ANX-Al-'- saline: 710: L-62 sec' vs. ANX-Al"* 
saline: 514-t28 sec', n=4, P<0.05). The WSR was not significantly different between 
the ANX-A I "' and the ANX-A I -'- after 6 hr zymosan treatment. 
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0-50 ýtm 50-100 ýtm 100- 150 ýim Total 
(0- 15 0 ýim) 
Genotype Treatment n Vessel RBC WSR 
diameter velocity (sec") 
OAM) (mm/see) 
ANX-A I Saline 4 29.42 : L-2.03 3.03 : L- 0.09 514: L- 28 
ANX-A I Sal i ne 4 26.58 ±2.20 3.74 ± 0.13 710 ± 62* 
ANX-A 1 "' Zymosan 4 26.29 ± 1.69 2.83 ± 0.34 532 ± 31 
ANX-A 1 -'- Zymosan 4 27.10 ± 1.84 3.02 ± 0.17 574 ± 63 
Table 3.5. H aemodynamic parameters of zymosan-inflamed cremasteric 
venules of ANX-Al' and WT mice. ANX-A I I" and ANX-A I` mice 
were injected with either saline (400 [tl: Ohr zymosan) or zymosan (30 ýtg in 
400 [d saline). Later mice were prepared for intravital microscopy so 
measurements were made at 6 hr post injection. Vessel diameter and RBC 
velocity were measured and WSR calculated. Values are mean±sem of n--4 
micepergroup. *P<0.05 ANX-Al' vs. ANX-A I'll at same time-point. 
Summary 
Saline treatment for 6 hr seems to cause only a minimal degree of activation to vessels 
with only very low numbers of cells adhering and emigrating (not dissimilar to 
numbers found in untreated cremaster muscle preparation-see earlier data). Zymosan 
however, caused a marked increase in cell adhesion and emigration in both the ANX- 
Al-'- and ANX-Al" mice. Zymosan treatment did not affect cell rolling or cell flux, at 
least at the time-point examined. It seems as if the ANX-Al' mice became more 
activated than the ANX-Al"' mice, with respect to cell emigration, however this was 
only seen when cell emigration was monitored further into the tissue than usually 
examined. The difference is unlikely to be due to differences in zymosan phagocytosis 
by emigrated cells as no difference was seen between the ANX-A I "' and the ANX-A I- 
/- mice with respect to phagocytosis. 
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3.2.4. Effect of Ac2-26 in the Cremaster Muscle Preparation of FPR71 Mice 
As this model of intravital microscopy was proving to be a good for examining 
leukocyte recruitment and the role played by ANX-Al, a series of experiments were 
performed utilising the FPR' mice that were also available in our department. Previous 
experiments highlighted the fact that ANX-Al is a likely agonist of the FPR and this 
may be the receptor through which ANX-A I is exerting its actions. An examination of 
the effects of peptide Ac2-26 in the cremaster model was therefore a worthwhile 
experiment. In addition these experiments would complement those carried out with 
administration of the peptide to C57BU6 mice. 
FPR: ' mice were prepared for intravital microscopy of the cremaster muscle. Just prior 
to superfusion of 100 nM PAF mice were injected with 200 [tg peptide Ac2-26 (in 200 
[d of sterile PBS). Control mice were injected with 200 [d PBS alone. Superfusion of I 
100 nM PAF was then started and continued for 90 min. 
Rolling Velocity 
Rolling velocity in the FPR' mice in response to 100 nM PAF is shown in figure 3.55. 
Data is presented as a percentage of basal (0 min) cell rolling velocity. 100 nM PAF 
significantly reduced rolling velocity at the later time-points of 60 and 90 min in the 
vehicle control FM' animals. This is different to the results obtained with the 
C57BU6 mice controls for the FPR' mice. This is shown in figure 3.28 where the 
rolling velocity decreased from 30 min. 
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In the peptide treated FPR-'- mice cell rolling velocity was significantly lower than basal 
from 45 min onwards. Following peptide treatment in C57BL/6 mice the cell rolling 
became significantly slower than basal from 30 min (see figure 3.28). When 
comparing the two treatment groups (peptide and PBS treated controls) no differences 
were seen between them at any of the time-points measured. 
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Figure 3.55. Effect of Ac2-26 on cell rolling velocity as assessed in the 
inflamed cremaster muscle of FPR-1- mice. FPR-1- mice were prepared for 
intravital microscopy. Mice were treated with either PBS 0 or 200 g Ac2-26 
Fý (time 0) and then superfused with 100 nM PAF. Rolling velocity is shown 
as % of basal rolling velocity. Values are mean±sem of n=4 mice per group), 
ýT<0.05 vs. corresponding time 0. 
CeY Flux 
Figure 3.56 shows the cell flux in FPR-'- animals superfused with 100 nM PAR 
Significant differences were not seen in cell flux over the time course in either the 
vehicle control animals (PBS treated) or the peptide treated group. Although a lower 
cell flux was noted in the peptide treated animals compared to the 0 min time point this 
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did not reach sionificance at any of the time points. This data fits with the cell flux Z, 
seen in the C57BL/6 mice (figure 3.29). 
No significant differences are found between the vehicle control group and the peptide 
treated mice except at the 90 min time-point (90 min; vc: 49.75. t: 17.13 vs. pep: 
11.58: t4.40, n=4, P<0.05). 
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Figure 3.56. E ffect of Ac2-26 on cell flux as assessed in the inflamed 
cremaster muscle of FPR-1- mice. FPR-'- mice were prepared for intravital 
microscopy. Mice were treated with either PBS 0 or 200 [Lg Ac2-26 [3time 
0) and then superfused with 100 nM PAR Cell flux was measured as the 
number of cells passing a fixed point in the vessel/min. Values are mean±sem 
of n=4 mice per group, ij, P<0.05 PBS vs. peptide at same time-point. 
Adhesion 
The high dose of PAF (100 nM) caused a time-dependent increase in the number of 
adherent cells in the FPR- mice. This is shown in figure 3.57. There were 
significantly higher numbers of adherent cells compared to basal (0 min) from 60 min 
onwards in the vehicle control group. This is only slightly different to the C57BL/6 
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mice in which adhesion becomes significantly higher than basal at the 45 min time- 
point (see figure 3.30). 
Lower numbers of adherent cells were found in peptide treated mice compared to 
vehicle control animals, however, these values did not reach significance at the 5% 
level. The numbers of adherent cells only increased from basal at 90 min in the Ac2-26 
treated mice. This was in contrast to the peptide-treated C57BL/6 mice where 
significant levels of adherent cells appeared from 45 min onwards. This is shown in 
figure 3.57. 
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Figure 3.57. Effect of Ac2-26 on cell adhesion as assessed in the inflamed 
cremaster muscle of FPR-1- mice. FPR-1- mice were prepared for intravital 
microscopy. Mice were treated with either PBS N or 200 [Lg Ac2-26 [-] (time 
0) and then superfused with 100 nM PAF. Adhesion is measured as number 
of cells stationary for >30 sec. Values are mean±sern of n=4 mice per group, 
: T<0.05 vs. corresponding time 0. 
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Emigration 
Figure 3.58 shows the effect of 100 nM PAF on cell emigration in FPRl" mice. 
Vehicle-treated mice show that the number of cells that emigrated from the vessel 
increased over time up to 90 min. Numbers were significantly different to basal (0 
min) from 30 min onwards. These results are comparable to those obtained in the 
C57BU6 mice (see figure 3.3 1). 
The injection of Ac2-26 before the start of PAF superfusion caused a significant 
attenuation of leukocyte recruitment. There was still a time-dependent increase in 
emigration but this was only significant from 60 min. This is in contrast to results 
obtained in the C57BU6 mice where treatment of the animals with peptide abolished 
the increase in emigration over the whole 90 min of PAF superfusion. When 
comparing the numbers of emigrated cells in the peptide-treated FPR' mice to the 
vehicle control (PBS treated) mice a significantly lower number of emigrated cells were 
found at 45,60,75 and 90 min. Examining the latest time-point of 90 min the peptide 
caused a 53% inhibition of emigration. Overall, this gives an overall inhibition of 45% 
(as assessed by calculating the area under the curve). 
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Figure 3.58. Effect of Ac2-26 on cell emigration as assessed in the inflamed 
cremaster muscle of FPR KO mice. FPR` mice were prepared for intravital 
microscopy. Mice were treated with either PBS 0 or 200 [tg Ac2-26 [] (time 
0) and then superfused with 100 nM PAR Emigration is measured as number 
of cells either side of 100 jim vessel. Values are meantsem of n=4 mice per 
group, P<0.05 vs. corresponding time 0, yP<0.05 PBS vs. peptide at same 
time-point 
Albumin Leakage 
Figure 3.59 shows the albumin leakage measured in vessels of PBS and Ac2-26 treated 
animals after 90 min superfusion with 100 nM PAR No significant difference in 
albumin leakage was found between the mice treated with either PBS or peptide. 
Haemodynamic parameters 
The haemodynamic parameters measured in post-capillary venules of FPR-'- mice 
treated with either PBS or Ac2-26 and inflamed with 100 nM PAF are shown in table 
3.6. Superfusion with 100 nM PAF had no significant effects on RBC velocity or WSR 
over the 90 min time course. The treatment of mice with Ac2-26 caused a slight 
decrease in RBC velocity and WSR although these differences were not significant. 
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Figure 3.59. E ffect of Ac2-26 on albumin leakage as assessed in the 
inflamed cremaster muscle of FPR-1 mice. FPR-'- mice were prepared for 
intravital microscopy of the cremaster muscle. Mice were treated with either 
PBS N or 200 [tg Ac2-26E] (time 0) and then superfused with 100 nM PAF. 
At 90 min FITC labelled albumin was injected 5 min prior to analysis of 
albumin leakage. Values are mean±sem of n=3 mice per group. 
Treatment n Vessel 
diameter 
QAM) 
RBC 
velocity 
(mm/sec) 
WSR 
(sec-') 
100 nM PAF 4 33.81 ± 0.98 0 4.50 t 0.62 664 ± 86 
+ PBS 15 4.60 ± 0.71 677 ± 99 
(Vehicle control) 30 4.58 ± 0.77 671 100 
45 4.53 ±1.71 664 91 
60 5.20 ± 1.01 763 137 
75 4.63 ± 0.94 679 132 
90 4.90 ± 1.01 719 140 
100 nM PAF 4 32.00 ± 1.86 0 2.93 ± 0.24 470 62 
+ Ac2-26 15 3.58 ± 0.57 572 114 
30 3.73 ± 0.56 598 120 
45 3.43 ± 0.40 548 91 
60 3.23 ± 0.16 509 43 
75 3.25 ± 0.16 513 43 
90 3.25 ± 0.16 513 43 
Table 3.6. Effect of Ac2-26 on haemodynamic parameters of IOOnM PAF 
inflamed cremasteric venules of FPR-1- mice. FPR-'- mice were prepared for 
intravital microscopy of the cremaster muscle. Mice were treated with either 
PBS or 200 [tg Ac2-26 (time 0) and then superfused with 100 nM PAF. Vessel 
diameter and RBC velocity were measured and WSR calculated. Values are 
meamtsern of n=4 mice per group. 
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PBS Ac2-26 
Summary 
The superfusion of 100 nM PAF in the FPRt animals caused a decrease in cell rolling 
velocity with no effect on cell flux. Also, it caused a significant increase in cell 
adhesion and emigration. The administration of peptide Ac2-26 delayed the 
recruitment of adherent and emigrated cells so there was a significant reduction in 
numbers of emigrated cells compared to the vehicle treated controls over the 90 min of 
PAF superfusion. The extent of the inhibitory effect of the peptide Ac2-26 in the 
microcirculation of FPR71- mice was quantitatively and qualitatively similar to that 
observed in the C57BU6 mice. 
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4. Discussion 
The first year of this PhD study was spent learning the peritonitis model, the FACS and 
intravital microscopy techniques. Some problems were encountered during this PhD 
that were due to a shortage of ANX-AI-1- mice for experiments and there were also 
problems with animal licensing procedures. The next two years focused on the 
intravital. technique which had been learnt during a one month visit to the laboratory of 
Dr. N. Granger in Louisiana State University, Shreveport, USA. 
4.1. Flow Cytometry 
More neutrophils and less monocytic cells are found in the peritoneal cavity of the 
ANX-Al' mouse after 4 hrzymosan peritonitis compared to the ANX-ATII. 
Zymosan is a cell wall extract of the yeast, Saccharomyces cerevisiae that is widely 
used to promote inflammation, particularly in the peritoneal cavity where it induces a 
potent peritonitis. Zymosan initiates a complex inflammation via number of different 
pathways including stimulation of resident and infiltrating cells to release inflammatory 
mediators, activation of the alternative complement pathway and biosynthesis of 
eicosanoids. The zymosan-peritonitis model in the mouse has been well characterised 
(Ajuebor et al., 1998a; Kolaczkowska et al., 2001; Konno & Tsurufuji, 1983; Rao et 
al., 1994). Administration of zymosan (I mg by i. p. injection) produces a time 
dependent recruitment of inflammatory cells into the peritoneal cavity. Neutrophils 
begin to enter the cavity after the injection and increase up until 6 hr. By 24 hr the 
numbers are much lower (than at 6 hr) but not quite back to basal levels. The influx of 
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cells is maximal between 2 and 4 hr. Monocytic cells show an initial disappearance at 
2 hr but then a steady increase over the rest of the 24 hr time course (Ajuebor et aL, 
1998a; Kolaczkowska et al., 2001). 
The resident cells, macrophages and mast cells, are in close proximity to the post- 
capillary venules and are important in producing at least some of the initial signals 
responsible for the accumulation of cells in the peritoneal cavity. Experiments in 
which mast cells are depleted (by at least 95%) show a reduced PMN accumulation, 
likely due to the decreased levels of released chemokines (Ajuebor et aL, 1999). In line 
with this study, mast cell-deficient mice show a significantly lower degree of PMN 
influx in response to 6 hr zymosan treatment with decreased chemoattractant activity 
(measured in a chernotaxis assay) and decreased levels of inflammatory cytokines such 
as IL-lP and TNF-a compared to control mice. These defects were corrected in mast 
cell deficient mice by adoptive transfer of mast cells from congenic control mice 
(intraperitoneal transfer 3 weeks prior to peritonitis of cultured bone marrow-derived 
mast cells derived from congenic controls) (Kolaczkowska et aL, 2001). Peritoneal 
mesothelial cells are another resident cell type found in the peritoneal cavity that also 
contribute to inflammation in response to zymosan. They release cytokines and 
chemokines and zymosan also directly induces them to release NO (Yao et aL, 2004). 
Many chemokines have been shown to involved in zymosan peritonitis and are rapidly 
released into the peritoneal cavity between I and 4 hr post zymosan injection with 
levels then returning towards basal by 24 hr. The CC chemokines, which are 
predominantly chernotactic for mononuclear cells, such as MIP-la and MCP-I have 
been shown to be produced as well as certain CXC chemokines such as MIP-2 and KC, 
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which are both chernotactic for neutrophils (Ajuebor et al., 1998a; Ajuebor et al., 
1998c). Inflammatory cytokines such as TNF-a and IL-Ip are also released in a 
similar pattem (Ajuebor et al., 1998a; Kolaczkowska et al., 2001; Perretti et al., 1992). 
It has also been demonstrated that the anti-inflammatory cytokine IL-10 is released in 
this model (Ajuebor et aL, 1999). Therefore a balance between pro-inflammatory and 
anti-inflammatory signals in the peritoneal cavity regulates the response to zymosan. 
Eicosanoids produced during zymosan peritonitis are also involved in the regulation of 
inflammatory cell recruitment, with release of LTC4 arising predominately from 
resident cells and LTB4from both resident but mainly from infiltrating cells (Rao et aL, 
1994). These are important in the inflammatory process as they can increase vascular 
permeability (LTC4) and mediate many stages of inflammation including recruitment 
and activation of other inflammatory cells (LTB4). 
Work presented in this thesis uses the well-established protocol for zymosan-induced 
peritonitis although rather than having to manually distinguish and count cells a more 
objective protocol has been used (Henderson et aL, 2001). Gr-1 is a cell surface, 21-25 
kDa protein found on cells of the myeloid lineage (Fleming et aL, 1993). It can be 
used to distinguish neutrophils as these cells stain highly for Gr-I whereas monocytes 
and macrophages are either negative or have very low staining for Gr-I (Lagasse & 
Weissman, 1996). 174/80 is a 160 kDa glycoprotein found on the surface of murine 
macrophages and blood monocytes. It can be used to distinguish these cells from PMN 
as both peritoneal macrophages (Austyn & Gordon, 1981) and circulating blood 
monocytes (Nussenzweig et al., 1981) stain positively for F4/80 whereas PMN are 
negative for this marker (Austyn & Gordon, 1981). As lymphocytes do not stain 
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positively for either marker this fact can be used to remove these cells from the 
analysis. A comparison of the data obtained by the two methods shows that this is a 
specific technique that can be used to accurately and reproducibly assess the levels of 
different myeloid cells (neutrophils and monocYtic cells) in the peritoneal cavity of the 
mouse. It also has the added benefit of being able to measure the levels of other cell 
marker on these cells simultaneously. 
In line with the data obtained by manual cell counting, zymosan induced time- 
dependent recruitment of neutrophils into the peritoneal cavity could be quantified. As 
ANX-Al has been shown to be an inhibitory mediator of inflammation (see 
Introduction) mice with no ANX-Al (ANX-Al-l-) may be expected to have a greater 
inflammation compared to the ANX-AI'4". This might explain the increased levels of 
neutrophils found in the peritoneal cavity of ANX-Al 4- mice after 4 hr zymosan 
peritonitis. This would fit in with previous work from the department showing that 
neutralisation of endogenous ANX-Al successfully reverted the anti-migratory effect 
of DEX in zymosan peritonitis (Getting et al., 1997; Perretti et al., 1996a; Perretti et 
al., 1996b). Addition of exogenous ANX-Al or Ac2-26 reduces the influx produced 
by zymosan (Getting et al., 1997; Peffetti et al., 1993). These data predated the initial 
experiments performed with the ANX-Al' mice. Indeed, an increased level of 
neutrophil emigration (4 hr) after zymosan was observed in the ANX-Al-'- mice 
(Hannon et al., 2002). The data produced in this thesis confirm these findings, 
however this is the first time that peritonitis has been analysed using a more objective 
flow cytometry protocol. Using the combined Gr-I and 174/80 analysis the ANX-Al' 
mice show a significantly lower level of monocytic cells at the 4 hr time-point when 
compared the ANX-Al"'. Ajuebor et al and others noted the disappearance of 
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monocytic cells from the peritoneal lavage fluids at 2 hr in normal mice. It has been 
suggested that this could be a "consequence of a generalised activation and adhesion to 
the internal mucosa layers" (Ajuebor et al., 1998a; Kolaczkowska et al., 2001). The 
numbers of F4/80 positive cells returned to normal by the 24 hr time-point. This could 
be due to the activated cells in the cavity detaching from the internal mucosa to be 
freely available within the cavity rather than due to the influx of newly recruited 
monocytes. In the case of the ANX-AV- mice therefore, there could be a delay in cell 
detachment from the inside of the cavity and/or the cells could be more activated and 
therefore more firmly adherent. This idea would fit with previous data, for example, it 
has been shown that when exogenous ANX-Al (native protein or peptide Ac2-26) is 
administered adherent cells detach in inflamed mouse mesenteric post-capillary venules 
(Gavins et al., 2003; Lim et al., 1998). So it is possible that when the ANX-Al gene is 
absent, and no ANX-Al protein is present, the detachment process is delayed or 
diminished leading to a reduced return of monocytic cells to the peritoneal cavity. 
Alternatively, or in conjunction with this hypothesis, is the possibility that the F4/80 
positive cells could be more highly activated and more firmly adherent to the cavity 
wall, so that it takes longer for the cells to detach and to appear in the cavity. 
Along these lines, macrophages have been shown to be "super-sensitive" to an 
inflammatory stimulus (Yona et aL, 2004). Although basal CD IIb expression has been 
shown to be significantly reduced in the ANX-Al' mice compared to the ANX-All 
mice, cell activation by either fMLP or PAF augmented expression of CD IIb on ANX- 
AV- cells to a higher degree than on the ANX-Al"1" cells (Hannon et at., 2002). Data 
presented in this thesis reports on CDI lb expression in cells that have migrated into the 
peritoneal cavity in response to an inflammatory stimulus. These cells are clearly in an 
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activated state as they rolled, adhered and eventually emigrated through post-capillary 
venules to reach the cavity. Therefore CDllb expression was examined to highlight 
any alterations in the molecules expression which could be responsible for the 
differences seen in cell recruitment into the peritoneal cavity. Neither neutrophils nor 
monocytic cells collected from the 4 hr zymosan-treated mice showed a significantly 
different CD11b expression between genotypes. Also, the process of cell migration 
itself is accompanied by CDllb up-regulation (Jutila et al., 1989; Mori et al., 2000) 
such that it could be difficult to demonstrate differences modulated by any mediator as 
each extravasated cell may fully display CDI Ib on the cell surface. 
Cytokines released into the peritoneal cavity were measured in ANX-AI-1- and ANX- 
Al' mice before and after zymosan peritonitis. Although levels of TNF-a and KC 
were not found to be different between genotypes after 4 hr zymosan treatment this 
does not rule out the possibility that differences in cytokine levels between genotypes 
are, at least in part, responsible for differences in cell recruitment seen. Differences in 
cytokine levels may well be altered at time-points prior to 4 hr and this could cause a 
greater degree of cell recruitment in the ANX-Al"- mice compared to the ANX-AI"+ 
mice. Indeed, an increased IL-lP level was described in response to 2 hr zymosan 
peritonitis in the ANX-AI-1- mice (Hannon et aL, 2002). This may be one of the 
reasons why cell emigration is increased in the ANX-Al"- mice. Although this study 
would have benefited from examination of more time-points, this was not possible 
because of constraints on the numbers of ANX-Al' mice available. And the 4 hr time- 
point was chosen as this gave a reproducible and well-defined inflammatory response. 
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e Less neutrophils and more monocytic cells are found in the peritoneal cavity of the 
male ANX-Al"G mice after 4 hrzymosan peritonitis compared to the ANX-AILý 
Using the same model of zymosan peritonitis in male ANX-Al'G mice gave an almost 
opposite result to the ANX-Al-1- mice. These are the first investigations of innate 
immunity in these mice which were generated by Dr. N. Wells and which we were very 
fortunate to have access to for this thesis. However, it is clear that these mice will 
require further analysis and characterisation. In any case, a dramatic difference in the 
ANX-Al' mice was measured compared to the matched littermates (ANX-AlLm), 
using the flow cytometry protocol introduced into the laboratory during this study. 
At the 4 hr time-point of zymosan peritonitis, significantly lower numbers of Gr-I 
positive cells (neutrophils) were found in the cavity of the ANX-A ITG mice compared 
to the ANX-AlLm mice. This marked effect was mirrored by the detection of 
significantly higher numbers of F4/80 positive cells. It therefore seems that the over 
expression of ANX-Al is able to reduce the level of inflammation in response to 
Zymosan. Over-expressing ANX-Al therefore produces similar results to 
Ekdministration of exogenous ANX-Al protein or peptide (Getting et al., 1997; Perretti 
et al., 1993). As no data has yet been published using these mice this is a completely 
11ovel finding which fits in very well with the previous literature in the field. In 
Wition, the data obtained for the ANX-AITG mice are in line with the augmented 
1'esponse to zymosan quantified in the ANX-AV- mice. 
Interestingly, female ANX-AITG mice did not show any reduction in the inflammatory 
'ýesponse to zymosan compared to the ANX-Al"' mice which is in contrast to the 
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results obtained with the male ANX-AI'G mice. The female ANX-A 14" mice respond 
to zymosan peritonitis with a strong leukopenia as a result of a dramatic reduction in 
circulating neutrophils (Hannon et aL, 2002). This response is not seen in male mice 
suggesting a link between the sex hormones and the ANX-Al system. The data 
obtained with the female ANX-AITG mice also suggest that the sex hormones may 
contribute to the anti-inflammatory actions seen when over-expressing ANX-Al. 
Some other sex related differences have also been observed in this study, for examples, 
almost double the amount of TNF-cE was measured in peritoneal fluids from female 
mice compared to the males. This is not unusual; for example, in mice with a model of 
liver injury induced by concanavlin-A greater plasma levels of TNF-cc are found in 
female mice during the injury (Takamoto et aL, 2003). Macrophages from female mice 
with cartilage implants as a model of chronic inflammation release higher levels of IL, 
lp compared to males (Da Silva et aL, 1993). As many studies have shown that 
females mount a greater inflammatory response in a number of cell-mediated and 
humoral immune responses (e. g. Grossman, 1989) this greater response may be 
masking the protective effects likely due to the over-expression of ANX-A I. 
Dfferent degrees ofAAW-AI degradation are seen in individual mice 
ANX-Al is proteolytically cleaved in vitro by elastase yielding a number of 
degradation products with Mw ranging from 18-33 kDa (Huang et at, 1987). Human 
neutrophil elastase cleaves native 37 kDa ANX-Al to a 34 kDa protein in vitro, and 
samples of human bronchoalveloar lavage (BAL) fluids containing a higher number of 
PMN have proportionally less native ANX-Al (and more degraded ANX-Al) 
compared to samples with less PMN (Smith et al., 1990). A similar finding was made 
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when examining ANX-Al in BAL fluids from patients with interstitial lung diseases, 
those containing the degraded form of ANX-Al were those containing a higher 
percentage of neutrophils (rsao et al., 1998). Western blotting data from this thesis 
have shown in some cases, cells of both genotypes, showed a double band for ANX-A I 
that corresponded to intact ANX-Al and degraded ANX-Al whereas others only 
contained the lower band corresponding to the degraded form of ANX-Al. A few 
samples were assessed to see if a correlation exists between the levels of neutrophils 
found in the peritoneal cavity inflamed with zymosan and the mass of ANX-Al as 
assessed by western blotting. Animals with less Gr-1 positive events (less neutrophils) 
exhibited more degraded ANX-Al and less native ANX-Al compared to animals with 
more neutrophils. This does not entirely fit with the human study where patients with 
abnormal lungs that contained more PMN had more of the degraded ANX-Al (Smith 
et aL, 1990). However, both this study in mice and the previous work with humans 
have noted that the proportion of native to degraded ANX-Al can vary a great deal 
between subjects (Smith et aL, 1990). It is now accepted in the literature that the 
source of exudate ANX-Al is mainly the extravasated neutrophils such that higher 
numbers of tissue neutrophils are associated with higher ANX-Al content (Oliani et 
aL, 2001). In addition, neutrophil-infiltrated tissues, such as the gut of rats with 
induced colitis, display active secretion of ANX-Al (Vergnolle et aL, 1995). Thus, a 
scenario is emerging, in which endogenous ANX-A I moderates neutrophil recruitment 
(see data with ANX-Al' and ANX-AITGmice in the zymosan peritonitis model), 
however, once the cells have emigrated there is active de novo ANX-Al synthesis 
(Oliani et al., 2001). The western blot data obtained show higher ANX-A I degradation 
in conditions of higher neutrophil numbers. It is likely that a greater concentration of 
elastase or other serine proteases could be the cause of this. 
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In addition, it has been suggested that the degraded form of ANX-A I is inactive as it is 
the N-terminal of the protein is cleaved (Smith et aL, 1990) and this part confers the 
anti-inflammatory properties of the protein. In BAL fluid from smokers the 
predominant form of ANX-Al is the degraded isoform whereas the native protein was 
predominant in non-smokers (Vishwanatha et al., 1998). BAL fluid from patients with 
cystic fibrosis also exhibited degradation of ANX-Al whereas normal volunteers had 
very little of the degraded protein (Tsao et al., 1998). As emigrated cells in rat 
mesentery have been shown to contain more of the degraded/clipped isoform of ANX- 
Al compared to intact ANX-Al (Oliani et al., 2001) this may be a mechanism that 
down-regulates inflammation in normal situations. However, in certain disease states 
the degradation and therefore inactivation of ANX-Al may be important in 
contributing to the inflammation that characterises them. 
No difference was found in cell numbers in the peritoneal cavity of the ANX-Al' 
mouse after 4h IL-1,6peritonitis compared to the AAW-A]*' animals. 
The IL-lp-induced peritonitis model has also been characterised in our department 
(Ajuebor et aL, 1998b). ILAP injection (10 ng) into the peritoneal cavity causes a 
time-dependent accumulation of PMN. As in the zymosan-induced model, the 
maximal influx of PMN into the peritoneal cavity is between I and 4 hr post injection. 
Peak cell numbers are counted at 4 hr post injection and numbers remain high, even at 
24 hr. In contrast to the zymosan model levels of monocytic cells are not seen to 
change over 24 hr (Ajuebor et aL, 1998b). The data obtained for this thesis does not 
follow the previous study however, in the ANX-Al' the numbers had returned to 
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basal by 24 hr. However, the profile of monocytic cells remained stable over 24 hr 
following the previous study. Differences could be due to a number of factors 
including the different species used for each study. Of most importance, and in 
contrast to the zymosan-peritonitis model, no differences were found between ANX- 
A14- and ANX-AI'4' mice with respect to the cell numbers found in the peritoneal 
cavity after 4 hr IL, IP peritonitis. 
It is clear that zymosan and IL-Ip are very different inflammatory stimuli. Zymosan 
can activate a very complex inflammatory response whereby a number of different 
pathways are activated leading to endothelial cell activation. ILAP also initiates 
inflammation which is largely attributed to the direct activation of endothelial cells 
leading to induction of endothelial CAM such as E-selectin and ICAM-1 (Bevilacqua 
et al., 1987; Dustin et al., 1986; Osborn et al., 1989). This means that many other 
pathways activated by zymosan may not be activated in the IL-10 model and although 
endothelial cells are activated and leukocytes recruited in both cases, the two models 
are different from each other. Figure 4.1 is a very simple schematic to show how 
zymosan and IL-IP could induce inflammation. As ANX-A14- and ANX-A I*'* mice do 
not respond differently to IL-IP-induced inflammation but respond with increased 
leukocyte emigration in zymosan-induced peritonitis this could suggest that one 
difference in the ANX-AI-1- mice is in a pathway other than the IL-IP route. For 
example, as mentioned previously IL-10, a cytokine with anti-inflammatory properties 
is released during zymosan-peritonitis (Ajuebor et aL, 1999). A recent in vitro study 
has demonstrated that hrANX-AI can stimulate the release of IL-10 from a 
macrophage cell line primed with LPS (Ferlazzo et al., 2003). If this pathway is down 
regulated in the ANX-AI-- it could cause a higher degree of inflammation. Recent 
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work in the department showed that ANX-AI'4- macrophages are more susceptible to 
activation following stimulation with several stimuli; for instance, they produce more 
PGEý after LPS addition (Yona et al., 2004). An inherent defect in the ANX-AI-1- 
macrophages (and maybe mast cells) could be responsible, in part, for the modulation 
exerted by endogenous ANX-Al in the peritonitis response produced by zymosan. 
This step, involving resident cells, is likely by-passed by IL- I P, such that the difference 
seen when zymosan is used as a stimulus, was not seen when using IL-1p as a stimulus. 
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Figure 4.1. Schematic to show how zymosan and IL-10 can induce inflammation. 
Zymosan can activate resident leukocytes and tissue cells to produce pro-inflammatory 
cytokines including IL-1p. These activate endothelial cells leading to the eventual 
recruitment of leukocytes into the tissue. 
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4.2. Intravital Microscopy 
0 PAF-induced inflammation 
Data obtained from the flow cytometry experiments showed that ANX-Al gene 
deficiency rendered mice more susceptible to inflammation, with a greater influx of 
inflammatory cells being measured in the inflamed peritoneal cavity in response to 
zymosan. Also, differences in the peritonitis model were more likely due to changes in 
the activation of resident cells. Thus, the second part of this thesis was conducted to 
examine more closely the actual process of leukocyte recruitment, at the site of 
emigration, the post-capillary venules. Therefore, it was decided to first examine the 
effect of a more direct-activating chemoattractant, PAR Zymosan is a pro- 
inflammatory agent that has a wide range of effects. It can activate many distinct 
pathways including cytokines, chemokines and lipid mediators. As PAF directly 
activates the circulating leukocytes (Kubes et al., 1990; O'Flaherty et al., 1986) this 
seemed a sensible choice of inflammatory agent to highlight potential inherent defects 
in ANX-Al leukocytes and the process of leukocyte recruitment. Previous studies 
have reported the use of PAF superfusion to inflame both the rat mesentery (Tailor et 
al., 1997; Zimmerman et al., 1994) and the mouse cremaster muscle (Henninger et al., 
1997; Hickey et al., 2000). In all of these studies, 100 nM PAF was made up in the 
superfusing buffer. Zimmerman and colleagues found that superfusion of the rat 
mesentery with PAF significantly reduced the rolling velocity of cells and significantly 
increased cell adhesion and emigration within 30 min superfusion (Zimmerman et al., 
1994). A study by Tailor and colleagues used the same strain of rat and also showed 
that PAF superfusion of the mesentery significantly increased cell adhesion and 
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emigration. However, even though leukocyte recruitment was examined over a longer 
time period (60 min compared to 30 min in the previous study), PAF had no effect on 
leukocyte rolling (velocity or flux of leukocytes) (Tailor et al., 1997). A third study, by 
a different group, this time using the mouse cremaster muscle superfused with PAF, 
found that although PAF increased cell adhesion over 30 min the extent of emigration 
was not significantly altered (Henninger et al., 1997). It is clear to see then, that before 
embarking on the study for this thesis, the effects of PAF superfusion would need to be 
carefully examined. Studies of the ANX-Al' mice showed that, in the case of the 
cremaster microcirculation, 100 nM PAF superfusion does indeed cause a significant 
inflammation over the 90 min time course examined. A time-dependent increase in cell 
adhesion and emigration is seen, with a reduction in leukocyte rolling velocity and cell 
flux. Examination of the ANX-Al"' cremaster muscle under basal conditions shows 
that the preparation is stable over 90 min as none of the parameters indicative of 
inflammation (cell rolling, adhesion and emigration) are altered over the time course 
examined. So the model presented in this thesis was deemed suitable to use. Careful 
examination of the time-course of the cellular events promoted by PAF indicated that 
cell rolling, adhesion and emigration occurred in a time-related fashion. Indeed, the 
lowest WBC rolling velocity value was recorded at 30 min post start of PAF 
superfusion; cell adhesion was maximal at 45 to 60 min and emigration at 75 min. 
Since these phenomena are functionally related, this time-dependency further indicated 
that validity of this model. 
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9 Ac2-26 can abolish cell emigration in the PAF-inflamed cremaster muscle 
The action of the ANX-Al mimetic, peptide Ac2-26 in the cremaster muscle 
preparation, had not previously been examined. The fact that it could significantly 
reduce emigration in response to PAF further reinforced the idea that this model was 
suitable to compare differences, if any, in leukocyte recruitment between the ANX-Al- 
/- and ANX-AI'4' mice. Both zymosan-induced (Lim et al., 1998) and I/R-induced 
emigration (Gavins et al., 2003) in the mouse mesentery is significantly reduced by 
intravenous administration of the peptide Ac2-26. Now this list can be extended to 
include inhibition by the peptide of PAF-induced cell emigration in the mouse 
cremaster muscle preparation. One difference between the models is the fact that in the 
mouse mesenteric preparations mentioned above the peptide was also shown to inhibit 
cell adhesion as well as reducing emigration. This finding was not mirrored in the 
cremaster preparation and the difference could be due to the difference in inflammatory 
stimulus and differences in the vascular beds. Interestingly, Mancuso and colleagues 
applied direct-acting stimuli onto the hamster cheek pouch preparation (fMLP and 
substance P) observing that peptide Ac2-26 displayed inhibitory effects selectively on 
the leukocyte emigration step (Mancuso et at., 1995). 
* ANX-AT'* mice exhibit a higher extent of cell emigration compared to ANX-Al' 
mice in response to I nM but not 100 nM PAF 
Data presented in this thesis show that although only minor differences were found 
between the ANX-Al-l- and the ANX-AI'4' cremaster microcirculation when inflamed 
using 100 nM PAF, bigger alterations were seen in the ANX-AI4' mice when a milder 
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stimulus was used (I nM PAF). In this case, cell emigration was found to be 
significantly higher in the ANX-AI"- mice compared to the ANX-Al"' mice. This is in 
line with unpublished work in this department, where cells from the ANX-AI-1- mice 
activated ex-vivo with I nM PAF were significantly more activated (with respect to 
CD 1 Ib expression) compared to the ANX-A I' cells, a difference which was not seen 
when using 100 nM PAR In line with previous studies (Lim et al., 1998; Mancuso et 
al., 1995), it seems that it is the actual emigration stage of leukocyte recruitment that is 
affected by endogenous ANX-A I. In more general terms, these results indicate a tonic 
inhibitory role for endogenous ANX-Al that can be unmasked by using moderate 
stimulation. This fact is unsurprising and in a way reinforces the modulatory nature of 
this mediator. When stronger stimuli are applied, then, its protective effect can be 
overcome. Similar findings were found by Yang et al who were able to highlight 
greater joint inflammation in the ANX-Al' mice when a low dose of methylated BSA 
was used (Yang et aL, 2004). Data presented in this thesis help to clarify this point 
further. 
0 Alterations in the detachment phenomenon could be seen between ANX-Al' and 
ANX-A I*" mice only prior to the start of inflammation 
The next step was to see if an alteration in detachment could be an explanation to as 
why more cells emigrate in these animals. One possible role of endogenous ANX-Al 
may be to cause detachment as exogenous ANX-A I has been shown to do this (Gavins 
et al., 2003; Lim et al., 1998; Mancuso et al., 1995). If this is the case then the lack of 
ANX-Al in the ANX-AV- mice could result less cell detachment and this could be a 
reason for the increased cell emigration found in these animals. In this context it 
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should be noted that the leukocyte detachment phenomenon occurs "spontaneously", 
i. e. without administration of ANX-Al. In fact, in the hamster cheek pouch 
microcirculation 20% of adherent cells were noted to detach spontaneously (Mancuso 
et al., 1995). During neurogenic inflammation of the respiratory tract in the rat 
approximately half of the adherent neutrophils detached and re-entered the circulation 
within 4 hr of the inflammation (Umeno et al., 1990). However, analysis of the 
detachment phenomenon proved to be complex and very time consuming. The number 
of adherent cells that detached rather than emigrated could be assessed and although a 
difference was seen between the genotypes with respect to the degree of detachment 
before the start of the inflammatory process this effect was lost during PAF-induced 
inflammation. The time taken for cells to detach was also not significantly different 
between the genotypes. So alterations in the detachment phenomenon per Se do not 
seem responsible for differences seen between ANX-Al", and ANX-Al' mice in 
terms of low dose PAF-induced cell recruitment. 
e Zymosan-induced Inflammation 
As data obtained from the flow cytometry experiments demonstrated that ANX-Al' 
mice were more sensitive to inflammation in the zymosan peritonitis model it was 
decided to next study the effect of this stimulus in the cremaster muscle preparation. 
This stimulus has been used previously in intravital studies in both the mesentery (Lim 
et al., 1998) and the cremaster muscle (Young et al., 2004). As the response to 
zymosan had previously been characterised (Young et al., 2004) the dose of zymosan 
(30 [tg) and time-point (6 hr) were chosen for this study. A new technique was 
incorporated into the intravital procedure whereby the zymosan injected was 
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fluorescently labelled so that the emigrated cells could be examined for assessment of 
the degree of phagocytosis. 
0 Leukocytes emigrate further in ANX-Al-- mice compared to the ANX-A]*'*. No 
difference in phagocytosis between genotypes is observed. 
A pilot study was caffied out to study the effect of zymosan on both leukocyte 
emigration and phagocytosis. These parameters were quantified as per field of view 
and showed a significant increase in cell emigration in the ANX-AI-1- mice compared 
to the ANX-Al' animals. These data correlate well with the flow cytometry 
experiments showing that the ANX-AI4- mice respond to zymosan with exaggerated 
leukocyte recruitment. 
Recent data (Yona et al., 2004) has shown that macrophages from ANX-AI4- mice 
have a 'frustrated' phagocytosis whereby although they do phagocytose zymosan 
particles it takes them longer to do so. A reduction in phagocytosis was found in ANX- 
AV- macrophages although this was only seen with non-opsonised zymosan and not 
when opsonised zymosan was used (Yona et al., 2004). So it was decided that the 
novel model of Young and colleagues would be ideal to measure phagocytosis in vivo 
and see if there were inherent differences between the ANX-Al"' and the ANX-Al-- 
animals with respect to neutrophil phagocytosis (Young et aL, 2004). However, the 
extent of phagocytosis of zymosan particles was not found to differ significantly 
between the ANX-Al+'+ and the ANX-AI4-. These data may show that although ANX- 
At is involved in the macrophage phagocytosis process it is might not be involved in 
neutrophil phagocytosis. Alternatively the data obtained may substantiate the previous 
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study because in that study differences were not found between ANX-AI-1- and ANX- 
Al"' macrophages with respect to opsonised zymosan phagocytosis (Yona et A, 
2004). It is likely that in the experimental conditions in this study, being injected 
zymosan would be opsonised thus cancelling the potential difference between the 
genotypes. It should also be noted that a 'frustrated' phagocytosis was reported in 
ANX-AI4- macrophages and since zymosan was eventually phagocytosed it is also 
possible that the time-point used to determine neutrophil phagocytosis might have been 
too late to show differences in phagocytosis. 
* Cell flux, rolling, adhesion and emigration directly next to the vessel wall induced 
by zymosan are not significantly different between genotypes 
Since a different protocol was used for the cremaster muscle studies in Dr. S. 
Nourshargh's laboratory, it was deemed necessary to replicate the experimental model 
using a protocol similar to that applied for the PAF experiments. In this manner cell 
flux and rolling velocity, cell adhesion and cell emigration close to the vessel wall 
could be monitored. Local injection of zymosan was given into the scrotum and after 6 
hr a significant inflammatory response was seen in the ANX-Al"' mice with a 
significant increase in cell adhesion and emigration. No significant changes in 
response to zymosan treatment with respect to cell rolling velocity or cell flux were 
evident at this time-point which is in line with a previous study (Young et aL, 2004). 
This response was also seen in the ANX-AI-1- mice and no significant differences were 
found between the genotypes with respect to any of the parameters measured. This 
includes cell emigration which had been shown previously, in the pilot study, ' to be 
significantly higher in the ANX-AI4- mice than the ANX-AI*" mice. As in the first 
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study emigration was measured per field of view and not measured directly next to the 
vessel wall, the idea emerged that in the ANX-Al' mice there is an increased 
movement of emigrated cells further into the surrounding tissues. So using a method 
previously validated (Tailor et aL, 1997) cell emigration was assessed at different 
distances from the vessel under analysis. It was then observed that, in the ANX-A I' 
mice, the numbers of cells that had emigrated into the tissue decreased significantly the 
further from the vessel wall the measurement was made. In the ANX-Al' cells had 
emigrated further before the numbers decreased significantly from the initial 
emigration seen directly next to the vessel wall. Thus, ANX-Al' neutrophils likely 
have an increased movement into the sub-endothelial tissues/space. 
Previous intravital studies along with data produced in this thesis have shown that 
administration of the ANX-Al mimetic peptide, Ac2-26 has no effect on rolling 
velocity whilst still being able to reduce cell adhesion (although not in the cremaster) 
and emigration (Gavins et al., 2003; Lim et al., 1998). Emigration is altered in the 
ANX-AV- mice compared to the ANX-Al" with no difference in rolling and adhesion 
seen. As rolling is predominantly mediated by the selectin family of adhesion 
molecules the lack of effect of Ac2-26 on rolling suggests that ANX-Al is unlikely to 
exert its anti-inflammatory activities by action on selectin expression and/or function. 
However, recent investigations have suggested another role for L-selectin, that is 
modulation of some of the inflammatory events downstream of rolling, i. e. emigration 
and extravascular locomotion (Hickey et al., 2000). During PAF-induced 
inflammation of the mouse cremaster muscle, the absence of L-selectin (L-selectin' 
animals) reduces leukocyte emigration without effect on leukocyte rolling or adhesion. 
The leukocytes that did emigrate in the L-selectin4- mice did not travel as far into the 
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extravascular tissue as wild type leukocytes, even though they were travelling at a 
similar velocity. This was the case for both non-directional locomotion (induced by 
PAF or KC superfusion) and also for directional chernotaxis (induced by controlled 
release of KC in the cremaster) (Hickey et aL, 2000). It seems, therefore, that L- 
selectin may also have a role in leukocyte emigration and extravascular locomotion. 
It has been noted that GC can induce L-selectin shedding form peripheral blood 
neutrophils (Jilma et al., 1997). It is possible that this may be one mechanism by 
which GC inhibit neutrophil recruitment in vivo. However, GC have not been shown to 
directly cause L-selectin shedding. DEX applied to human peripheral blood does not 
alter L-selectin expression whereas ANX-Al does induce a dose-dependent decrease in 
L-selectin expression on blood neutrophils and monocytes (Strausbaugh & Rosen, 
2001). Blocking L-selectin shedding (using a sheddase inhibitor) attenuates the ANX- 
Al. decrease in L-selectin expression (Strausbaugh & Rosen, 2001). So ANX-Al may 
be a mediator for GC-induced L-selectin shedding in vivo, and this may be at least one 
of the mechanisms responsible for the regulation of the inflammatory response exerted 
by endogenous ANX-A I. To look more closely at the role of L-selectin shedding, the 
process can be blocked using inhibitors or by using mice with mutant versions of L- 
selectin. In a model of L-selectin dependent rolling in the cremaster intravital model 
(TNF-a stimulated E/P-selectin-- mice), the blockade of L-selectin shedding was 
achieved using a hydroxamic acid derivative, KD-IX-73-4 (Hafezi-Moghadam et al., 
2001). The rolling velocity of leukocytes was reduced and cell adhesion and 
emigration increased. In addition to this, leukocytes were more activated. This group 
suggested that by blocking the continuous L-selectin shedding that occurs in vessels 
leads to less jerky leukocyte rolling which in turn allows cells to be in closer contact 
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with the endothelium and inflammatory signals so this leads to increased activation, 
adhesion and emigration (Hafezi-Moghadam et aL, 2001). Another study used gene- 
targeted mice which express modified L-selectin resistant to cleavage. These mice had 
increased numbers of neutrophils migrating into the peritoneal cavity in response to 
thioglycollate challenge and the response was prolonged, i. e. numbers of leukocytes in 
the cavity were still high after 24 hr (whereas in the wild type mice the numbers were 
decreasing) (Venturi et al., 2003). These results indicate that L-selectin cleavage and 
shedding is not an absolute requirement for emigration but also that in the absence of 
L-selectin shedding the density on cells is increased or maintained and this facilitates 
the entry of neutrophil to the peritoneal cavity. The shedding of L-selectin may be a 
physiological process that regulates leukocyte recruitment such that it dampens down 
the inflammatory response. When exogenous ANX-Al is administered it may cause or 
increase the degree of L-selectin shedding, however cells may not be committed to 
emigration and so they detach (Gavins et al., 2003; Lim et al., 1998) and in this way 
leukocyte recruitment could be reduced. The removal of the ANX-Al gene in the 
ANX-AI-'- mice could mean that there is an absence or reduction in Lselectin shedding 
in response to inflammatory stimuli and this may be functionally linked to the greater 
degree of cell extravasation observed these animals. 
Another related point is that L-selectin4- mice have reduced emigration and reduced 
movement from the vessel wall into the extravascular tissues (Hickey et al., 2000). If 
ANX-Al is involved in patho-physiological L-selectin shedding, then the cells of the 
ANX-AI'4- mice would have a lower degree of L-selectin shedding so the emigrating 
leukocyte would have a greater density of L-selectin on their surface. In fact, higher 
levels of L-selectin have been reported on peripheral blood neutrophils and monocytes 
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taken from ANX-Al' mice (Hannon et al., 2002). This could lead to an effect 
opposite to what is seen in the Lselectin4- mice, i. e. there may be an increased 
movement of emigrated cells and so they move further from the vessel wall. This 
could begin to explain some of the results obtained in this thesis. Data obtained from 
zymosan-induced inflammation of the cremaster muscle showed no significant 
difference between the ANX-AI*"' and the ANX-AI4- mice with respect to cell 
emigration when it was measured directly next to the vessel wall. However, when 
emigration further into the tissue was analysed a significantly higher number of 
emigrated cells were found in the ANX-Al' mice compared to the ANX-Al"' mice. 
This may be due the higher L-selectin density on the surface of ANX-AI-1- cells (due to 
the fact that ANX-Al is not present to induce/increase L-selectin shedding) causing the 
cells to emigrate further from the vessel wall. This may also explain why a greater 
difference was seen when inflammation was induced using I nM PAF but not with 100 
nM PAR The higher dose of PAF may induce more emigration than the lower dose 
but as cells from the ANX-AI-1- animals have higher L-selectin levels (as ANX-Al not 
present to increase shedding) they may have emigrated further from the vessel. 
However, these differences may not be seen between genotypes when cell emigration 
was assessed immediately adjacent to the vessel wall. In the case of I nM PAF, as this 
was a milder stimulus the cells would take longer to emigrate, and at the time-points 
examined the cells were still close to the vessel and so a difference was found between 
genotypes. Figure 4.2. is a simple summary of these ideas. This scheme highlights the 
importance of the time frame during which the mice are examined. Differences 
obviously exist between the genotypes as has been shown with I nM PAF and zymosan 
but there may be certain times where greater differences between genotypes will be 
detected and other times where no differences will be found. Future assessment of 
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ANX-Al inhibitory (anti -m i gratory) properties in genetically modified mice (mice 
deficient in L-selectin or with an uncleavable version of L-selectin) would be of great 
help to test this hypothesis. 
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Figure 4.2. ANX-Al and L-selectin shedding. Simple summary diagram 
to explain suggestion that ANX-Al-induced shedding of L-selectin could 
regulate leukocyte recruitment during inflammation. 
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0 Peptide Ac2-26 reduces cell emigration in the FPR-1- mice although not to the same 
extent as in C57BIJ6 (wild type) mice 
A final study was carried out to investigate the role of FPR in the effect of the peptide 
Ac2-26 on the leukocyte-endothelial cell interactions in the PAF-inflamed cremaster 
muscle preparation. Much interest in the ANX-Al f ield derives from the identification 
of the ANX-Al receptor. Recent work in the literature suggests that members of the 
FPR family might mediate the anti-inflammatory action of ANX-Al and its peptides 
(Perretti et al., 2002; Walther et al., 2000). Also a model of I/R in the mesentery 
showed that FPR-'ý mice are less sensitive to the effects of Ac2-26 (Gavins et al., 2003). 
In the C57BU6 mice (wild type), peptide Ac2-26 reduced cell adhesion and emigration 
induced by I/R back to the levels seen in sham operated animals. In FPR' mice the 
levels of cell adhesion and emigration were significantly reduced compared to vehicle, 
although not back to sham levels; this indicates that FPR is only partially involved in 
mediating the effect of Ac2-26 in the mesentery. The data presented in this thesis show 
that the peptide Ac2-26 can significantly reduce the degree of 100 nM PAF-induced 
cell emigration in both the FPR: "- and C57BU6 wild type mice. In line with the 
previous study emigration in the C57BU6 mice is reduced to basal levels and, although 
it is reduced in the FPR' mice, emigration is not completely blocked. This supports the 
notion that FPR whilst important is not the sole receptor responsible for the anti- 
inflammatory actions of ANX-Al. In contrast to the previous study however, cell 
adhesion seems to be unaffected by the addition of exogenous Ac2-26 (even though a 
higher dose was used here). The effect of the peptide seems to be dependent either on 
the vascular bed examined or the inflammatory stimulus used. This conclusion is 
clearly in line with that observed for native ANX-Al. Another recent study that 
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illustrates this point well is the effect of peptide Ac2-26 in a model of heart I/R in the 
rat. I/R of the heart produces significant damage to the heart ventricle and this could be 
reduced by the administration of peptide Ac2-26 given after the reperfusion period. 
None of the doses of peptide tested managed completely to reverse the damage levels 
back to sham levels. To assess the potential role of FPR in the protective effects of 
Ac2-26, the FPR antagonist Boc2 was used. Boc2 significantly reversed the actions of 
Ac2-26 reinforcing the proposal that ANX-Al peptides interact with FPR (La el al., 
2001). A similar finding is made in the mouse model (Gavins et al., 2004), that is, 
Ac2-26 is protective in heart I/R and these effects are blocked by the FPR antagonist, 
Boc2. However, this study looked more in depth at the role of FPR by using mice 
deficient in this receptor (FPR-'ý mice). The same protective effect of Ac2-26 was also 
seen in these mice indicating that the FPR is not the receptor responsible for the effects 
of ANX-A I in the heart model. In the case of heart I/R different results are obtained to 
those from I/R of the mesentery where complete inhibition by peptide Ac2-26 is seen 
and a partial role for FPR can be found. This is another case of tissue specific actions 
of peptide Ac2-26, which may be linked to the receptor expression in different tissues. 
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4.3. Conclusion 
In summary, this study has found; 
Peritonitis induced by zymosan-, but not IL-lp-, in the ANX-Al' mice leads to higher 
levels of inflammatory cell recruitment, i. e. more inflammation, at the 4 hr time-point 
than in the ANX-Al"' mice. 
Male ANX-AITG mice show reduced cell recruitment, in response to 4 hr zymosan 
peritonitis. This is effectively the opposite result to that obtained in the ANX-Al' 
mice. This pattern is however not seen in female mice. 
In the mouse cremaster muscle peptide Ac2-26 can effectively abolish cell emigration 
induced using 100 nM PAF superfusion, with no effect on cell adhesion or rolling. 
ANX-AV- mice have a significantly higher cell emigration in response to 1 nM PAF 
superfusion as measured by the intravital microscopy studies in the cremaster muscle 
with no differences being found in cell rolling or adhesion. Basal leukocyte 
recruitment and inflammation induced by a higher concentration of PAF (100 nM) are 
not significantly different between the ANX-A 14- and ANX-A 1'4' mice. 
Local injection of zymosan causes a similar effect on cell rolling velocity, increase in 
cell adhesion and initial cell emigration in the cremaster muscle preparation in both 
genotypes however, in the ANX-AI4- there is an increased movement of emigrated 
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cells from the blood vessel. No difference in phagocytosis by emigrated cells in ANX- 
A 1'4' and ANX-A 14- mice was seen. 
Peptide Ac2-26 can reduce, but not abolish, cell emigration in the cremaster muscle of 
FPRt mice inflamed with 100 nM PAF suggesting FPR is not the sole receptor 
responsible for the anti-inflammatory actions of ANX-Al. The peptide does not affect 
cell rolling or adhesion in this model. 
Data obtained in this thesis have helped to dissect out the role of endogenous ANX-Al 
in inflammatory conditions and add considerably to the few data so far obtained in the 
newly generated ANX-Al' mice. It seems the effect of removal of the ANX-Al gene 
is not as striking as may have been expected from the many previous studies using 
exogenous ANX-Al and its peptido-mimetics. What has become clear is the role of 
endogenous ANX-A I as a modulator of inflammation, although careful choice of time- 
points and inflammatory agents are needed to unmask this action. 
Findings made in this study clearly need further investigation and this could form the 
basis of further PhD studies in the department. Important experiments would be to 
deduce further the actual mechanism by which ANX-Al is modulating the 
inflammatory response. An example for future experiments could be the examination 
of the role of ANX-Al in mice which are deficient in L-selectin to test further the 
hypothesis that ANX-Al induced L-selectin shedding could be involved in the 
recruitment of leukocytes to the site of inflammation. Also future experiments could 
make more use of the newly developed ANX-AITG mice. 
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Importantly, during the completion of this PhD a number of new techniques have been 
introduced into our laboratory including the flow cytometry protocol as an accurate and 
objective method to analyse cell recruitment into the peritoneal cavity. More 
importantly perhaps is the introduction of the cremaster muscle preparation for 
intravital microscopy which mean that these experiments can now be carried out on 
older mice and for longer periods of time than were possible in the mesenteric 
preparation which was previously used. 
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